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ABSTRACT 
The serine proteinase inhibitor (serpin) gene superfamily encodes a large group of pro-
teins with diverse biological functions. The best characterised serpins are inhibitors 
found in mammalian serum. These modulate the proteolytic cascades responsible for 
fibrinolysis, tissue degradation and the inflammatory response. X-ray crystallograpy 
analysis indicates that an inhibitor presents an external peptide loop, the reactive centre, 
to its target proteinase during inhibition. The loop resembles an ideal substrate, but is 
cleaved relatively slowly. Synthetic or spontaneous mutations in the reactive centre 
region often alter the proteinase specificity of the inhibitor, without affecting the innate 
inhibitory mechanism. 
A subfamily of rodent serpins, the Spi-2 genes, were previously shown to have 
undergone accelerated evolution in their reactive centre coding sequences. This may have 
been due to positive Darwinian selection for resistance to parasitic proteinases secreted as 
virulence factors. This project involved attempts to characterise the mode and tempo of 
this evolutionary phenomenon. 
An RNA sequencing technique was developed to analyse reactive centre sequence 
divergence of an Spi-2 gene, contrapsin, in mouse species closely related to Mus domes-
ticus. This indicated that the contrapsin reactive centre stabilised and became fixed for a 
specific inhibitory function following a period of rapid divergence during murid radia-
tion. Analysis of two closely related rat Spi-2 genes suggests that non-synonymous point 
mutations may be the main mechanism of reactive centre sequence divergence. 
A number of Spi-2 genomic sequences were isolated from inbred mouse strains. 
Analysis of these showed that the mouse Spi-2 locus consists of at least twelve closely 
linked genes, all with distinct reactive centres. Sequence analysis of the genes confirmed 
the previous observation that the reactive centre region is hypervariable in this gene fam-
ily. No obvious structural peculiarity of the genomic sequences which could account for 
the reactive centre divergence was observed. The amplification of the Spi-2 locus in the 
genus Mus appears to have been a recent and relatively complex process. A potential 
candidate for the primordial Spi-2 sequence was characterised at this stage. 
Cloning and analysis of expressed Spi-2 genes in the mouse revealed expression of 
novel Spi-2 transcripts in the liver and in a chondrocytic teratocarcinoma cell line. The 
reactive centre of one cDNA sequence closely resembles that of a human serpin from a 
separate subfamily. An Spi-2 transcript showing several similarities to the unique human 
Spi-2 gene, al-antichymotrypsin, was also isolated and may represent the functional 
rodent equivalent. In situ hybridisation to 16-day mouse embryos confirmed Spi-2 
expression in cartilage, suggesting previously unsuspected functions for the duplicated 
genes. The isolation of two distinct Spi-2 subtypes from three separate rodent species 
suggests a model for the evolution of the Spi-2 family during rodent radiation. 
In conclusion, the work described in this thesis confirms and extends the previous 
observations of serpin reactive centre hypervari ability in rodents, and demonstrates that 
this process may be evolutionarily punctuated for expressed sequences. The mode of 
divergence appears to be mainly by non-synonymous point mutations, although closely 
linked divergent reactive centres suggest a potential role for restricted sequence conver-
sion events. The process of acquisition of novel reactive centre specificities may be 
ongoing in the genus Mus, and is probably linked to gene duplication events. 
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The term protease has been used for almost a century to describe enzymes which 
hydrolyse peptide bonds (Hedin, 1903). This vast group of., molecules has since been 
divided into the Endopeptidases (or Proteinases) which cleave peptide bonds within ami-
noacid polymers, and the Exopeptidases which can only remove residues from, or cleave 
bonds close to, the ends of polypeptides. Proteinases can in turn be subdivided into four 
groups (Hartley, 1960) on the basis of their catalytic mechanisms. Originally these were 
defined as the serine, thiol, acid and metal proteinases; this grouping has become slightly 
amended to the serine, cysteine, aspartic and metallo proteinases, respectively (Barrett, 
1980). Examples of each class have been sequenced at the protein level and their struc-
ture determined by X-ray crystallography. 
Certain structural features are common to all four groups. The catalytic cleft lies 
along the surface of the enzyme. The target peptide sequence lies along this cleft during 
cleavage, and residues lining the cleft are important in determining which peptide 
sequences are bound and cleaved. This has given rise to a terminology for substrate-
binding subsites, and their complementary substrate residues (Berger and Schlechter, 
1970). Residues in the substrate are numbered P1, P2, P3 in an amino terminal direction 
away from the peptide bond cleaved by the proteinase. Residues towards the carboxyl 
end are numbered P1', P2', P3', etc. Sites responsible for binding the substrate in the 
enzymes cleft are numbered Si, S2, S3 towards the substrate amino terminus, and Si', 
S2', S3' towards the carboxyl end. 
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Each type of catalytic mechanism may have arisen more than once during evolu-
tion. Where this is the case, and it is established for at least the serine and cysteine pro-
teinase families, one subfamily appears to have been more successful than the others and 
is consequently more widely dispersed. The classic example is that of the chymotrypsin 
and subtihisin superfamilies in the serine proteinases. Examples of the chymotrypsin 
superfamily have been found in most major prokaryotic and eukaryotic groups, whereas 
subtilisin related enzymes have only been found in bacteria. The two groups have 
acquired a very similar catalytic mechanism by convergent evolution (Hartley, 1970). 
The mechanism used by the serine proteinases has now been fairly well esta-
blished. The critical serine residue, Ser-227 in chymotrypsin, was shown to be esterified 
by diisopropyl fluorophosphate when this compound inactivated chymotrypsin (Hartley, 
1960). Similar experiments demonstrated the importance of a histidine residue, His-60. 
The hydroxyl group of the serine residue appears to attack the carbonyl carbon atom in 
the peptide substrate, giving a tetrahedral intermediate. The histidine residue supplies a 
basic environment to facilitate the reaction. Breakdown to an acyl-enzyme and release of 
an alcohol or amine is followed by water-mediated hydrolysis of the acyl-enzyme com-
plex to yield enzyme and products. The Asp-102 residue was at one time considered to 
have an essential role in the process, forming the "charge-relay" system, but the 
discovery of serine proteinases which do not possess an appropriate aspartate residue 
now challenges this view (Lazure et al., 1984). 
Serine proteinases have a huge range of specificities. As mentioned above, residues 
lining the catalytic groove dictate the nature of substrate peptides bound, and the extent 
of the interactions depends upon the particular proteinase. In general, sites towards the 
amino terminus of the active site are more important in serine proteinases. An example 
is trypsin, which has an absolute requirement for an arginine or lysine residue in the 
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substrate at the P1 position. Trypsin will hydrolyse most peptides at these residues, as 
would be expected for a broad range digestive enzyme. However, many other serine pro-
teinases which also cleave at basic 'residues have developed increased specificity in the 
S2 and S3 positions, thus restricting their potential target range and refining their role. 
This can result in enzymes which will cleave only one or a few particular peptide bonds 
in vivo. An extreme example is nerve-growth-factor y-subunit endopeptidase which has 
no general proteolytic activity and is specific for nerve growth factor proprotein cleavage 
(Berger and Shooter, 1977). Other groups of serine proteinases show specificity for 
cleavage at large hydrophobic P1 residues such as tryptophan and phenylalanine (eg the 
chymotrypsin family), or small aliphatic P1 residues such as valine and alamne (eg the 
elastase family). Again, these specificities may depend largely upon the P1 residue, or be 
attenuated by the surrounding substrate sequence 
Protein Inhibitors of Serine Proteinases 
Inhibitors of proteinases in vivo are normally proteins which act by binding tightly 
to the catalytic cleft as a potential substrate, but only being cleaved very slowly. 
Described kinetically, a typical enzyme:inhibitor interaction will have a very high 
kc /Km  typically 104 to 106  moles/second, indicating that the inhibitor is an excellent 
substrate. However, both k cat  and KM  have values several orders of magnitude lower '  
than typical substrate cleavages, making the hydrolysis of the reactive site bond 
extremely slow (Laskowski and Kato, 1980). Examinations of the factors which retard 
cleavage have employed extensive X-Ray crystallographic analysis of inhibitor:proteinase 
complexes and of the isolated components (Read and James, 1986). These have demon-
strated that, as expected, most inhibitors have a reactive centre (the polypeptide loop 
containing the P1 residue) complementary to the catalytic cleft of their target enzyme. 
They also possess rigid structures, presenting the reactive centre region as an exposed 
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loop, the degree of inhibitor rigidity increasing with increasing target specificity. This 
rigidity is often contributed by multiple disulphide bonds in the smaller inhibitors, but 
can be attained by other structural means, such as extensive p-pleated sheet structure 
around the reactive centre loop. At least ten families of protein inhibitors of serine pro-
teinases have been characterised and some typical examples will be described. 
The Kunitz Inhibitor Family 
The pancreatic trypsin inhibitor (Fr!, also described as Kunitz) family contained 
the first inhibitor to be characterised and sequenced, and its structure, free and in com-
plex, studied by X-ray crystallography (Kunitz and Northrop, 1936; Huber et al., 1974). 
Bovine FF1, the most studied example, is a small inhibitor (58 amino acids) found in 
most bovine organs. Its reactive site contains Lys-Ala at the Pi-Pi' position, and as 
expected it is an efficient trypsin inhibitor. The 3D structure of PT! in complex with 
bovine trypsin, trypsinogen, and kallikrein has been determined (Read and James, 1986). 
The inhibitor is pear shaped, with the reactive site on an exposed loop at the narrow end 
of the molecule. The loop conformation is not radically altered during complex with pro-
teinase; the reactive site loop and catalytic cleft fit one another in a classical "lock and 
key" fashion. PT! contains three disulphide bonds which help to stabilise a small hydro-
phobic core region, and a n-pleated sheet region is located immediately to the carboxyl 
side of the reactive site loop region. Members of the PTI(Kunitz) family have been 
found in mammals, reptiles, molluscs and sea anemones; the family may predate the 
radiation of multicellular organisms (Laskowski and Kato,1980). Examples exist of tan-
demly repeated copies of P'fl (Kunitz) subunits within larger proteins; eg inter-a-trypsin 
inhibitor, a protein of 160,000 kD,' which contains two FF1-like inhibitor domains (Morii 
and Travis, 1985). In the case of the Red Sea turtle egg-white inhibitor, chelonianin, the 
first of two tandemly linked inhibitor domains is a typical FrI (Kunitz) structure, while 
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the second is unrelated, and may represent a new inhibitor family (Kato et al., 1980). 
The Kazal Inhibitor Family 
A second very large inhibitor family is the Pancreatic Secretory Trypsin Inhibitor 
(Kazal) [PSTI(Kazal)] family. Examples of this have also been well characterised by 
sequencing and X-ray crystallography (Kazal et al., 1948; Weber et al., 1981). This 
inhibitor looks quite different from the FF1 (Kunitz) family, forming a wedge-shaped 
disc, with the reactive site at the narrower edge. As in FF1 there are three disulphide 
bonds, but they are in nonhomologous positions. Despite an entirely different tertiary 
structure, the reactive site loop of PSTI is very similar in its conformation to that of FrI. 
Studies of enzyme inhibitor complexes show that the loops of both families contact the 
proteinase catalytic cleft in a very similar manner; a clear case of two different structural 
solutions to a biological problem (Read and James, 1986). The PSTI (Kazal) family is 
also an ancient one, predating vertebrate radiation, with examples in leeches (Krejci and 
Fritz, 1976). 
Several other families of small inhibitors have been described, each apparently 
unrelated (at least by recent evolutionary descent) to the others (Laskowski and 
Kato,1980; Read and James, 1986). They share the common characteristics of the FF1 
(Kunitz) and PSTI (Kazal) families: defined secondary structure despite their small size, 
presence of a reactive centre loop at the surface of the molecule, frequent tandem repeti-
tion of inhibitor units within a larger protein, and retention of activity (though against 
novel proteinase targets) despite substitution of the P1 residue by chemically different 
amino acids. 
The Serine Proteinase Inhibitor (Serpin) Supe,family 
A mechanistically distinct class of inhibitors, first characterised in mammalian 
plasma, displays several differences from the numerous families of small inhibitors 
described above (reviewed in Travis and Salvesen, 1983). These inhibitors are consider-
ably larger (about 400 amino acids), with a single inhibitory site, and do not occur as 
repetitive subunits within a protein. Unlike classical (small) inhibitors, they do not obey 
the equilibrium reaction; upon cleavage they become completely inactivated as inhibitors. 
They also appear to form a covalent bond with the proteinase during complex formation; 
this structure is resistant to SDS or urea treatment. It is not clear whether this bonding 
occurs during complex formation, or as a result of denaturing agent treatment Irreversi-
ble modification of the serpin molecule by proteinase, accompanied by active proteinase 
release, occurs in many instances. This often occurs with greater efficiency during 
interactions between non-cognate inhibitors and proteinases. 
Isolation and partial amino acid sequencing of two inhibitors, al-antitrypsin and 
antithrombin III, and a third protein, chicken ovalbumin, revealed that all three were 
related to one another. The three proteins had apparently diverged some 500 million 
years ago (Hunt and Dayhoff, 1980), and formed the first characterised members of a 
novel protein superfamily, the serp ins (serine proteinase inhibitors). Several other inhibi-
tors from mammalian serum were rapidly characterised at the DNA level, and it has 
become clear that the serpins form a very large, complex family, with a convoluted evo-
lutionary history (Carrell et al., 1987). Proteins from several unexpected sources have 
been found to be members of the serpin family, some of them, like ovalbumin, with no 
detectable inhibitory activity towards any serine proteinase. The recent report of a inhibi-
tory serpin in an insect raises the question of how ancient the family really is (Kanost et 
al., 1989). Before examining some facets of the evolutionary behaviour of the family, 
the biology of the most studied serpin, al-proteinase inhibitor (al-PI, formerly Cd-
antitrypsin) will be described in more detail. 
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al-Proteinase Inhibitor - the Archetypal Serpin 
al-Proteinase Inhibitor is a globular serum protein of 394 amino acid residues 
(Carrell et al., 1982). It is primarily synthesised in the liver parenchymal cells, where it 
forms a substantial fraction of the mRNA population (05%). It is a major component of 
plasma ( 3mg/mi), only less abundant than albumin and the immunogiobulins.The phy-
siological role of al-PI is thought to be the inhibition of neulrophil elastase, with which 
it forms a highly stable complex (k ass = 10 sec in vitro, the most rapid 
serpin/proteinase association rate known. [Travis and Salvesen, 1983]). It also inhibits 
a wide range of other proteinases, and may play a significant secondary role in vivo in 
the control of certain physiological proteinases, in addition to neutrophil elastase 
(Heidtmann and Travis, 1986). The primary function of al-PI appears to be the preven-
tion of uncontrolled degradation of elastin fibres, especially in the lung, by neutrophil 
elastase. Mutations in the al-Fl gene, or conditions in which inhibitor levels are reduced 
(eg smoking-induced al-PI oxidation), cause pulmonary emphysema (Laureil and Eriks-
son, 1963). A number of bacterial and other non-serine proteinases rapidly inactivate 
al-PI as an ideal substrate (Johnson et al., 1986). This involves a single cleavage in the 
reactive centre region causing irreversible inactivation, with no detectable inhibition of 
the proteinase. 
Several mutations of the human al-PI gene have been described (Carrell et al., 
1989). The majority of these, which abolish or drastically affect correct translation and 
folding of the protein, tend to give rise to a phenotype of emphysema of variable sever-
ity. Mutations affecting glycosylation also occur, with altered proteins being 
inefficiently secreted from the liver and causing liver cirrhosis as a second symptom 
(Jeppsson, 1976). All of these types of mutation tend to give a classical null effect for 
the mutated allele. However a second class of al-PI mutants exists. These are mutated 
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at the P1 residue, altering the target proteinase specificity of the inhibitor, but not the 
structural ability of the protein to efficiently inhibit a proteinase. The classic example for 
al-PI is the Pittsburgh mutation (Owen et al., 1983). The normal P1 residue in al-PI is 
methionine, an amino acid most efficiently recognised by elastase. In al-PI Pittsburgh, 
the methionine residue has mutated to arginine, altering the specificity of the inhibitor 
towards the tryptic proteinases. The inhibitory efficiency of al-PI Pittsburgh towards 
elastase was decreased by four orders of magnitude, while inhibition of trypsin-like pro-
teinases (thrombin, plasmin, kallikrein) increased to the same degree. A normal (cxl -P1) 
level of expression of the mutant, coupled with the new specificity, would be expected to 
cause major physiological effects. In fact the individual with this mutation suffered from 
an eventually fatal inability to form blood clots, due to the inappropriate antithrombin 
activity of al-PI Pittsburgh. This ability of the serpins to undergo complete change of 
proteinase specificity, via mutation of the P1 residue, without losing the general struc-
tural features which cause anti-proteinase activity, is very similar to that of the smaller 
inhibitor molecules discussed above (Laskowski and Kato, 1980). 
A number of studies have been carried out to examine the effect of site-directed 
mutation of the P1 residue on target specificity (Rosenberg et al., 1984; Courtney et al., 
1984; Jallat et al., 1986; Holmes et al., 1987). These have confirmed that the primary 
determinant of an inhibitor's proteinase specificity is the P1 residue, and that this can be 
modified in a predictable manner, without loss of innate inhibitory activity. Mutants with 
"improved" al-PI activity have been produced, replacing methionine with leucine or 
valine. These proteins retain very similar biochemical specificity to al- P1, but are not 
susceptible to the methionine oxidation and consequent inactivation thought to occur in 
smoking-induced emphysema. They may prove to be useful therapeutic agents for 
emphysema sufferers (Carrell and Travis, 1985). 
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Tertiary Structure of Serpins 
Attempts to characterise the three dimensional structure of the serpins have not 
been very successful. Intact, unmodified, inhibitor crystals have proved difficult to pro-
duce, despite several attempts. The reason for this may be that the intact serpin structure 
is in a highly stressed conformation. One line of evidence which supports this theory 
comes from successful crystallographic analysis of elastase-cleaved al-PI (Loebermann 
et al., 1984) which revealed that the P1 methionine and P1' serine residues lie at oppo-
site ends of the molecule, about 70 Angstroms apart. A representation of the structure is 
shown in Figure 1.1. Since these residues would be adjacent in native (unmodified) inhi-
bitor, it is clear that a major conformational change has occurred in the protein as a 
result of proteinase:inhibitor interaction. 
Attempts to crystallise ovalbumin, a distantly related serpin, have also proved 
difficult, except for proteinase-treated ovalbumin, plakalbumin (Wright, 1984). The struc-
tural instability of intact serpins may prove to be the rule for most family members. 
However there are preliminary reports of the production of native antithrombin III cry-
stals (Correll et al., 1987), but these have not yet yielded detailed structural data. There 
are no known reports of X-ray analysis of serpin:proteinase complexes. 
The al-PI X-ray analysis (Loeberman et a!, 1984), revealed other notable features 
of the tertiary structure. Flanking the reactive centre loop are two highly conserved 
regions of amino acid sequence. These form two well defined strands of -pleated sheet 
in two of the three f3-sheets in the protein. 
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Figure 1.1 Representation of the three dimensional structure of modified al-PI (Loeber-
mann et al., 1984). a-helices are shown as cylinders, and n-pleated sheet strands as rib-
bon arrows. The residues. Met-358 and Ser-359 which comprise the PI-P1' residues are 
indicated by asterisks at opposite ends of the modified molecule.The -barrel structure 
discussed below is the cup-like structure at mid-left of the molecule, formed by the two 
minor n-sheets and surrounding a- helices. 
IZ 
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The reactive centre region itself forms a strand of the major n-sheet A in the modified 
inhibitor, but presumably exists as a surface loop in the native molecule. This flanking of 
the reactive centre by defined secondary structure is also reminiscent of the small inhibi-
tor families, and may echo the requirement for a stressed conformation in the bait 
region. 
The concept of two forms of serpin, stressed (S) and relaxed (R) has been 
developed by Carrell and others (Carrell and Owen 1985; Carrell et al., 1987, Bruch et 
al., 1988). Considerable increases in the heat stability of a number of serpins occur fol-
lowing proteolytic modification of the reactive centre, presumably due to rearrangements 
similar to the one which occurs in modified al-PI. The modified R form:proteinase com-
plex may exhibit novel epitopes to enable clearance of complexes from the circulation by 
specific receptors (Pizzo et al., 1988), and may also play a role in localised hormone 
release by certain serpins (Pemberton et al.,1988, and see below). This overall view of 
serpin structure, passing from a strained intact inhibitor to a relaxed, irreversibly inac-
tivated, modified form, has been challenged recently (Gettins 1989). Nuclear magnetic 
resonance studies of proteolytically modified ovalbumin showed no marked conforma-
tional change from the, intact state upon cleavage. Gettins suggests that the major change 
seen in some serpins may. be due to disruption of internal salt bridges exposed by 
cleavage of the reactive centre loop rather than to the direct release of a strained confor-
mation by loop cleavage. 
Another feature of the cleaved al-PI structure is the existence of a a-barrel struc-
ture at one end of the molecule. This is formed by the two n-sheets not containing the 
cleaved reactive centre strand, and can be seen at the mid-left of the molecule in Figure 
I.I. The barrel structure is surrounded by most of the basic residues in the molecule, 
and echoes the n-barrel structures found for example in transthyretin, a major plasma 
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thyroxine-binding protein (Blake et al., 1974). An indication that this structure may be 
involved in hormone transport in some serpins is presented below. 
The Diversity of Serpin Function 
Most serpins characterised to date have a defined anti-proteinase activity, which in 
several cases had been defined biochemically before the advent of gene cloning. Most 
characterised mammalian serum inhibitors belong to the serpin superfamily. However 
several serpins have been found in unexpected roles. 
The rat glia-derived neurite-promoting factor (GdNPF)is a 43kD glycoprotein 
involved in neurite outgrowth and displays inhibitory activity to several serine protei-
nases. Cloning of the gene by hybridisation-selected translation revealed that GdNPF 
was a serpin, with 25 - 40 % identity to other mammalian inhibitors (Sommer et al., 
1987). The action of GdNPF in promotion of neurite extension is shared by other seririe 
proteinase inhibitors (including synthetic tri-peptides), but other effects of GdNPF, such 
as peripheral nervous system regeneration, granule cell neuron migration, and astrocyte 
proliferation, are unique. These may be due to effects of the products of GdNPF proteo-
lysis, rather than to proteinase inhibition. - 
Thyroxine binding globulin (TBG), the major, vertebrate thyroxine-binding protein, 
was cloned using polclonal anti-TBG antibodies to screen 'a A.-gtl 1 expression:.library 
(Funk et at, 1986) The cDNA sequence showed a high degree of similarity to serprn 
sequences, particularly the functional inhibitors al-PI and .al-antichymOirypsin. TBG 
has no known inhibitory activity, but appears to undergo the major confOrthtional 
change typical of several other serpins when treated with proteinase (Pemberton et al., 
1988). The thyroxine binding site is proposed to be the 13- barrel domain described 
above, since transthyretin, which binds two thyroxine molecules, contains two 13-barrel 
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domains (Blake et al., 1974). A second hormone-binding protein, corticosteroid binding 
globulin (CBG) (Hammond et al., 1987), also proved to be a serpin, again with no obvi-
ous anti-proteinase activity. Pemberton et al. (1988) propose that the retention of the 
switch from S to R in these proteins is required to allow altered delivery of hormone at 
inflammatory sites where proteinase activity is increased. 
The gene for a 38kD protein from cowpox virus responsible for lesion haemor-
rhage has been cloned using a series of deletion mutants (Pickup et al., 1986). The 
sequence showed 30% identity to several serpins, with greater conservation of internal 
hydrophobic residues. Viruses containing the sequence produce localised lesion haemor -
rhage upon infection, but the specificity of the inhibitor is unknown, although the P1 
residue is probably alanine. The inhibitor is presumed to perturb the normal serine 
proteinase-mediated coagulation cascade. The origins of this gene are uncertain but may 
well have arisen by horizontal evolution via gene transfer from the host to the virus, as 
is thought to occur for viral oncogenes. 
A cDNA isolated from an insect (Manduca sexta) fat-body eDNA library has been 
sequenced, and encodes a serpin with inhibitory activity (Kanost et al., 1989). The inhi-
bitor is anti-elastase in type, with an alanine at the P1 position, and shows anti-elastase 
and antichymotiyptic. activity. Comparison of the sequence to mammalian serpins indi-
cates that the progenitor gene ezisted before the divergence of vertebrates and inver-
tebrates. To date s this is probably the most distant characterised member of the super-
family from the mammalian serum inhibitors. 
The Nature of Rodent Serpin Gene Complexes 
A previous report from this laboratory (Hill et al., 1984) described the sequences 
of two serpins derived from a mouse liver cDNA library. One of these was the putative 
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murine equivalent of cxl-Proteinase Inhibitor, and the second was the serum inhibitor 
contrapsin (Takahori and Sinohara, 1982), which has an anti-tryptic type activity. There 
is no known equivalent of contrapsin in human serum, but screening of a human liver 
cDNA library enabled isolation of a contrapsin-related sequence expressed at moderately 
high levels (0.1% of clones). This sequence proved to be al-antichymotrypsin, a well 
characterised human serum serpin with an antichymotryptic spectrum of activity, princi-
pally active against cathepsin G and mast cell chymase (Reilly et al., 1982; Wintroub et 
al., 1982). It is an acute phase reactant, with levels rising rapidly in response to infection 
or inflammation (four-fold in eight hours (Fey and Fuller, 1987) The human and mouse 
sequences showed 70% identity at the nucleotide level, with high conservation of the 
amino acid residues thought to comprise the internal hydrophobic domains of the pro-
tein. However, the reactive centre regions were completely dissimilar, with one residue 
in sixteen in common between the two proteins. This apparently accounts for the marked 
difference in specificity between the muse and human proteins. Contrapsin and al-
antichymotrypsin would appear to have acquired different functions since rodent/primate 
divergence, specifically by reactive centre divergence. 
Further analysis of the conirapsin and al-PI genes in the mouse (Hill et al., 1985) 
demonstrated that each was a member of a separate clustered multigene family. The two 
gene families, designated Spi-1 (W-PI) and Spi-2 (contrapsin) are closely linked on 
chromosome 12, and would appear to have arisen-as a series of duplications from a sin-
gle primordial serpin sequence. In man, the situation is simplified; the al-PI gene (and a 
related sequence) lies within 120 kb of the single al-antichymotrypsin sequence on 
chromosome 14 (P. Kearney, personal communication). The al-PIIal-antichymotrypsin 
divergence clearly predates rodent/primate divergence since both gene types are found in 
both lineages. However the evolution of the Spi-1 and Spi-2 loci after rodent/primate 
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divergence has been very different in man and mouse. An intriguing evolutionary 
phenomenon which has occurred in the rodent Spi-2 gene complex will be discussed 
after a brief review of some mechanisms of multigene family evolution 
General Features of Multigene Family Evolution 
The unusual evolutionary behaviour of multigene families has been studied in 
many different organisms at several different levels and has given rise to a number of 
basic concepts of molecular evolution. Following an initial gene duplication event pro-
viding two linked related sequences a series of processes act simultaneously upon the 
genes. These may include amplification and deletion of genes or parts of genes by 
unequal crossing over, sequence dispersion to unlinked loci, inter- and intra-family 
sequence conversion, slippage replication, selection and drift. The processes all exert 
varying degrees of influence upon individual genes within a family and upon the homo-
geneity of the family (Arnheiin, 1983; Maeda and Smithies, 1986; Dover and Strachan, 
1987). 
Mechanisms for Gene Duplication 
The initial event which produces two linked copies of a gene can occur in a 
number of ways. Chromosome breakage and reunion can rescue two copies of a unique 
sequence onto one chromosome. This process can be random, as no recombination sig-
nals have been discovered for certain families which appear to have arisen in this way. 
An example is the human haptoglobin locus where two separate, apparently random, 
breakages have generated both intragenic and intergenic duplications (Maeda and S,ithp 
1986; Bensi et al., 1985). A second powerful mechanism involves duplication by homo-
logous recombination between repeated sequences flanking the original gene. Recombi-
nation between two truncated Kpnl repeated sequences appears to have been responsible 
for the duplication of the primordial foetal haemoglobin gene in man as remnants of the 
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repeat sequence are located between the duplicated genes, and at the 5' and 3' boun-
daries of the duplication (Shen et al., 1981). Alu repeated sequences appear to have 
mediated the initial duplication event in the human growth hormone/human chorionic 
somatomammotrophin in an identical fashion (Barsh et al., 1983). 
A repeat-dependent homologous recombination mechanism can equally well expand 
or contract an extant multigene family, and mediate intragenic duplication or deletion. 
However, the principal mechanism for expansion or contraction of the copy number of a 
multigene family would appear to be unequal crossing over between the previously 
duplicated sequences. In the 3-globin locus this has been demonstrated both within 
genes, yielding chimaeric proteins, and between genes, causing duplications and dele-
tions (Flavell et al., 1978; Jones et al., 1981). Unequal crossing over events frequently 
generate fluctuations in copy number in certain multigene families (Hill et al., 1986; 
Geliebter and Nathenson, 1987). The isolation of a sequence by dispersion to a separate 
chromosome, or by physical separation from related sequences on the same chromosome 
often leads to the development of two related, but evolutionarily independent, subfami-
lies. This has presumably occurred in the unlinked a-globin and 3-globin multigene fam-
ilies (Jeffreys, 1982) and the linked but isolated Igh-V subfamilies in the mouse (Riblet 
et al., 1987; Tutter, 1988). 
Gene Conversion in Multigene Family Evolution 
Gene conversion, the non-reciprocal transfer of sequence from one gene to another 
related one, is a major mechanism in multigene family evolution. The process can cause 
the phenomenon of concerted evolution, where genes within a species are more closely 
related to one another than to their orthologues in a separate species (Arnheim, 1983). 
Gene conversion was first demonstrated at the nucleotide level for the two human foetal 
globin genes, G and A. thought to have duplicated twenty to forty million years ago, 
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yet which on a single chromosome were found to possess pronounced sequence similar-
ity over a 1500 basepair region (Slightom et al., (1980). The process of gene conversion 
can also generate novel polymorphism in coding sequences by highly localised conver-
sion events, as demonstrated for the H2Kt)ml  mouse major histocompatibiity gene 
(Schulze et al., 1983; Weiss et al., 1983), and accelerate sequence divergence of recently 
duplicated genes, as shown for the human immunoglobulin V K  genes (Bentley and Rab-
bitts, 1983). 
Two contrasting examples of fairly recent multigene family amplifications in the 
mouse are the mouse major urinary proteins, or MUPS (Bishop et al., 1982; Clark et al., 
1984) and the kallikrein family (Mason et al., 1983; Evans et al., 1987). The MIJP 
amplification unit appears to consist of a class 1 (active) and class 2 (pseudogene) 
sequence in a divergent transcriptional orientation within a 45 kb genomic domain. The 
pseudogene component appears to have become inactivated before the amplification 
occurred (Ghazal et al., 1985), although it may have acquired a secondary biological 
function (Clark et al., 1985). The kallikrein family contains a similar number of genes 
and pseudogenes (about fifteen of each) to the MUP locus, but the duplication mechan-
ism has resulted in tandem linkage of all the sequences, with inactivation presumably 
occurring after duplication (Drinkwater et al., 1987; Evans et al., 1987). 
Unusual Evolutionary Behaviour in the Spi-2 Multigene Family 
During further analysis of Spi-2 genes in rodents, (Hill and Hastie, 1987) the isola-
tion of two rat Spi-2 cDNAs from liver libraries revealed additional highly unusual evo-
lutionary behaviour. As mentioned above, the murine contrapsin and human al-
antichymotrypsin genes which had been presumed to be orthologous showed consider-
able divergence at the nucleotide and amino acid levels in their reactive centre regions. 
This had led to distinct inhibitory specificities, apparently in the period since 
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rodent/primate divergence. The rat sequences, Spi-2.1 and Spi-2.2, were sufficiently 
related to one another and to contrapsin to fall within the Spi-2 family; and presumably 
to have arisen from an Spi-2 family amplification event following rodent/primate diver-
gence. The Spi-2.2 sequence shares several characteristics of the human ctl-
antichymotrypsin gene; in terms of induction following acute phase inflammation, tran-
script size, and especially chemical nature of the P1 residue, this gene appears to encode 
a functional rat equivalent of the human gene. In contrast, the Spi-2.1 gene resembles the 
mouse contrapsin gene, with a similar size of transcript, a high constitutive level of 
expression, and the probable specificity of the P1 residue. However, if the rat Spi-2.1 
represented the true orthologue of the mouse contrapsin, it appeared to have undergone 
extremely rapid nucleotide evolution in the reactive centre region since Spi-2.1 and 
Spi-2.2 divergence, and also in the shorter evolutionary period following mouse/rat 
divergence. Contrapsin and Spi-2.1 display less nucleotide identity in the reactive centre 
region than contrapsin and al-antichymotrypsin. 
To establish in more detail the quantitative nature of the sequence divergence, 
analysis of the four sequences, contrapsin, Spi-2.1, Spi-2.2, and al-antichymotrypsin was 
carried Out using the method of Li, Wu, and Luo (1985). This sophisticated algorithm 
estimates rates of synonymous and asynonymous substitution in related sequences, 
applying values derived from mammalian genes for the different probabilities of different 
codon changes. The program calculates a rate of about 6 x 10 substitutions per site per 
year for pseudogene sequences in mammals. A rate of 0.8 to 1 x 10 is typical for non-
synonymous (ie amino acid altering) substitutions, and a five-fold higher value (4.65 x 
lO u) for synonymous (translationally silent) nucleotide substitutions. This is in accord 
with molecular evolutionary theory which would predict that synonymous substitutions 
should occur at a rate close to that of substitutions in (non-selected) pseudogenes, and 
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considerably more frequently than possibly deleterious nonsynonymous substitutions. 
However, the calculated rates of nonsynonymous substitution in the reactive centre 
regions (Region 2) of the Spi-2 sequences were four-fold higher than the rates of 
synonymous substitution in the more conserved upstream sequences (defined as Region 
1) using the Li program. Actual substitution rates were not always calculable for Region 
2, due to the degree of sequence divergence. The rate of nonsynonymous substitution for 
the contrapsin and rat Spi-2.1 genes was 6-8 times that of the overall substitution rate for 
two mouse pseudogenes (Hill and Hastie, 1987). The explanation proposed for these 
extremely rapid evolutionary rates, in the region of the protein most important for func-
tional specificity, was postulated to be the occurrence of positive Darwinian selection for 
amino acid altering mutations in the reactive centre. Rapid evolution of novel inhibitory 
specificities against exogenous proteinases secreted by parasites as virulence factors 
could provide an appreciable selective advantage to a host, causing rapid fixation of 
favorable nonsynonyrnous mutations.. The relatively high synonymous rates in the reac-
tive centre region, where these are calculable, indicate that the situation may be complex. 
The difficulty of aligning reactive centre sequences from different genes may exceed the 
ability of the computer program to determine realistic values. 
A separate observation supporting the idea that the rodent Spi-2 sequences might 
have a role in defence against parasites was recently reported (Mohda et al., 1988). A 
component of mouse serum found associated with schistosome worm isolates from 
infected mice was shown by immunoprecipitation to be contrapsin. The exact nature of 
the interaction is not clear, but the secretion of serine proteinases by schistosomes is 
thought to play a major role in tissue invasion by this parasite. Contrapsin with altered 
electrophoretic mobility, perhaps representing a proteinase-modified form, was detected 
in the serum of infected compared to control mice 
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Following the observation by Hill and Hastie, a similar instance of reactive centre 
hypervariability was reported for the avian ovomucoid inhibitors (Laskowski et al., 
1987). The protein sequences of ovomucoid inhibitory domains from one hundred avian 
species were established, and the most variable amino acid found to be the specificity-
determining P1 residue. These small Kazal-type inhibitors have been subjected to crystal-
lographic analysis in complex with several serine proteinases; the importance of the P1 
residue is not in doubt. No nucleotide sequence analysis has been reported for these pro-
teins, therefore relative synonymous and nonsynonymous substitution rates cannot be 
deduced, but it appears probable that a similar phenomenon is occuring in the reactive 
centre regions of the ovomucoid inhibitors (Leigh Brown, 1987) 
The proposition that the cause of accelerated reactive centre sequence divergence in 
the Spi-2 genes is due to positive selection has been challenged recently (Graur and Li, 
1988). Using an index of protein mutability (Graur, 1985), the authors claim that the 
intrinsic amino acid composition of the Spi-2 sequences in the reactive centre regions 
will permit increased rates of evolution, relative to the remainder of the molecule. They 
also postulate that the reactive centre region is free of compositional constraint, and state 
that a positive selection scenario is not necessarily required to account for the sequence 
data reported by Hill and Hastie. Graur and Li predict that the reactive centre regions 
will tend to be highly polymorphic within populations, since innate reactive centre muta-
bility with no selection would not tend to homogenise a particular sequence within a 
species. They suggest that a positive selection mechanism will tend to rapidly drive 
advantageous mutations to fixation, reducing intraspecies polymorphism (Nei and Graur, 
1984). The extreme polymorphism of, for example, the MHC gene cluster in most mam-
mals contradicts this view, at least for some gene classes (Steinmetz and Hood, 1983; 
Klein, 1986)). 
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Aims of the Project 
Comparison of rodent Spi-2 genes revealed the highly unusual phenomenon of 
accelerated evolution in the reactive centre region (Hill and Hastie, 1987). It was of 
great interest to determine whether this was a general phenomenon for this gene family 
in rodents, the mechanisms which might promote accelerated evolution, and the actual 
divergence rates involved. 
One approach involved determining the nature of the contrapsin reactive centre 
sequence in murids closely related to the laboratory mouse. At this stage, the status of 
the contrapsin reactive centre sequence in rodents was uncharacterised, except for the 
original Swiss inbred mouse strain (Hill et al., 1984) and the putative orthologue in the 
rat, Spi-2.1 (Hill and Hastie, 1987). A strictly neutralist prediction would be that this 
region would continue to evolve rapidly over comparatively short periods of time, due to 
its predicted intrinsic mutability (Graur and Li, 1988). Additionally, if the accelerated 
sequence divergence were due to a hypermutational mechanism peculiar to the Spi- 2 
reactive centre, analysis of closely related murine species might reveal intermediates in 
the process. However, if the divergence had been due to a positive selection for a par-
ticular novel endogenous reactive centre specificity, then stabilisation of the sequence 
might have occurred at some stage during murine radiation. This type of "internal race" 
would be more likely to result in stabilisation than selection by exogenous parasitic pro-
teinases, where continuous rapid co-evolution might be expected (Clarke, 1976). 
A second area of research involved the nature of the Spi-2 complex in rodents. It 
was clear that the family had become amplified since primate/rodent divergence and, to 
some extent, since mouse/rat divergence (Hill et al., 1985). How many genes the mouse 
possessed at the Spi-2 locus, their mode of amplification, their intragenic structure, and 
the range of specificities in functional inhibitors encoded within the locus, were ques- 
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tions which could be addressed by genomic analysis. If accelerated evolution was 
occuring in several family members specifically within the reactive centre region, was a 
rodent-specific intron/exon structure responsible? Which genes in the family had 
acquired a specific physiological role, and was their evolution similarly accelerated? And 
finally, did the mouse possess a functional, or evolutionary, orthologue of the (ances-
tral?) single-copy human Spi-2 gene, al-antichymotrypsin. This thesis describes 
attempts to answer some of these questions. 
CHAPTER TWO 
Materials and Methods 
Chemicals - unless otherwise stated, all chemicals were obtained from BDH Reagents 
Ltd. 
Enzymes - unless otherwise stated, all enzymes were obtained from BCL Ltd. 
1. SEQUENCING 
1.1 RNA Sequencing 
For RNA sequencing in the project, modifications of the dideoxy chain termination 
technique (Sanger et al., 1977) were always used. Template material was normally total 
liver RNA, but occasionally liver mRNA (oligo d(T) method- section 4.2). Initially no 
standard protocols were available, and a method was independently developed. Later, 
published protocols were obtained (Weismann, 1986; Geliebter, 1987) which were 
broadly similar to the methods used in the project. Specific oligonucleotides complemen-
tary to 3'coding regions of specific mRNAs were used as primers, and the same criteria 
applied regarding length and composition as for DNA sequencing. 
Primers for sequencing were radiolabelled with 32P 'y-ATP using T4 polynucleotide 
kinase (Amersham International). This precluded the requirement for inclusion of a 
radioactive nucleotide during the extension reaction. This often gave better results, prob-
ably due to the fact that only poly-nucleotides initiated from the labelled primer were 
detectable, thus reducing background signal due to nonspecific priming. This can 
represent a particular problem when directly sequencing a highly complex population of 
nucleic acids However, unlabelled primer and free radioactive nucleotides were used in 
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initial stages of the project and often gave reasonably low background. 
10 p.1 of total RNA (in a volume of 4 to 5 p.1) was heat-denatured at 90 °C for three 
minutes and then briefly spun in a microfuge. One p.1 of RNAsin (ribonuclease inhibitor 
- Promega Biotech) was added, followed by 25 ng of pre-labelled oligonucleotide pri-
mer (in a volume of 5 p.1) (Section 7.3) Four p.1 of 5X RT buffer was added (5X RT 
buffer = 250 mM Tris-HC1 pH 8.0, 50 mM MgCl2, 200 mM KC1 and 50 mM DTF) and 
the reaction mix left to anneal at 37 °C for twenty minutes. One p.1 of reverse transcrip-
tase (BCL) was added and 3.5 p.1 aliquots were added to each of four reaction tubes: A, 
C, G, T which contained 2.5 p.1 of the appropriate deoxy/dideoxy nucleotide mixes. The 
final concentrations for these were 
A' dATP 0.2 mM ddATP 0.15 mM dCII', dGTP, dTP 0.2 mM 
C' dCTP 0.2 mM ddCTP 0.15 mM dATP, dGTP, dTTP 0.2 mM 
0' dGTP 0.4 mM ddGTP 0.15 mM dATP, dCTP, dTFP 0.2 mM 
T' dTIP 0.2 mM dd'fl'P 0.30 mM dATP, dCFP, dGTP 0.2 mM 
The tubes were then incubated at 42 °C for 10 minutes. In the initial reactions, 1 p.1 
of a chase mix (1 mM dATP,dCTP,dGTP,dTFP) was added and the temperature raised 
to 500C for a further 5 minutes but this did not significantly improve the sequence data 
and was dispensed with. The reactions were stopped by the addition of 4 p.1 formamide 
dye mix (100 ml formamide, 0.1 g xylene cyanol, 0.1 g bromophenol blue, 4 ml 500 
mM EDTA) and heated to 90 °C for three minutes immediately before loading onto a 
polyacrylamide gel (Section 1.3). 
1.2 dsDNA Sequencing 
Double-stranded DNA sequencing was modified and used for the project in prefer- 
ence to standard M13 single-stranded sequencing for two reasons. Since isolated 
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genomic clones often contained two or more related genes, subcloning was often 
required prior to detailed analysis and was carried out routinely for the individual Spi-2 
sequences. Secondly, plasmid subclones from genomic inserts were frequently several 
kilobases in size, for ease of isolation, and to ensure that the entire 3' end of the gene 
was present. Inserts of more than 1 to 2 kb can be difficult to propagate in M13. Double 
stranded DNA sequencing is less efficient overall than single-stranded M13 sequencing, 
but in this project, where directed sequencing was often possible, was quite adequate. 
3 pg of CsC1 purified, supercoiled, plasmid DNA was added to 40 ILl of denatura-
tion soln. (0.2M NaOH, 2mM EDTA) and left at RT for five minutes. 4 p1 of neutraliz-
ing soln. (0.4M NaOAc pH 4.5) was then added, followed by 90 p.1 of EtOH. The DNA 
was then spun for 15 minutes, and the pellet washed (80% EtOH) and dried. It was then 
resuspended in 5 p.1 of endlabelled oligonucleotide primer (=25 ng), 3 p.1 of TE and 2 
p.! of 5x Sequenase sequencing Buffer. After vortexing, template and primer were 
annealed at 37 °C for 20 minutes. Two p1 of diluted (1:7 ) Sequenase was then added 
and gently mixed. Three p.l of the RM was then added to each of four ddNl'P reaction 
tubes which already contained 2 ILl of the appropriate termination mix. 
A' 8j.iM MAT? 	80p.M dATP, dCTP, dGTP, dTFP 
C' 8p.M ddCTP 	80p.M dATP, dCTP, dGTP, dTTP 
G' 81iM ddGTP 	80j.tM dATP, dCTP, dGTP, dTFP 
T' 81iM ddTFP 	80p.M dATP, dCTP, dOT?, dTFP 
The tubes were spun to mix and incubated at 37 0C for five minutes. Four p.1 of 
formamide dye mix was added to each tube and samples heated to 80 °C for 3 minutes 
just before gel loading. 
This protocol was adapted for sequencing intact phage DNA or supercoiled cosmid 
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DNA in suitable circumstances. Both adaptions followed the plasmid sequencing proto-
col for reagents. Cosmid sequencing required more template DNA (> 10 jig) to yield 
comparable results but was otherwise very similar to plasmid sequencing. Phage DNA 
also required more template, and in addition heat denaturation rather than alkali dena-
turation was used as the DNA was already linear. Both modifications were useful on 
occasion, but never provided the quality of data that plasmid sequencing yielded. 
1.3 Polyacrylamide Urea Gel Electrophoresis 
Sequencing gels were run on 50 cm glass plates in TBE buffer (TBE - section 
6.2)One glass plate was coated with MPTS (30 jil garnnia-methacryloxypropyl-
trimethoxy silane [Sigma] in 10 ml EtOH + 300 jil 10% glacial acetic acid). This treat-
ment ensures adhesion of the gel to the plate. The second plate was silane-coated with 
2% dimethyldichiorosilane in trichioroethane [BDH] to ensure that the gel adhered to 
the MP'FS plate only. The plates were taped together, separated by 0.5 mm PTFE 
spacers and the gel mix added by pipette. The gel mix contained (per 200 ml): 
84g urea, 30m1 40% acrylamide stock (38% acrylamide, 2% bisacrylamide), 40m1 5X 
TBE, to 200m1 with ddH20. 180 jil 10% ammonium persulphate and 90 jil TEMED 
added per 40 ml of gel mix immediately before pouring. 
After setting, the gel was put onto a vertical gel apparatus, 1X TBE buffer added, and 
the comb carefully removed. The wells were rinsed with buffer immediately before run-
ning to remove urea, and three ul of reaction mix added per well. Samples were electo-
phoresed at 27 watts for 90 to 100 minutes for a standard run. Fixing was carried out in 
10% methanol 10% aceticacid for 10 minutes, and the gel was then washed thoroughly 
(>5 mm) in running water and dried at 80 0C Overnight exposure to Kodak XAR-5 film 
was generally sufficient to read 150 to 200 nucleotides without ambiguity. Sequences 
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were normally read directly into vi files on the Vax and were then processed using the 
dnaprog facility, written by P. Jeppesen (MRC HGU). Later sequences were occasion-
ally read in to the Staden system, using a Gratbar digitiser 
2. LIBRARY SCREENING 
2.1 Plasmid and Cosmid Library Screening 
There were no major differences in screening plasmid or cosmid libraries during 
the project, although plating density was often higher for cosmids. Screening was nor -
mally carried out on 20 x 20 cm petri-dishes as this allowed plating of large numbers (2 
x 101 to 1 x 105  ) of bacterial colonies. The method of Grunstein and Hogness was used 
(Maniatis 1982). The library was plated on a 20 x 20 cm Nitrocellulose (Schleicher and 
Schuell) or Hybond-N (Amersham) filter which was laid dry on a freshly poured L-
Agar (containing selective antibiotic) 20 x 20 cm dish. After incubation at 37 °C over-
night, replica "slave" filters (normally two) were taken from the master filter, marking 
paired filters with waterproof ink to enable accurate keying of autoradiographs to the 
master plate. All three filters were then reincubated on L-Agar and antibiotic for four to 
five hours, to permit regrowth of the colonies. 
Slave filters were then processed by laying onto saturated 3MM (Whatman) filter 
paper in 20 cm dishes: 
Membrane Lysis 	10% SDS soln 	 2 minutes 
DNA Denaturation 	0.5M NaOH, 1.5M NaCl 	3 minutes 
Neutralization 	1.5M Tris-Cl, 1.5M NaCl (pH 5.5) 3 minutes 
Filter Wash 	2xSSC 	 3 minutes 
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After removing bacterial debris by gentle agitation, filters were blotted dry and then 
fixed by baking (Nitrocellulose: 2 hrs, 80 0C) or UV irradiation (Hybond-N: 3 minutes on 
UV-transilluminator). Filters were prehybridised and hybridised in Quick-Hybe as 
described in Southern Blotting (Section 7.). After auto-radiography for the required 
period (1-3 days at -70 0C), films for both slave filters were transposed and compared. 
Duplicate spots were selected, and relevant areas isolated from the master filter (stored at 
4°C during probing). Filter fragments were put into 1 ml L-BrothI15% Glycerol and vor-
texed to solubilise colonies. They could then be stored frozen indefinitely. Secondary 
screens were carried out by plating small (1 x 10 -3 ) aliquots of the primary pick stock. 
These were generally plated on gridded Nitrocellulose filters in 9 cm petri-dishes. The 
process of replicating, regrowing, denaturing, and probing was carried out as for the pri-
mary screen. Depending on the density of colonies on the secondary plates, individual 
colonies could be selected at this stage, or a tertiary screen performed. 
2.2 Phage Library Screening 
Phage Library screening was similar in methodology to plasmid screening. 
Libraries were plated on 20 x 20 cm plates at similar densities to cosmids (maximum of 
1 x io plaques per plate), normally on L-Agar medium. Fresh E. coli of the appropriate 
strain (see section 5), previously grown to stationary phase in L- Broth + 10mM MgC1 2 
+ 0.2% Maltose, were spun down and resuspended in 0.5 volumes of 10mM MgCl 2. 
Phage stocks (previously titred) were added to 1 ml of the bacterial suspension in a 50 
ml Falcon Tube and incubated at room temperature for 15 minutes. The cells were then 
diluted with 40 ml of molten Top L-Agar (450C), swirled to mix, poured over a dried 
L-Agar petri dish, and incubated at 37 0C overnight. Nitrocellulose or Hybond-N filters 
were laid, dry, onto the top agar, and keyed with a needle containing waterproof ink. 
The first filter was left on the plate for 1 minute, subsequent filters for 2 to 3 minutes. 
29 
The filters were then processed exactly as for plasmid screening, omitting the 10% SDS 
Membrane Lysis step. After hybridisation, and selection of duplicate positives, relevant 
areas of top agar were cut out and put into 1 ml of SM (50 mM Tris, 5 mM MgC12) in 
an eppendorf. This stock could be stored at 4 0C for several months. Aliquots of the 
stock were then used for secondary screens, as for plasmids, on 9 cm petri-dishes. 
3. DNA PREPARATION 
3.1 Plasmid DNA Preparation 
Purification of closed-circular supercoiled plasmid DNA from bacterial cultures is a 
central technique in molecular genetics. For analysis of several independent colonies 
from a cloning experiment, a rapid, efficient method is required to isolate small (p.g), 
relatively pure amounts of plasmid DNA. For the preparation of milligram quantities of 
highly pure, RNA and E.coli DNA-free plasmid for sequencing, T7 or SP6 polymerase 
transcription, or vector construction, a more elaborate protocol was employed. 
Small scale plasmid preparation. 
Bacterial colonies were added to 15 ml of L-Broth (see Section 5) plus appropriate 
antibiotic and shaken at 37 0C overnight in 50 ml Falcon tubes. The tubes were spun at 
3000 rpm for 10 minutes to pellet the bacteria, and pellets then resuspended in 1 ml of 
TELT with 1 mg Lysozyme (Sigma) TELT is 50 mM Tris-Ci pH 7.5, 62.5 mM EDTA, 
2.5 M LiCl, 0.4% Triton-X100. After transfer to Eppendorf tubes, the samples were 
boiled for 1 minute. After 5 minutes incubation on ice, the tubes were spun in a micro-
fuge for 15 to 30 minutes to pellet E.coli debris and denatured chromosomal DNA. 
Between 0.5 and 0.8 ml of supernatant was removed, and the plasmid DNA precipitated 
with 0.6 volumes of Isopropanol. After spinning for 15 minutes, the plasmid pellet was 
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washed with 80% ethanol, dried and resuspended in 50 .tl TE. This method yielded 20 
to 50 .tg (with pUC based plasmids) of DNA, of sufficient purity for restriction enzyme 
analysis, and for use in nick-translation or random-priming reactions (Section 7). It was 
not always sufficiently pure for sequence analysis. It was also unsuitable for cosmid 
minipreps, since boiling tends to irreversibly denature circular DNA molecules of larger 
(50 kb) size. 
Large scale plasmid preparation. 
Bacterial colonies were innoculated into 250 ml of Terrific Broth or into 500 ml of 
L-Broth plus appropriate antibiotic, and shaken at 37 0C overnight. The culture medium 
was decanted to 250 ml Sorvall centrifuge tubes and spun at 8000 rpm for 10 minutes. 
The pellets were resuspended in 5 ml of cold GTE (50 mM glucose, 50 mM Tris pH7.5, 
10 mM EDTA), and 5 ml cold GTE + 10 mg lyzozyme added. After 15 minutes on ice, 
20 ml of alkaline SDS (0.25 N NaOH, 1% SDS) was stirred in, to denature chromo-
somal DNA. After a further 10 minutes, 15 ml of high salt soln.(3M Potassium Acetate, 
2M Glacial Acetic Acid pH 4.5) was added to precipitate E. coli debris and chromo-
somal DNA. The supernatant was filtered into a 50 ml Falcon tube through muslin to 
remove the coarse precipitate, and 0.6 volumes of isopropanol added. Samples were left 
for 15 minutes at room temperature, and centrifuged at 3000 rpm for 10 minutes to pel-
let the plasmid DNA. Pellets were washed with 80% ethanol, lyophilized until almost 
dry, and redissolved in 3.8 ml TE. After addition of 4.2 g CsC1 (BCL) and 200 jil ethi-
dium bromide (10 mg/ml, Sigma) tubes were left in the dark at room temperature for 30 
minutes to allow precipitation of any remaining bulk protein. This was removed by spin-
ning at 3000 rpm for 5 minutes, and the optical density of the DNA solutions then 
adjusted to between .930 and .945 by addition of CsC1. The samples were spun at 40000 
rpm overnight in a Sorvall Ultracentifuge. Piasmid bands were removed with a needle or 
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fine-tipped pastette, and ethidium extracted with butanol. DNA was then precipitated by 
addition of 2.5 volumes of 80% ethanol, DNA spooled when possible, washed in 80% 
ethanol, dried, and resuspended in TE. 
This method was suitable for cosmid DNA preparation, and a scaled down version 
was used (minus the CsCl gradient steps) to prepare minipreps of cosmid DNA when 
these were required. Plasmid DNA purified by CsCl gradient centrifugation was capable 
of essentially any enzymic manipulation: sequencing, RNA polymerase transcription and 
for use in novel constructs. 
3.2 Bacteriophage DNA Preparation 
As with plasmid preparations, two forms of bacteriophage DNA preparation proto-
col were used; a small scale, rapid method yielding 1 to 10 p.g of DNA and a larger 
scale protocol yielding 50 to 100 jig DNA. These were very similar to each other and 
only the large scale one will be described in detail. 
Plating bacteria of a suitable strain were grown in L-Broth + 10 mM 2 + 0.1% 
maltose at 370C overnight. These were spun down at 3000 rpm and resuspended in 0.5 
volume 10 mM MgCl2. About 5 x 1O5 phage were added to 1 ml of cells, and incu-
bated at RT for 15 minutes. Molten top-agarose ( 40 mls at 42 0C) was added to the bac-
teria and plated onto a 20 cm x 20 cm pre-poured L-Agarose petri-dish. This was incu-
bated at 37 °C overnight, without inversion. The plate was inspected for complete lysis of 
bacteria; if this had occurred, 20 mls of SM Was added to the plate, which was then agi-
tated at room temperature for five hours. The SM was pippeted into a 50 ml Falcon tube 
and spun at 3000 rpm for 20 minutes to pellet agarose aggregates. The supernatant was 
carefully decanted, 0.1 mg/ml DNAse and 0.1 mg/nil RNAse added, and incubated at 
250C for 30 minutes. An equal volume of 20% PEG 6000 (Polyethylene glycol MW 
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6000, Sigma), 2M NaCl was added to the tube to precipitate phage particles, and the 
samples left on ice for 2 hrs. Prolonged precipitation times (overnight) increased final 
yields. Loose precipitates were decanted into 13 ml tubes and spun at 10000 rpm for 20 
minutes to pellet the phage. The pellet was then resuspended in 4 ml 50mM Tris-Cl pH 
7.5 10 mM MgC12 and extracted three times with chloroform to remove all traces of 
PEG. The phage particles were then disrupted by the addition of EDTA, pH 8.0 to a 
final concentration of 20 mM followed by rapid extraction with phenol. Following a 
second phenol extraction and two chloroform extractions, the phage DNA was precipi-
tated by addition of NaCl to 0.2M and two volumes of ethanol. DNA was spooled onto 
a glass rod when possible, washed with 80% EtOH and resuspended in TE. This bac-
teriophage DNA was sufficiently pure for most enzymic manipulations, and was used for 
direct DNA sequencing on occasion. 
Oligonucleotide Synthesis 
Oligonucleotides were synthesised and purified according to manufacturers instruc-
tions on an Applied Biosystems 381A Oligonucleotide Synthesiser. 
4. RNA ISOLATION 
Analysis of rodent liver RNA formed an important part of this project. I was for-
tunate to have access to large stocks of RNA already prepared by R. Hill and R. 
Meehan. These included all the inbred Mus domesticus and Rattus stocks used in the 
project. J. Ansell (Zoology Dept. Edinburgh University) kindly provided Mus caroli 
animals. F. Berger (University of South Carolina) kindly provided samples of total liver 
RNA from M. hortulanus, M. cookii, M. cervicolor, M. pahari, M. saxicola, and M. 
minutoides. Specimens of Apodemus sylvaticus were trapped at the Bush Estate, Roslin 
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using Longworth Traps, with the assistance of R. Hill and J. Ansell. 
4.1 Total Mouse Liver RNA 
This protocol was carried Out as previously published (Hill et al., 1985). Whole 
liver was quickly removed from freshly killed mice and homogenized in 20 ml of 8M 
Guanidinium Hydrochloride (BRL) in TE, for 45 seconds, using a motorized tissue 
mixer. The suspension was centrifuged for 10 minutes at 8000 rpm, and the supernatant 
carefully removed. Half a volume of cold ethanol was added, and after storage at -20 °C 
for 30 minutes, RNA was pelleted by centrifugation at 10000 rpm for 15 minutes. The 
pellet was resuspended in 15 ml of 6M Guanidimum Hydrochloride in TE, and reprecip-
itated with 0.5 volumes cold EtCH. After 30 minutes, the RNA was repelleted, and the 
6M extraction repeated. The RNA pellet was resuspended in 10 mls of DEPC Water 
(0.1% Diethylpyrocarbonate in double distilled water, autoclaved). Resuspension often 
required use of a Dounce homogeniser. NaCl was added to a concentration of 0.2M, and 
RNA precipitated with 2.5 volumes of ethanol. This precipitation was repeated, and the 
RNA was finally resuspended in 5 mIs of DEPC water and stored at -70 °C after measur-
ing its concentration by absorbance at 260 nm. The RNA was sufficiently free of inhibi-
tors at this stage to be used for reverse transcriptase sequencing. 
4.2 Mouse Liver poly (A)+RNA 
This followed the method of Aviv and Leder (1972). Total RNA (1 to 2 mg) was 
diluted to 1 mg/ml and heated at 65 0C for 5 minutes. An equal volume of 2X loading 
buffer (20mM Tris.Cl pH 7.5, 0.5M NaCl, 1mM EDTA, 0.1% SDS) was added to the 
RNA. An oligo (dT) cellulose (Sigma) column (1 ml volume) was poured and equili-
brated with loading buffer. The RNA was then applied to the column and the eluate 
reheated, and reapplied. The column was then washed with 5 volumes of loading buffer, 
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and then with buffer containing 0.1M NaCl. The flowthrough buffer was retained at this 
stage. Elution buffer (10mM Tris.Cl pH 7.5, 1mM EDTA, 0.1% SDS) was then added 
(3 volumes) and 0.5 ml fractions collected. Each fraction was checked for RNA by spot-
ting onto a dried agarose/ethidium bromide plate and visualising with UV. Positive frac-
tions were pooled and precipitated with ethanol, and the poly (A)+ pellet resuspended in 
DEPC water at ljig/il, and stored at -70 0C. 
5. SUBCLONING 
This section deals with general DNA subcloning resources and methods which 
were used with numerous variations during the project. The main reference for these is 
Maniatis et a! (1982) Molecular Cloning, A Laboratory Manual, but protocols and 
methods were frequently updated and modified during the project. 
5.1 Cloning Vectors 
The most frequently used plasmid during this work was pBS (formerly Bluescribe, 
Stratagene) a 3 kb general-purpose cloning vector derived from pUC 19 (Messing, 
1983). It possesses a number of useful features including high copy number in E. coli, 
the lac Z blue-white complementation test for inserts, the pUC19 Multiple Cloning Site 
containing 13 unique cloning sites, and Phage T3 and T7 promoter sequences flanking 
the polylinker, enabling production of specific single stranded RNA transcripts. Other 
less frequently used subcloning vectors were pSP64, pTZ18R, and for expression experi-
ments, pJLA502 (gift of J. McCarthy), ptac85 (gift of J.Myles), and pSVL (Pharmacia). 
Clones isolated from the DBA cDNA library and from B. Hill were in pBR322, these 
were transferred to Bluescribe where necessary. The 129/St mouse cosmid library (gift 
of L. Stubbs, ICRF) was cloned in pcosEMBL2 (Ehrich et al., 1987). The DBA mouse 
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genomic library (from R. Hill) was cloned in XEMBL3. The bacteriophage cDNA 
libraries (R. Hill and Clontech) were cloned in XgtlO. 
5.2 Bacterial Strains 
The most frequently used strain of E. coli used was JM83 (Messing, 1983), as it is 
readily made transformation competent by a number of procedures, has a stable pheno-
type, and does not require IPTG to induce the lac Z promoter on the Bluescribe plasmid. 
Its genotype is: E coli JM83 ara, iacpro, strA, thi, o8Od, lac Z ^M15 
For screening phage libraries, E. coli LE392 and BNN 102 were used as recommended in 
Maniatis (1982). For E. coli expression of foreign proteins, several bacterial strains were 
employed, notably CAG629 (gift from J. Myles), a protease deficient strain. 
ts Its genotype is CAG629: iacZ (am), t,p (am), pho(am), supC, ma!, rpsL, ion, htpR 
5.3 Bacterial Media 
E. coli were normally grown on LB (Luria-Bertani) agar plates or in LB medium. 
LB medium, per litre (pH 7.5): lOg bacto-tryptone (Difco), 5g bacto- yeast extract 
(Difco), lOg NaCl. LB Agar: LB medium plus 1.5% Agar (Difco). LB Top Agar: LB 
medium plus 0.7% Agarose (Sigma). 
H agar plates were used when the lac Z blue-white test was used to detect inserts, in 
conjunction with 0.02% BCIG (5-bromo-4-chloro-3- indolyl--D-galactoside; stock solu-
tion = 2% in dimethylformamide). H agar, per litre (pH 7.3): lOg bacto-tryptone 
(Difco), 8g NaCl. 
Terrific Broth (Tartoff and Hobbs, 1987) was used latterly, for large scale plasmid 
preparations as it gave considerably higher yields of DNA than LB medium. This is 
presumably due to the supplementation of phosphate, and of an additional rich carbon 
source, glycerol. Terrific Broth, per litre : 15g bacto-tryptone, 30g bacto-yeast extract, 
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5m1 Glycerol. 1/10 volume of 1M K 2HPO4 added before innoculation. 
Antibiotics to select for plasmid maintainance were used at the following concentrations: 
Ampicillin (Sigma) lOOp.g/ml, Tetracyclin (Sigma) 25j.tg/ml, Kanamycin (Sigma) 
30j.tg/ml. Stocks were 1000X and stored at -20 0C. 
5.4 Subcloning DNA Fragments 
Subcloning of DNA fragments into plasmid vectors for further analysis was one of 
the most frequently performed procedures during the project. DNA fragments of interest 
were either isolated by agarose electrophoresis and purified before ligation or "shot-
gunned" into a plasmid mini-library and the correct clone identified by plasmid miniprep 
or by Grunstein-Hogness hybridisation. In either case, the purity of the insert DNA was 
the most important factor in the success of ligations, as T4 DNA ligase (BCL) appears 
to be strongly inhibited by agarose contamination. This phenomenon is much more pro-
nounced in blunt-end ligations, which never became routine. Elu-tips (Schleicher and 
Schuell), Spin-X columns, and DEAE-paper (Whatman) were all successful at times, but 
never totally reliable for blunt-ended DNA. For "sticky-end" (overlapping cohesive ter-
mini) ligations, use of GTG or LW Agarose (Seakem) and careful sequential phenol 
(twice), and chloroform (twice), extractions usually provided DNA of sufficient purity. 
Vector to insert ratios varied depending on insert size, but was usually 1:5 on a molar 
basis. 25 ng of linear vector was ligated to insert in a 10.t1 reaction volume with 1111  T4 
DNA ligase. Ligation was at room temperature for 2 to 4 hours. Ligations could be 
stored indefinitely at -20 0C before transformation. 
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5.5 Bacterial Transformation 
E. coli were normally made competent for DNA uptake by the method of Simianis 
(Hanahan, 1985), and could be stored for at least six months at -70 0C at an efficiency of 
5 x 106 colonies per jig of supercoiled plasmid DNA. The strain JM83 was normally 
used (Section 5.2) but other strains adapted well to this method. Cells were grown to an 
A260 of 0.5 in LB medium + 10mM MgC1 2 . After chilling on ice and pelleting at 
3000rpm for 10 mm, cells were resuspended in 0.3 volumes of RF1 solution (RF1 = 
100mM Rubidium chloride, 45mM manganese chloride, 30 mM potassium acetate, 
10mM calcium chloride, and 15% w/v glycerol, pH 5.8) and left on ice for 30 minutes. 
The cells were respun and resuspended in 0.1 volumes of RF2 solution (RF2 = 10mM 
MOPS, 10 mM rubidium chloride, 75 mM calcium chloride, and 15% w/v glycerol, pH 
6.8). After 15 min on ice, the cells were flash-frozen in liquid nitrogen in 200j.ti aliquots 
and stored at - 700C. For transformations, the cells were thawed at room temperature 
and placed on ice. Ligated DNA (< lOjtl) was added to the cells and left to adsorb on 
ice for up to 1 hour. After a 90 second heatshock at 42 °C, the cells were chilled on ice 
for 1 minute, 0.8 mis of LB medium added, and the cells allowed to develop antibiotic 
resistance for 1 hour at 37 0C. Suitable aliquots of the transformation were then plated on 
selective media and grown overnight at 37 0C. 
This transformation procedure proved very reliable throughout this work and 
methods producing more highly competent E. coli (eg Hanahan, 1983) were rarely 
resorted to. 
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6. SOUTHERN AND NORTHERN BLOTTING 
6.1 Genomic DNA Digests 
Genomic DNA was stored at 4 0C until required. Routinely, 5.tg of DNA per gel 
lane was digested with restriction enzyme, before electrophoresis. Enzyme digests were 
carried out at 37 0C according to manufacturers instructions. The standard DNA concen-
tration for digestion was 0.1 to 0.2 mg/ml, with an enzyme excess of 3 units per micro-
gram. Digestion was for a minimum of four hours, for mammalian DNA, and normally 
overnight. The standard digestion conditions were 50 mM Tns-CI (pH 7.5), 100mM 
NaCl, 10 mM MgC12 and 5 mM spermidine. Reactions were halted with Stop Mix 
(30% Ficoll, 0.25% Orange G, 0.5M EDTA, and lOX TAE buffer) and stored at room 
temperature before loading. 
6.2 Agarose Gel Electrophoresis - DNA 
Agarose Gels were either run in TAE (Tris-acetate) or TBE (Tris-borate) buffer. 
20X TAE = 0.8M Tris-Cl, 0.4M NaOAc, 20mM EDTA, pH adjusted to 8.2 with Glacial 
Acetic Acid. lOX TBE = 1M Tris-Cl, 0.8M Boric Acid, 20mM EDTA, pH 8.3. For 
Southern blotting, large (25 cm x 20 cm, 250 - 300 ml) gels were run at 40V overnight 
in TAE buffer. Up to 24 lanes per gel could be loaded, with phage ? DNA digested with 
HindIll used as a size marker. The concentration of agarose was varied, depending on 
the size of DNA bands expected, but was normally about 0.8% in lx TAE. In the 
cosmid partial mapping experiments the gels were about 0.4% agarose in TAE. Mini 
gels (20 ml volunie) were normally run in TBE as this buffer is less prone to overheat-
ing at higher voltages; these gels had ten lanes and were used for rapid subcloning 
analysis. The size marker for mini gels was PhiX 174 DNA digested with Haeffi. 
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6.3 Southern Transfer 
This broadly follows the method of Southern (1975). Following photography of a 
gel, the DNA was denatured by immersion in three gel volumes of denaturing solution 
(0.5M NaOH, 1.5M NaCl) for forty minutes. This was followed by thirty minutes in 
neutraliser solution (1M Tris-Cl, 1.5M NaCl pH 5.5). The gel was then laid on a transfer 
apparatus, a wick of Whatmans 17MM filter paper with a reservoir of 20X SSC (20X 
SSC = 3M NaCl, 03M Na citrate, pH 7.4.) A nitrocellulose (Schleicher and Schuell) or 
Hybond-N (Amersham) membrane was carefully placed on the gel, avoiding any air 
bubbles. Two sheets of Whatmans 3MM filter paper were placed over the filter, followed 
by paper towels to a depth of 5 cm. A weight (about 1 kg) was placed on the assembly, 
and transfer carried out for at least eight hours. The membrane was then baked for two 
hours at 80°C (nitrocellulose) or UV irradiated for three minutes (Hybond-N). For mini-
gel blotting, the denature step was reduced to fifteen minutes, the neutraliser step omit-
ted, and transfer time reduced to thirty minutes. 
6.4 RNA Electophoresis and Northern Blotting 
RNA was also electrophoresed in agarose, with the inclusion of 18% formaldehyde 
to ensure that secondary structure in the RNA (a cause of mobility anomalies) was 
minimised. Up to lOp.g of total RNA or 2p.g of poiyA RNA was loaded per gel track. 
RNA was denatured for 10 minutes at 45°C in 2 volumes of l.SX Sample Buffer (300 AI 
deionised formamide, 108p.l formaldehyde solution, 6p1 1M phosphate buffer). The gel 
was prepared in 10mM sodium phosphate buffer (IM NaPO 4 buffer pH 6.5 = 70% 1M 
NaH2P02 + 30% 1M Na2HP02. 1.5g of agarose was melted in 82 mis of buffer, and 
after cooling to 55°C, 18ml of formaldehyde solution (BDH) was added and the gel 
poured quickly. 0.1 volumes of Loading Mix (0.1% bromophenol blue in Stop Mix) was 
added to the RNA samples, and the gel run at 40V (15V overnight), after loading. The 
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low voltage was necessary as the gels were prone to buffer failure at high current or 
temperature and this degraded the RNA. Buffer failure was detected by change of the 
bromophenol blue to a yellow colour. The gel was soaked in 1 litre of 2X SSC for 2 
hours to remove the Formaldehyde, and any marker lanes were removed for ethidium 
staining. The remainder of the gel was blotted on a Northern transfer apparatus (as 
Southern but with lOX ssc in the reservoir) for at least eight hours. Filters were then 
processed as for Southern blots. 
6.5 Hybridisation 
Pre-hybridisation and hybridisation for Southern and Northern filters were carried 
out in Quick-Hybe hybridisation mix. This consisted of 5X SSC, 0.1% bovine serum 
albumin, 0.1% ficoll, 0.1% polyvinylpyrrolidine, 0.5% SDS, 0.5% sodium pyrophosphate 
and lOOp.g ml denatured salmon sperm DNA. It was stable for several months at room 
temperature. Filters were sealed in plastic bags with about 1 ml Quick-Hybe per 20cm 2 
of filter. After prehybridisation at the appropriate temperature for at least twenty minutes, 
the probe was carefully added to the bag, and hybridised for an appropriate period. For 
genomic blots, total RNA blots, and primary library screens this was normally overnight, 
but under more favourable conditions could be reduced to two hours. The bag was then 
carefully opened in a 2X SSC wash (4X SSC for oligonucleotides) at the hybridisation 
temperature, the probe discarded to drain, and the filters washed at the appropriate 
stringency until the signal reached an acceptable level. Filters were then wrapped in 
clingfilm, keyed with radioactive pen, and autoradiographed at -70 °C with Kodak XAR-
5 film. Films were developed in a Fuji RGB-2 Automatic Film Processor. 
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7. NUCLEIC ACID PROBES 
7.1 Nick Translation of DNA 
This technique was used in early stages of the project. It is essentially the method 
of Rigby(1977). DNA (lOOng to 300ng) incubated with DNA polymerase I from (E.coli) 
and bovine pancreatic DNAse I in the presence of a radioactively labelled nucleotide, 
and the three other unlabelled nucleotides, will incorporate label as the polymerase 
removes and replaces tracts of DNA initiating at single stranded nicks produced by the 
DNAse. The reaction is carried our at 15 0Cwhich permits template extension by Pol I, 
but prevents excessive DNA degradation by DNAse. Reactions were carried out in lOjfl 
with li.i.l lox salts (500mM Tris-Ci (pH 7.8), 50mM MgC12, 0.2mM 
dATP,dCTP,dGTP, and lOOj.tg/ml bovine serum albumin.), lOOng DNA in 5j.iJ ddH2O, 
3W (=30g 32P dl'TP, and lp.l of DNA polymerase IJDNAse I mixture (0.4units/j.Ll). 
This was incubated at 15 °C for 1 hour, and incorporation of radioactivity measured by 
TCA precipitation. Successful reactions had 100p.1 of denatured salmon sperm (10 mg/ml 
stock) added to them and were boiled for ten minutes immediately before addition to the 
prehybridised filter. 
7.2 Random Priming of DNA 
This technique was used later in the project as it was more convenient (BCL Ran-
dom Priming Kit), more reliable, and gave higher specific activity of probe than nick 
translation. The technique is based on the method of Feinberg and Vogelstein (1983), 
and uses random hexanucleotides to act as primers for polymerase chain extension in the 
presence of radiolabelled nucleotides. As little as lOng of DNA could be used, even in 
an agarose fragment. Routinely, 50ng of DNA (plasmid or insert), was denatured in 
10p.l TE for 10 minutes by heating to 100 0C. The sample was chilled on ice, and 5p.1 of 
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random-prime buffer/dNTPs was added, followed by 4j.i.l p  dC'FP, and liii  Kienow 
fragment of DNA Polymerase I. Random-prime buffer consists of hexanucleotides in 
4X Kienow Buffer, and 200tM dATP,dGTP,dTIP. The reaction was incubated at 37 °C 
for 1 hour, and incorporation checked by TCA precipitation. If satisfactory incorporation 
(> 20% of free counts) was obtained, lOOjil of denatured salmon sperm DNA (10 
mg/ml) was added, the probe heated to 100 9C for 8 minutes, and added to the prehy -
bridising filter. 
7.3 Oligonucleotide Labelling 
Oligonucleotides were radiolabelled for use in sequencing or hybridisation experi-
ments by T4 polynucleotide kinase. This enzyme transfers the y-phosphate from 32P 7- 
ATP to the 5' OH group of a dephosphorylated oligonucleotide. For sequencing or probe 
reactions, 30ng of oligonucleotide in 4j.tl TE, i.t1 lOX kinase buffer (0.5M Tris-Ci pH 
7.5, 60mM MgCl2)  50mM DTI'), 3p1 p y-ATP, and ljii T4 polynucleotide kinase was 
incubated at 37 °C for 30 minutes. Incorporation was checked, if necessary, by chroma-
tography on DEAE paper in 3M ammonium formate. lOOp.! of denatured salmon sperm 
was then added to probe reactions, and the mixture added to the prehybridisation. Oh-
gonucleotides for sequencing proceeded into the sequencing protocol. Occasionally, oh-
gonucleotides were used for Southern Blots. In these experiments, 80p.Ci rather than 
30p.Ci of label was used to obtain a higher specific activity of probe. 
7.4 Synthetic RNA for Hybridisation and Translation 
RNA probes were produced in vitro using the SP6 and T7 phage polymerase sys-
tems (Kreig and Melton, 1984; Melton et al, 1984). Briefly, a plasmid containing the 
insert of interest and a flanking SP6, T3, or 11 promoter sequence (eg pBluescribe) was 
linearised with a restriction enzyme distal to the insert. After phenol and chloroform 
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extractions, DNA was incubated with appropriate polymerase, and ribonucleotides, at 
37°C for an hour. Inclusion of a radio-labelled ( 32P or 35S) nucleotide (minimum con-
centration lOp.M to prevent truncated transcripts) produced a single stranded probe of 
high specific activity. (The template can then be removed by DNAse digestion if 
required, but this was not always necessary). Large amounts of unlabelled capped RNA 
can be produced by the inclusion of a m 7GpppG dinucleotide cap analogue in the reac-
tion mixture (Contreras et al, 1982). The Transprobe T (Pharmacia) kit was used to pro-
duce mRNA for in vitro translation (section 8.2) by this method, according to manufac-
turers instructions. 
8. PROTEIN ANALYSIS 
8.1 SDS Polyacryla,nide Gel Electrophoresis 
SDS PAGE gels were run using an LKB (Pharmacia) system (Laemnili, 1970). For 
optimal separation of proteins in the 4OkD to 50kD size range, 11% gels were normally 
poured. Gels were composed of 13m1 30% acrylamide stock (58g acrylamide, 2g bis-
acrylamide in 200m1 H20), 9mls of separating gel buffer (1.5M Tris-Ci pH8.8, 0.5% 
SDS) and 14m1 of ddH2O. 50j.tl of TEMED (N N' tetramethylethylenediamine) and 
lOOjil of 10% ammonium persuiphate were added just before pouring to polymerise the 
mix. Sufficient space for the stacking gel was left at the top of the gel, which was 
covered in water saturated isobutanol while it set. Stacking gel consisted of 1.5m1 of 
acrylamide stock, 2.5m1 of stacking gel buffer (05M Tris-Cl pH 6.8, 0.5% SDS) and 
5.7m1 ddH2O. 30tl ammonium persulphate and 10.tl TEMED were added just before 
pouring over the separating gel, which had been rinsed to remove unpolymerised 
acrylamide and isobutanol; After setting, wells were thoroughly rinsed before running to 
remove unpolymerised stacking gel acrylamide. Gels were run in electrophoresis buffer 
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(lOx EB = 0.5M Tris-Ci, 0.5M glycine, 10% SDS). Protein samples were added to 2 
volumes of smash buffer (10% stacking gel buffer, 2% SDS, 5% -mercaptoethanol, 
10% glycerol, 0.005% bromophenol blue) and boiled for 5 minutes before loading. Gels 
were run at 6 to 10 mA overnight, until the dye-front reached the end of the gel. After 
soaking in destain (45% methanol, 45% H20, 10% acetic acid) gels were either stained 
with Coomassie Blue (Sigma) to visualise the protein bands, or soaked in Amplify 
(Amersham) and dried down for autoradiography. 
8.2 Translation of mRNA with Reticulocyte Lysate 
Translation of in vitro produced mRNA from full length cDNA sequences was per -
formed using the Amersham Rabbit Reticulocyte Lysate kit N.90, according to manufac-
turers' instructions. In the presence of added mRNA, and radiolabelled L-{ 35S] 
methionine, the lysate will synthesize specifically the mRNA-encoded proteins. A typical 
reaction included 40J11 of lysate mix, 7tl (=70pCi) of radiolabelled methionine (Amers-
ham SJ.204) and 3tl (=1ig) of capped synthesized mRNA. After incubation at 30 0C for 
70 minutes the incorporation of label was measured by TCA precipitation and the sam-
ples were subjected to SDS PAGE and autoradiography, with or without prior incubation 
with putative target proteinases. 
CHAPTER THREE 
The Evolution of Contrapsin in the Genus Mus 
Introduction 
Hill and Hastie (1987) demonstrated that accelerated evolution had occurred 
specifically within the reactive centre regions of four Spi-2 cDNAs. These were contrap-
sin, from the laboratory mouse strain Swiss, Spi-2.1 and Spi-2.2 from inbred R. norveg-
icus (Buffalo strain), and human al-antichymotrypsin. The nucleotide sequences of rat 
Spi-2.1 and contrapsin were as divergent (33% identity) from one another in the reactive 
centre region as either sequence was from al-antichymotrypsin (31% and 41% identity 
respectively). It was assumed that the contrapsin and rat Spi-2.1 sequences were ortholo-
gous as they shared P1 residue specificity (arginine), had a very similar mRNA size, and 
were transcribed in the liver at similarly high levels ( - 0.5% of mRNA). If a consensus 
divergence time of fifteen to twenty million years is accepted for rat and mouse (Figure - 
3. 1), their rate of evolution during this period is calculated to be higher than that of neu-
tral regions such as pseudogenes or 3' untranslated sequences. A computer analysis to 
calculate the rate of nonsynonymous (K A)and synonymous (Ks) substitutions (Li et al., 
1985) showed that the K   values for the reactive centre, Region 2, were four-fold higher 
than the KS  values for the 5' coding sequence, Region 1. By several criteria, including 
KdKA ratios in the remainder of the gene, expression levels of the Spi-2 transcripts in 
the liver, and probable inhibitory activity for both contrapsin (Takahori and Sinohara, 
1982) and rat Spi-2.1 (Le Cam et al., 1987), the two genes appear to be active. It was 
suggested by Hill and Hastie that the genes are diverging in the reactive centre region at 
a rate which involves positive Darwinian selection for mutation. 
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The neutral theory of molecular evolution (Kimura, 1983) predicts that the great 
majority of observed substitutions during sequence divergence are due to random 
occurrence of mutations in a DNA sequence; that is unselected changes. Advantageous 
mutations are predicted to be comparatively rare, and disruptive mutations to be more 
abundant but subject to negative selection, and therefore ultimately lost from a popula-
tion. The majority of observed mutations are considered to be neutral, due to codon 
degeneracy, conservative amino acid substitutions, or substitutions in domains which do 
not perturb protein function. Thus the majority of sequence polymorphism in a popula-
tion will be due to the ongoing process of random fixation of alternative neutral alleles. 
The theory has become widely accepted, as a large body of sequence data indicates that 
a considerable amount of mutation is effectively neutral (Li et al, 1985). 
However, there are examples of sequence analysis which are effectively incompati-
ble with the neutral theory. Hudson et al (1987) have shown that the level of 
synonymous polymorphism in the Drosophila melanogaster alcohol dehydrogenase 
(Adh) gene is four fold higher in the coding region than in the 5' flanking region. This 
appears to be at odds with the neutral theory, which would predict that a coding region 
should be under greater evolutionary constraint than a non-coding flanking sequence, and 
should therefore contain less neutral variation. Comparison with a separate fruitfly 
species showed that the observed difference was not due to variation in mutation rate 
between coding and non-coding regions, but rather an "excess" of polymorphism in the 
Adh coding region. It would appear that there is positive selection for polymorphism in 
this region. In fact, it has long been held that there is selection for a balanced polymor-
phism for two electrophoretically distinct Ad/i alleles (Greenough and Harvey, 1987) 
Given the substitution rates determined for the rodent Spi-2 genes, the neutral 
theory would predict that the reactive centre region of the Spi-2 genes should be highly 
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polymorphic, both within and between species. Either the reactive centre region is not 
under stringent compositional selection, or the genes lack an inhibitory function, and the 
reactive centre, as an external loop, would be free to evolve at almost pseudogenic rates. 
This neutralist explanation of the Spi-2 data has been advanced by Graur and Li (1988), 
as discussed in Chapter 1. 
However, if positive Darwinian selection was acting upon specific nonsynonymous 
reactive centre substitutions, the reactive centre might not be expected to be highly 
polymorphic within a species, or to have diverged rapidly between closely related 
species. This would assume rapid fixation and subsequent stablising selection for an 
unchanging inhibitory specificity. Conversely, if the selective agent were a co-evolving 
parasitic proteinase, frequency dependent selection might cause pronounced intra-species 
reactive centre polymorphism. This type of process has received a theoretical treatment 
(Clarke, 1976), and has been proposed as a possible cause of the pronounced polymor-
phism of certain MHC sequences (Bodmer, 1972). A recent analysis suggested that 
MHC polymorphism may instead be due to overdominant selection, ie heterozygote 
advantage (Hughes and Nei, 1988) 
A frequency dependant selection scenario has been suggested as a possible source 
of the high synonymous substitution rate found for the Spi-2 reactive centres (J. Howard, 
personal communication), since fixation might be retarded by frequency dependent selec-
tion, allowing linked silent mutations to occur. An alternative explanation for the high 
synonymous substitution rate may be simply that the reactive centre sequences are too 
short and too divergent to provide suitable input for the computer program in its present 
form. 
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Figure 3.1 Consensus phylogeny for rodents used in this study. Earlier divergence 
times are particularly uncertain, especially the date of Rattus/Mus divergence. Areas of 
uncertainty about divergence times or branching order are shown as dashed lines, 
although the overall structure is broadly accepted. The timescale below is also a con-
sensus, with contrasting estimates of up to two-fold higher or lower. The tree is based 
on data from mitochondrial DNA, ribosomal spacer DNA, immunoprecipitation, electro-
phoresis of soluble protein and restriction analysis of nuclear genes (reviewed in Sarich, 
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It was felt that an analysis of Spi-2 reactive centre sequence stability among 
species which had diverged very recently might reveal intermediates in the divergence 
process, and indicate possible evolutionary mechanisms for this phenomenon. 
The genus Mus was a suitable choice for an analysis of this type, because of the 
existence of several murid species which diverged at intervals after mouse and rat diver-
gence. A consensus molecular phylogeny of species for which liver RNA was available 
is shown in Figure 3.1. The actual divergence times for more distantly related Mus 
species are tentative, especially for the Mus/Rattus divergence which is thought to have 
occurred between 10 and 30 million years ago (Sarich, 1985; Bonhomme, 1987). The 
contrapsin gene was the most suitable Spi-2 sequence for examination, due to its high 
levels of expression in the liver, and the fact that it had previously been sequenced (Hill 
et al., 1984). 
Northern Blot Analysis of Contrapsin Evolution in Mus 
Experiments were carried out to examine the nature of the contrapsin reactive cen-
tre region in closely related species within the genus Mus. Initially this was carried out 
by oligonucleotide hybridisation to Northern.blots of mouse total liver RNA. Oligonu-
cleotides were used as probes since the variable reactive centre region comprises less 
than five percent of the total Spi-2 coding region, and cDNA probes are unable to distin-
guish between reactive centres within the conserved remainder of the gene. Short (< 20 
nucleotide) oligonucleotides were used as these can detect single basepair mismatches in 
a complementary sequence under stringent conditions (Wallace et al., 1979). An 18mer 
antisense oligonucleotide (p54/RC-) was synthesised to complement the reactive centre 
region of contrapsin surrounding the P1 residue (Figure 3.2). This was used to hybridise 
to various inbred mouse and less closely related mouse RNAs (Figure 3.3B) and control 
rat RNA (not shown). 
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Figure 3.2 Sequence of the pLv54 contrapsin 3' coding region showing the location of 
oligonucleotides used. Also shown are the predicted positions of intron-exon junctions in 
the rodent Spi-2 genes, based on the human al-antichymotrypsin and cxl-proteinase inhi-
bitor genes. Numbering of sequence is as in Hill and Hastie (1987). Oligos are shown as 
asterisks, arrowed at their 3' ends. Region 2 sequence is boxed and in lower case, except 
for the P1 residue. Region I is the entire coding sequence 5' to Region 2, and Region 3 
is defined as the remainder of the coding sequence 3' to Region 2. 
P54/1+ 
1 	***************> 	 exon2 <!> exon3 
GTGGTGCTGGTGTTACATCTACTTTAGGCATGGAAGATATCCTTTGACCCCCAG 




D T F ES K F Y L D E KR S V K V P MM 
121 
AA TGAAGTTACTGACCACACGCCACTTCCGTGAT CTATTGCTCTGTGTTG 
KM K L L T T R 	FR D E E L SC S V L 
181 
GAGCTGAAGTACACAGGAAATGCCAGCGCCCTGCTCATCCTCCCTGACCAGGGCAGGATG 




Q Q V K AS L Q PET L R K W R K T L F 
p54/X4+ 
301 < 	> exon 4 	
***************> 
CCCAGCCATAGAGGAGCTACCTGCCCGTTCTCCATCGCTAGTCTACAGGCTG 
PS Q I EEL N L P K F S 	A S 	Y 	L 
361 
GAGGAGGATGTCCTTCCAGAITGGGGATTGGGTCTTCACCGCGCTGACCTA 
E ED V L P E MG I K E V FT E 	A DL 
421 	 exon4 <!> exonS 
TCTGGGATCATAGAAACCAAGAAACTGAGTGTGTCTCAGGTGGTCCACGGCTGTGCTG 
S G lIE T K K L S VS Q V V H K A V L * * ** * * **** * * ** ** 
p54/ XV+ 
p54/129+ 	p54/5'+ 
481 	 ***************>**********> 
GATGTGGCTGAGACAGGCACAGAAGCAGCTGCTGCCACAGGGGTIattggtggcattCGT 





k a ii P  a v h F N R P FL F VI Y H T 




S A Q S 	L F MA K V N NP K **** ** * * 
p54/3'- 
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Figure 3.3 Northern blot of mouse liver RNAs. A: probed with oligo p54/1- ; B: probed 
with oligo p54/RC- ; C: probed with oligo p54/3'-. Five ji.g of total liver RNA was 
loaded for each mouse strain. The position of ribosomal size markers is indicated 
A Internal 1—mer. 	B Reactive center 18—mer. 	C C—terminal 18—mar. 
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The contrapsin signal was present in all the inbred mice examined, although at reduced 
levels in C57BL/6 mice. It was also present in wild M. domesticus , M. spretus, and 
surprisingly in M. caroli, a considerably more distant relative ( 6 to 8 million years 
diverged - Fig 3.1) of the laboratory mice. 
The signal intensity for wild M.musculus (Danish - from G.Bulfield) was also 
reduced, to the same degree as that of C57BL/6. There was no detectable hybridisation 
of the contrapsin oligo to Sprague Dawley rat RNA (not shown). The blot was then 
probed with an antisense 16mer oligonucleotide (p54/1-) to a highly conserved region in 
the centre of the contrapsin sequence (Fig 3.3A); this hybridised to all the mouse RNAs 
more equally and indicated that the dimunition of reactive centre signal from C57BL/6 
and M. musculus might be due to a genuine sequence difference in the reactive centre of 
these mice. A third oligonucleotide, p54/3'-, hybridised strongly to all the mice, although 
less strongly to Mus caroli, indicating possible 3' divergence for this less related species 
(Figure 3.3C). Interestingly, two transcripts of similar abundance were observed in M. 
caroli; an 18S band (typical of other mice) and a 20S band, only seen faintly in some 
inbreds and in Mus domesticus, never in C57BL/6 or Mus musculus. The fact that Mus 
spretus (and Mus caroli) appeared to express a completely conserved reactive centre 
sequence was an indication that some degree of functional conservation had occurred in 
the contrapsin gene in the last 4 to 8 million years. 
Attempted PCR Analysis of Contrapsin Reactive Centre 
To confirm and extend this analysis, it was decided to attempt to obtain sequence 
data for the reactive centre region of the murine contrapsins. The initial efforts centred 
upon the use of the Polymerase Chain Reaction (PCR) technique which had been 
recently published (Saiki et al., 1985). This method of amplifying specific segments of 
polynucleotide sequence within a complex mixture employs two specific oligonucleotide 
53 
primers complementary to opposite strands of sequences flanking the desired segment. 
The PCR technique, and more recent associated strategies (Ehrlich, 1989) have since 
become of central importance to molecular biology. 
It was decided to amplify the reactive centre region using a sense oligonucleotide 
(p54/5'+) and an antisense oligonucleotide (p54/3'-) to span the reactive centre and car-
boxyl terminus (Fig 3.2). Successful PCR should yield a DNA fragment of 144bp which 
could then possibly be analysed by sequencing, fine restriction mapping, or an RNAse 
protection assay (Winter et al., 1985). The PCR was to have been carried out on total 
RNA samples from mouse liver, the first amplification step being carried out by reverse 
transcriptase to produce a cDNA template for subsequent amplification. 
To test the system, initial experiments were carried out using the pLv54 plasmid 
which contained the original contrapsin cDNA clone. The plasmid was linearised by 
restriction with Eco RI, to allow efficient heat denaturation of the plasmid during the ini-
tial cycle. Two reactions containing lOng and ing of plasmid in 50pl of 1X Klenow 
Buffer, and 2mM dNTPs were then performed, using Klenow enzyme, adding 5 units at 
every cycle. Initial PCR reactions were carried out for 20 cycles, which should have 
yielded clearly visible DNA fragments of 144bp by agarose gel electrophoresis. However 
neither reaction gave visible bands of the correct size, after ethidium bromide staining. 
The experiment was repeated using plasmid DNA cut with Msp I which cuts internally 
to the GC tails known to flank the contrapsin cDNA. It was thought that the GC tails 
might be inhibiting denaturation of the cDNA sequence, or enhancing rapid reannealling. 
This experiment also gave negative results. PCR was abandoned at this stage in favor of 
other methods. It is worth noting that several improvements have been made to the tech-
nique since then, notably the use of heat stable DNA polymerase from Thermus aqua-
ticus which does not have to be added at every cycle. PCR has since been frequently 
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used for the type of rapid RNA analysis hoped for above, and would certainly be 
attempted again if the project was still at this stage. 
Sequencing of Contrapsin Reactive Centres in Mus 
Since contrapsin is abundantly expressed in the rodent liver (0.5% of mRNA), the 
3' oligonucleotide p54/3'- (Figure 3.2) was used to directly sequence total liver RNA 
using reverse transcriptase (RT) and dideoxynucleotides. Kaartinen et al, (1984), 
reported the use of reverse transcriptase to sequence purified mRNA from hybridomas 
producing monoclonal antibodies of interest. The technique has since been applied to 
determine the evolution of the lysozyme signal peptide sequence in various fowl species 
(Weisman et al, 1985). In this project initial attempts followed DNA sequencing pro-
cedures, substituting RT for Kienow enzyme (and the appropriate buffer) and incubating 
at 40°C during the termination reaction. However, Klenow enzyme and RT have dramat-
ically different affinities for dideoxy, compared to deoxy nucleotides. Kienow enzyme 
requires ratios of about 25:1 dideoxy:deoxy for efficient (mis)incorporation of the termi-
nation analogue, whereas RT is less nucleotide specific (ratio of 1:1 dideoxy:deoxy). 
This became apparent when initial gels, run with reverse transcription reactions using 
Klenow dideoxy:deoxy mixes, only gave one to two bands in each lane at the bottom of 
the gel. This was readily corrected, and useful sequence data was obtained after a few 
further modifications. 
Initially, three total liver RNAs (DBA, M. domesticus, M. spretus), and one polyA 
liver RNA (BALB/c) were sequenced. An early gel is shown in Figure 3.4. From this 
data, sequence for the total RNAs could be established for more than 90 basepairs, up to 
and including the P1 residue (Figure 3.5). 
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Figure 3.4 Example of early RNA sequence autoradiograph. A,B,C,D for each sample 
refers to the A°, CO , G°, and TO dideoxynucleotide reactions. The P1' residue sequence 
(AAG) can be seen at the very top of the photograph. 
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Figure 3.5 Sequence of contrapsin reactive centres and 3' coding region for various 
mice. The nucleotide and predicted protein sequences are shown. Dashes below the ori-
ginal pLv54 Swiss sequence indicate sequence identity. Region 2 (the reactive centre) 
sequence is boxed and shown in lower case, except for the P1 residue (CGT). 
swiss 	 GTG CTG GAT GTG GCT GAG ACA GGC ACA GAA GCA GCT GCT GCC ACA GGG 
DNA 
C57BL/6 	--- --- --- --- --- --- --- T-- --- --- --- --- --- --- --- --- 
t4.musCulus - --- --- --- --- T-- --- --- --- --- --- --- --- --- 
t4.hortulanus 
M.caroli 
V 	L D V A E T G T E A A A A T 	G 
C 
- . C 
swiss 	 GTT att ggt ggc att CGT aag gcc ata tta cca gct gtg cat TTC AAC 
DBA 
M.domesticus 
C57BL/6 	--- - g -- --- --- --- --- tg - ---- ---  
N.musculus --- - g -- --- --- --- --- tg - ---- ---  
M.hortulanus --- tg  --- --- 
M.spretus 
.caroli ----a --- tc- ---- ---  
V i g g i R k a i 1 p a v h F N 
V - 	- 	- 	- 	C 	- 	- 
V - 	- 	- 	- 	C 	- 	- 
C 	- 	- 
C 	- 	- 
5 - 	- 
swiss 	AGG CCA TTC CTG TTT GTT ATC TAT CAC ACA AGT GCT CAG AGT ATC CTC TTT 
DBA 
M .dornest. --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- 
C57BL/6 	--- --- --- -- T A -- --- --- --- --- --- --- --- --- ---  
M.muscul. --- --- --- -- T A______________________________________ 
M.hortul. -  --- --- --- --- --- --- --- --- --- --- 
spretus 
caroli --- --- --- --- -- G --- --- --- -- G --- G-- T -- --- --- --- -- A 
R 	P F L F V I Y H T S A Q S I L 	F 
- 	 - - 
- I 
- 	 - - 
- I 
- 	 - - 
- L - - - Q - G S 
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This confirmed the indications from the Northern data, described above, that the 
sequence surrounding the P1 residue appeared to have evolved at k5pical rates since the 
divergence of Mus domesticus and Mus spretus (2 to 4 mya). No differences were found 
between DBA/2 and wild Mus domesticus (Greek, from G. Buifleld). 
Comparison of the pLv54 and Mus spretus contrapsinsequences revealed only one 
base change over the original region sequenced. This was an A to G transversion, caus-
ing a histidine to arginine substitution at the boundary of Region 2 (reactive centre) and 
Region 3 (as defined in Hill and Hastie (1987)). This is a conservative amino acid sub-
stitution, and would be unlikely to cause an alteration in contrapsin inhibitory specificity. 
The BALB/c polyA sample did not sequence as well as the total RNA samples. 
The reason for this was never clearly established, but was unexpected given a theoretical 
20-fold enrichment of the sequencing template. Reaction conditions may have become 
limiting (eg nucleotide concentration) with higher concentrations of template, or degrada-
tion of template may have occurred during mRNA isolation. Experiments to optimise 
sequencing of purified polyA never established a cause, or solved the problem. In any 
case, the partial BALB/c sequence which was obtained was identical to that of the DBA 
and Mus domesticus genes. 
Evolution of the Contrapsin Gene in More Divergent Mice 
The fact that Mus spretus contrapsin is so similar in sequence to the original (Mus 
domesticus) contrapsin, pLv54, indicates that the accelerated evolution (Hill and Hastie, 
1987) appears to have slowed or halted, before the divergence of Mus domesticus and 
Mus sprerus. These species are considered to have diverged two to four million years 
ago (Figure 3. 1), about one fifth of the M. domesticus/rat divergence time. This raised a 
question: at what stage of murine radiation did fixation of the extant contrapsin actually 
occur? 
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Several murine species more distantly related to Mus domesticus (Figure 3.1) exist 
as laboratory stocks, and efforts were made to obtain some of these. Mus caroli was 
kindly donated by Dr. J. Ansell (Dept of Zoology, Edinburgh University), and total liver 
RNA was prepared from the liver of one male and one female individual. Sequencing of 
the RNA proved more difficult than for the inbred mice, possibly due to a mismatch 
between the primer, p54/3'-, and the M. caroli contrapsin (Figure 3.3C). Eventually, 
successful sequencing of the M. caroli RNA was achieved (Figure 3.5), which demon-
strated the presence of a typical mouse contrapsin with twelve of thirteen amino acid 
residues in the reactive centre region conserved, a histidine to serine substitution at the 
Region 2/Region 3 boundary being the only change. This represented an independent 
mutation at the same residue which was altered between Mus spretus and Mus domes-
ricus, indicating a lack of conservation at this position. There were several nucleotide 
substitutions in Region 3 of the Mus caroli contrapsin, reflecting the considerable evolu-
tionary distance between M. caroli and Mus domesticus (consensus divergence time six 
to eight m.y.a.). Surprisingly, two thirds of these nucleotide substitutions are 
asynonymous and would cause amino acid replacements. This could be due to relaxed 
selection at the carboxyl terminus of the protein due to lack of conformational constraint, 
but might be an indication that contrapsin is not under overall stringent selection in one 
or both of the species. Also, in the original Spi-2 study (Hill and Hastie, 1987), Region 
3 was evolving appreciably more rapidly than Region 1, and it may be that this region 
of the inhibitor is also involved in proteinase interaction. To address the question of 
relaxed carboxyl terminal constraints, other liver-encoded RNAs for serum proteins were 
sequenced, as described below. - 
At this stage, C57BL/6 and Mus musculus contrapsins, which had also been refrac-
tory to sequencing, were also successfully analysed. The reactive centre probe, p54/RC-, 
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had never hybridised as efficiently to these mice as to the other inbreds, Mus domesricus, 
or Mus spretus. The reason for this became apparent when the sequences were com-
pared. An A to G mutation causing an isoleucine to valine substitution was found in 
Mus musculus at the P2' position within the reactive centre. This might not be expected 
to have major functional effects, but would certainly destabilise the reactive centre oligo 
under the hybridisation conditions used (Figure 3.3B). The C57BL/6 mouse shared an 
identical contrapsin sequence to Mus musculus, which included a further two amino acid 
substitutions as compared to the pLv54 standard sequence. It is likely that a Mus mus-
culus individual was the donor for the C57BL/6 contrapsin gene sequence during 
development of the inbred strain. Similarly the DBA/2 and feral Mus domesticus 
sequences were identical when compared, indicating that the DBAI2 strain may have 
derived its contrapsin sequence from a Mus domesticus individual prior to isolation of 
the inbred strain. To illustrate this further, an oligonucleotide, p54/BL6-, (Figure 3.2) 
complementary to the Region2/Region3 boundary sequence for the C57BL/6 contrapsin 
was used to probe a Northern blot of mouse liver RNAs (Figure 3.6). This demonstrated 
that the C57BL/6, M. musculus, and C3H contrapsins are identical in this region, and 
distinct from the pLv54 (Swiss)/DBAIM. domesticus contrapsin group. Presence of the 
M. domesticus contrapsin is associated with the constitutive expression of a 20S form of 
the contrapsin sequence, which is not observed in M. musculus or in certain strains of 
inbred mice (Hill et al., 1985). The Mus musculus specific oligonucleotide p54/BL6-
only hybridised to strains lacking a constitutive 20S transcript. Thus, specific oligonu-
cleotides can be used to assign the contrapsm gene from inbred mouse strains to either a 
M.musculus or M.domesticus donor sequence. 
Figure 3.6 Northern blots of rodent liver RNAs with oligo p54/BL6-. 18S specific 
hybridisation can be seen for Mus musculus, and the inbred strains C57BL/6 and C3H, 
indicating that these mice share the cysteine variant contrapsin. 
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Divergence of Contrapsin in Ancient Mice 
The existence of a functionally similar contrapsin in both Mus domesticus and Mus 
caroli was unexpected. Stabilisation of the contrapsin reactive centre region appears to 
have occurred before the divergence of these mice, six to eight million years ago. This 
reduces the period during which contrapsin diverged from the rat Spi-2.1 sequence (see 
figure 3.1), and consequently further increases the rate of reactive centre divergence, as 
calculated by Hill and Hastie (1987). 
To further determine the point at which contrapsin became functionally stabilised in 
the ancestors of modern Mus, studies were carried out on murine species which diverged 
from the rat lineage before Mus caroli. The wood mouse, Apodemus sylvaticus, is a 
major non-commensal murine species in Britain. It is thought to have separated from 
the Mus lineage after mouse/rat divergence (Figure 3.1) although this is not thoroughly 
established. Specimens of Apodenzus sylvaricus were trapped at the Bush Estate for 
analysis. Total liver RNAs from mouse, A. .sylvaticus and rat were probed with the rat 
Spi-2.1 cDNA pSPFL2.1 to determine the relative abundance and nature of Spi-2 
sequences in Apodemus (Figure 3.7). Apodemus proved to express both 18S and 20S 
Spi-2 transcripts, but at far lower levels than either rat or mouse. This could be due to 
increased evolutionary distance between Apodemus and the other two rodents. However, 
analysis of other mRNA sequences, (see below), did not support this possibility. Alterna-
tively, Apodemus may lack the contrapsin gene, at least as defined by level of expression 
in the liver. Several attempts to sequence Apodemus liver RNA with conserved Spi-2 oh-
gonucleotide primers failed. This could have been due to divergence in the rapidly 
evolving carboxyl terminus region, or to low abundance of a contrapsin transcript, but 
later cDNA cloning analysis confirmed the lack of a detectable expressed orthologue of 
the contrapsin sequence (Chapter 5). 
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Figure 3.7 Northern blot of rodent liver RNAs probed with rat Spi-2.1. The blot is 
heavily overexposed to reveal the presence of two Apodemus Spi-2 transcripts (18S and 
20S) at low abundance. Ten pg of total liver RNA was loaded for each species. 1. 
DBA, 2. C57BL16, 3. and 4. Induced C57BL/6, 5. Apodemus sylvaticus, 6. Rat, 7. 
Induced rat. Sizes of ribosomal markers are indicated. 
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Figure 3.8 Northern blot of rodent liver RNAs probed with the contrapsin subclone 
pBXC1.4. This membrane was used several times and accumulated a high nonspecific 
background. Ten jig of total liver RNA was loaded for each species. Lane 1. M. domes-
ticus RNA, 2. DBA, 3. M.musculus, 4. C57BL/6, 5. M. hortulanus, 6. M. sprerus, 7. M. 
caroli, 8. M. cooki, 9. M. cervicolor, 10. M. saxicola, 11. M. pahari, 12. M. minutoides, 
13. A. sylvaticus, 14. R. norvegicus. Sizes of ribosomal markers are indicated. 








Since Apodemus appeared to lack the contrapsin characteristic of the modern mice, 
species more closely related to Mus domesticus were examined next. Liver RNA from 
Mus pahari, Mus saxicola, and Mus minutoides were obtained from F. Berger (Univer-
sity of S.Carolina). These mice diverged from Mus domesticus some 10 million years 
ago, although their branching order is not clear (Figure 3.1). The RNAs were electro-
phoresed and Northern blotted with the contrapsin cDNA subclone pBXC1.4 (Figure 
3.8). This represents the 3' third of the coding sequence and is a more specific contrap-
sin probe than the rat cDNA pSPFL2. 1 used in Figure 3.7. The probe hybridises 
strongly to mice as divergent as Mus domesticus, Mus cervicolor and Mus caroli all 
already known to have a conserved contrapsin sequence. Less intense hybridisation is 
observed to Mus pahari and Mus saxicola RNA. There is no obvious hybridisation to 
Mus minutoides, Apodemus sylvaricus, or rat liver RNA. This may indicate the presence 
of a contrapsin sequence in M.pahari and M.saxicola which arose before these species 
diverged from the more recently separated mice. 
However, attempts to hybridise contrapsin-specific oligonucleotides to Northerns 
like the one shown in Figure 3.8 never revealed any hybridisation to the M.pahari or 
M.saxicola liver RNA (not shown), and attempts to sequence liver RNA directly were 
also unsuccessful. The contrapsin equivalent in these mice may have diverged from the 
pLv54 sequence in the sequences complementary to the oligonucleotide, or the hybridisa-
tion observed in figure 3.8 may be due to another Spi-2 sequence. This question will be 
discussed later (Chapter 7). 
RNA Sequencing of Albumin in Mus 
The increased rate of divergence observed in the carboxy terminus region of the 
otherwise conserved contrapsin gene raised the question of whether this was typical of 
serum proteins in relatively recently diverged species. Excluding the Spi-2 genes, the 
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most rapidly evolving coding sequences are those for the interferons and relaxins (Li et 
a!, 1985). This may be due to the fact that specific regions of these proteins are required 
for their physiological function, rather than the entire three-dimensional structure of the 
molecule. Conversely, highly conserved structural proteins such as the histones or actins 
are coupled closely to other intracellullar components in complex assemblies, and are 
presumably more evolutionarily restricted. Functionally monomeric serum proteins 
involved in transport or peptide recognition roles, may generally possess a high degree 
of sequence flexibility and display relatively rapid sequence divergence. This has been 
demonstrated for the albumin and alpha-fetoprotein genes (Minghetti et al, 1985), where 
the latter gene is diverging almost at the rate of a pseudogene. 
The RNA sequencing technique was applied to the albumin transcript as this is one 
of the most abundantly expressed in the mammalian liver. An 18-mer antisense oligonu-
cleotide was synthesised, complementary to the carboxy terminal coding sequence of the 
mouse gene (Figure 3.9). The sequence selected was highly conserved, though not ident-
ical, in the rat (Sargent et a!, 1981), and permitted sequencing of both species as well as 
intermediate murine types. A Northern blot of the oligonucleotide against an array of 
murine liver RNAs is shown in Figure 3.11. The major albumin transcript is clearly visi-
ble in mice as divergent as Mus saxicola, and faint transcripts can be seen in the Apo-
demus sylvaticus sample. The rat albumin message was not detected under these 
stringent conditions, but was clearly visible when a cDNA probe was used. The data 
obtained from the RNA sequencing of the rodent albumins are shown in Figure 3.9. 
Figure 3.9 Albumin 3' coding sequences from RNA sequencing. The nucleotide 
sequence only is shown. Dashes represent identity with the DBA sequence. The 
antisense 18mer oligonucleotide starts from the albumin translation termination codon 
(TAA). X represents an undetermined nucleotide. 
DEA 	AAA CAA ACG GCT CTT GCT GAG CTG GTG AAG CAC AAG CCC AAG GCT ACA 
spretus 
caroli 
cervic 	--- --- --- -- x --- --- --- --- --- --- --- --- -- - --- --- ---  
pahari --- --- --- --- --- --- --- --- --- --- --- -- c --> --- --- --- 
Apodem. 	----------------------------------TA --- --- --- -- G 
RatcDNA ---G --- --- --- -- C --- --- --- --- -- A --- --- --- --- --  
DBA 	GCG GAG CAA CTG AAG ACT GTC ATG GGT GAC TTT GCA CAG TTC CTG GAT 
spretus 	-A - --- --- --- --- -- c --- --- --- --- --- --- ____________ 
caroli -A ----- 
cervic-A - --- --- --- --- --- --- --- -- - --- --- --- --- --- --- ---  
pahari 	-A------G --- --- --- --- --- ___ --- --- --- --- --- --- --- 
Apodemus -AT ----- G 	 G -- --- --- ---  
Rat cDNA -AA --T --G --- --- -- G --G --- --- --- -- C --- -- A ---- G 	--C 
DEA 	ACA TGT TGC AAG GCT GCT GAC AAG GAC ACC TGC TTC TCG ACT GAG GGT 
spretus --- --- --- --- --- --- --- --- --- --- --- --- -- T --- --- ---  
caroli 	--- --- --- --- --- --- --- --- --- --- --- --- -- T 
cervic --- --- --- --- --- --- --- --- --- --- --- 	 --T --- ---  
pahari 	- 	 -- ---- X-- X -- --- --- --- -- X 
Apodemus --- --- --- G__ --- --- --- --- --- --- --- --- --- --- --- --- 
Rat CDNA -AG --- --- --- --- -- C --- --- -- T -A - --- --- G-C --- --- -- G 
DBA 	CCA AAC CTT GTC ACT AGAAGCAAAGAAGCCTTAGCCTAA 
spretus 
caroli 	--- --- --- --- --- 	 primer site 
cervic -XX --- --- --- X--  
pahari 	-XX XX- - 
Apodemus 
Rat eDNA --- --- --- -- T G-- 
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Albumin shows a greater degree of carboxyl terminus constraint than contrapsin for both 
synonymous and asynonymous base substitutions. Between Mus caroli albumin and 
inbred mouse albumin, only one synonymous, and one non-synonymous substitutions 
occur in fifty codons. The corresponding values for contrapsin are two synonymous and 
six non-synonymous substitutions in forty codons. Since albumin is considered to 
represent a compamtively rapidly diverging gene (Li et al., 1985; Minghetti et al., 1985), 
the rate of contrapsin Region 3 divergence is remarkable, especially in view of the reac-
tive centre conservation. 
RNA Sequencing of cxl-Proteinase Inhibitor in Mus 
RNA sequencing was also carried out on the al-Proteinase Inhibitor (al-
antitrypsin, al-PI) transcript as this is also highly expressed in the mammalian liver (> 
0.5% mRNA). An antisense 18mer oligonucleotide was synthesised complementary to a 
conserved region close to the 3' end of the coding region (Hill et al, 1984). This was 
used to probe the rodent Northern blot shown in Figure 3.11. The oligonucleotide gave 
strong hybridisation in mice as evolutionarily distant as M.domesticus and Mus minu-
toides, and a transcript can also be seen in Apodemus and rat liver RNA. Sequencing 
with the oligonucleotide provided data for several rodents, and even human HepG2 
hepatoma RNA was partially sequenced (Figure 3.10). The al-PI sequence appears to be 
evolving at a similar rate to contrapsin in the murine species examined, and more rapidly 
than albumin. It appears that rapid sequence divergence at the carboxyl terminus may be 
a general feature of the serpin family in rodents. 
Unexpectedly, the al-PI RNA sequencing analysis revealed that more than one 
al-PI related sequence is expressed at high levels in mouse liver. Extra bands were visi-
ble in the region of the P1 residue sequence on the autoradiograph, indicating that a 
mixed population of template was present. 
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Figure 3.10 al-Proteinase Inhibitor sequences obtained by RNA sequencing. Nucleotide 
sequence only is shown. Dashes represent identity with the published BALB/c al-PI 
sequence (Krauter et al., 1985). The P1 tyrosine variant, pLy 1796 (Hill et al., 1984), is 
shown below, mix represents the P1 position in DBA and M. musculus where both 
forms are present. X represents an uncharacterised nucleotide. HepG2 is a human hepa-
toma cell line. The P1 codon is the first in the sequence (ATG in BALB/c). 
BALD/c 	ATG TCT ATG CCC CCT ATC CTG CGC TTC GAC CAC CCT TTC CTT TTC ATh 
p1796 TAT 	---- --- --- --- --- --- --- --- -- -- - 
DBA mi- --- --- --- --- --- --- --- --- --- --- -- 
 
Danish 	mi- --- --- --- --- --- G 
Caroli --- --- --- --- --- --- --- 	--- A-- A-A --- --- A -- --- ---  
ApodemuS 	 GA- G-- AA --T --- AGA --- --- GC - --- ---  
Rat 	 C--------CAA G-- AA - --- --- --- --- --- A -- --- -- C 
I{epG2 --- --- -- C -----C GAG G-C AAG --- A-- AKA --C --T G-C --- 
BALB/c ATA TTT GAA GAA CAC ACT CAG AGC CCC ATC TTT GTG GGAAAAGTGGTAGATCCC 
p1796 	--- --- --- --- --- --- --- --- --- C--------***Primer site*** 
DBA--- --- --- --- --- --- --- --- --- C 
Danish 
Caroli 	--- G -- --- --- --- -- A 
Apodemus --- --- -- T ACG --G 
Rat 	--- G-- --- TC- G-A --X 
HepG2 --G A --C C-- A-T --C A-G T 
Me 
Figure 3.11 Northern blots of rodent liver RNAs probed with oligonucleotides specific 
for mouse al-PI (top) and mouse albumin (bottom). Ten pg of total liver RNA was 
loaded for each species. Lane 1. M. domesticus RNA, 2. DBA, 3. M.musculus, 4. 
C57BL/6, 5. M. hortulanus, 6. M. sprerus, 7. M. caroli, 8. M. cooki, 9. M. cervicolor, 
10. M. saxicola, 11. M. pahari, 12. M. minutoides, 13. A. sylvaticus, 14. R. norvegicus. 
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The existence of multiple al-PI forms was supported by the previous isolation of two 
very similar but distinct al-P1 cDNAs from mouse liver libraries (Hill et a!, 1984; 
Krauter et al, 1985). The main difference between the two sequences was the complete 
substitution of nucleotides in the P1 residue codon. In the Hill sequence (pLv1796) the 
codon is TAT (tyrosine), giving a predicted anti-chymotrypiic specificity. In the Krauter 
sequence (pliv3b) the codon is ATG (methionine), giving a predicted anti-elastase 
activity as in the mammalian sequence. RNA sequencing indicated that both messages 
are expressed in the mouse liver at similar levels. The tyrosine P1 variant was not 
detected in Apodemus, rat, or human liver RNA sequences. This gene may represent a 
very recent gene duplication event in view of its high overall similarity to the methionine 
P1 transcript, and its apparent absence from certain rodent species. If this is the case, the 
divergence at the critical P1 residue is remarkable and provides additional support for 
the concept of accelerated evolution to generate novel functional specificities in this gene 
family. 
The Rat 4.12B Gene - A Recent Spi-2.1 Duplication Event 
During the RNA sequencing experiments, two papers were published describing a 
third Spi-2 gene in the rat (Tecce et al., 1986; Yoon et al., 1987; Le Cam et al., 1987). 
This sequence, first described as 4.1213, was distinct from the Spi-2.1 and Spi-2.2 
sequences described by Hill and Hastie (1987). It is far more closely related to the Spi-
2.1 sequence and appears to represent a duplication event after, rather than before, 
rodent divergence. It resembles a "typical" Spi-2.1 sequence in several ways. Com-
parison of transcript size, abundance and low inducibility by inflammatory stimuli 
showed that it was controlled in a very similar fashion to the rat Spi-2.1 gene (Figure 
3.12). However the reactive centre regions of the two genes have diverged extensively, 
with 50% nucleotide conservation, but only three amino acid residues in common in a 
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fifteen residue polypeptide (Figure 3.13). Most of the substitutions which have occurred 
are non-synonymous, a feature shared by most of the substitutions which have occurred 
in Region 3. The carboxi terminus divergence is reminiscent of other Spi-2 genes, but 
the reactive centre divergence is clearly demonstrated in this comparison. It seems pos-
sible that the 4.12B/Spi-2.1 gene pair might represent the type of rapid evolution follow-
ing intraspecies gene duplication which was not found for the interspecies analysis of the 
contrapsin gene alone. This might be due to the fact that contrapsin, and presumably 
one of the 4.12B/Spi-2.1 pair, have become selectively constrained for a defined 
specificity unlike the other rat gene. 
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Figure 3.12 Northern blot of rat liver poly(A) RNA with specific Spi-2.1 and 4.12B 
reactive centre probes. Two p.g of poly (A) RNA were loaded for each sample. Dex = 
Dexamethsone-treated, PB = Phenobarbital-treated, 3MC = 3-Methylcholanthrene-treated 
animals. The 18- mer antisense oligonucleotides were: Spi-2.1, AGGTTGTCTACGTAT-
GAC; 4.12B, CGGTAAACTITITAGGGC. Blots were washed at high stringency (4X 
SSC, 500). The two probes show expression of the two genes are virtually identical in 
abundance, transcript size, and inducibility. 
Rat Liver Poly (A) RNA. 
A) Sp-2.1 reactive center B) 4.2 reactive center 







Figure 3.13 Comparison of 4.1213 and Spi-2.1 sequences in the reactive centre region. 
The nucleotide sequences for exon 5 of both cDNAs are shown. Nucleotide differences 
are indicated by asterisks. The complete amino acid sequence for the Spi-2.1 cDNA is 
shown above the DNA sequences, and that of 4.12B, where they differ, is shown below. 
Dashes represent deletions in the Spi-2.1 sequence. 2.1 = Spi-2.1, 2.3 = 4.12B. Region 2 
(the reactive centre) is boxed. 
V 	V 	H 	K 	A 	V 	L 	ID 	V 	ID 	K 	T 	G 	T 	E 	A 	T 	A 
2.1 GTC GTC CAC AAG GCT GTG CTG GAT GTG CAT GAG ACA GCC ACA GAA CCA ACT GCT 
	
* 	 * 	* * 
2.3 GTC GTC CAC AAA GCT CTC CTG CAT CTG CAT GAG ACA CCC ACA GAA CCA CCC GCT 
C A 
A T C V A T V I R R Q P 	R T 	 L 
2.1 CCT ACA CCC CTC CCT ACA CTC ATA CCT AGA CAA CCT CCA ACT --- --- --- CTC 
* 	** 	* * * 	* * 	*** 	* ** 	* 	* 	*** *** *** 
2.3 CCC ACA CCA CTC ACA CCA CCC CTA AAA ACT TTA CCC CAA ACT ATA CCT CTT CTG 
A 	T A A L K S L 	Q 	I P L 
NIF 	N 	Q 	P 	F 	M V 	F 	I 	T 	0 	N 	ID 	S 	Q 	S 	I 
2.1AATITTC AAC CAC CCA TTC ATC CTC TTT ATC ACT CAC ATC CAT ACT CAG TCT ATC 
I * * 	* 	 ** * 	* 	 * 
2.3 AATITTC AAC CCC CCA TTC ATC CTC CTT ATC ACT CAC AAT AAT CCT CAC TCT CTC 
R 	 L V 	 N N C 	 V 
L F V A K I T N P S 
2.1 CTC TTT CTT CCC AAA ATC ACT AAC CCC ACT TAA Srkt 
* 	* * 	* 	* 	 ** 
2.3 TTC TTT ATC CCC AAA CTC ACT AAC CCC ATC TAA 	1. 
F 	N C 	V 	 N 
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Conclusions 
This chapter examines the nature of contrapsin reactive centre stability in close 
relatives of Mus domesticus to determine whether the accelerated evolution found for 
Spi-2 sequences by Hill and Hastie is a general phenomenon for these genes in rodents. 
The contrapsin reactive centre was found to be highly stable in sequence, over a six to 
eight million year period (since the divergence of M.domesticus and M.caroli). This 
may indicate that fixation of the contrapsin specificity for a particular inhibitory activity 
occurred in the rodent ancestor of these mice. This would reduce further the period dur-
ing which the contrapsin gene and its rat orthologue(s) diverged, and hence increase the 
rate of evolution at this time. Sequence for the contrapsin gene from more distant rela-
tives of M.domesticus was not obtained, and there is some evidence that these mice may 
not express a contrapsin gene, at least at the levels of the more closely related mice. The 
carboxyl termini of the albumin and al-PI (Spi-1) genes were sequenced for these dis-
tantly related mice, and provide evidence that the carboxyl termini of both serpins are 
evolving more rapidly than that of albumin. The existence of a rat gene which has 
recently diverged from the rat Spi-2.1 sequence appears to represent an intermediate in 
the divergence process (compared to mouse contrapsin and rat Spi-2.1). A very high pro-
portion of asynonymous mutations in Region 2 and Region 3 was found for this gene 
pair. The data from this chapter suggests that the phenomenon of accelerated evolution 
in the Spi-2 gene family occurs during the period following gene duplication, and stabili-
zation occurs after a selectively useful specificity has been obtained. 
CHAPTER FOUR 
The Genomic Structure of the Spi-2 Locus 
Introduction 
Analysis of the Spi-2 locus in the inbred mouse was carried out for a number of 
reasons. Hill et al (1985) had shown previously that the Spi-2 locus contained several 
closely linked genes. The existence of several genes suggested the possibility that novel 
reactive centre specificities had evolved following gene duplication. Isolation and 
sequencing of genomic Spi-2 clones was required to indicate whether the genes con-
tained different reactive centres to those characterised at the cDNA level, and whether 
any with novel specificities were expressed. The proportion of pseudogenes in the locus, 
and the true complexity of the locus, were of interest in terms of establishing the evolu-
tionary mechanism of expansion of the locus. Finally, a detailed genomic structure for 
sequences within the locus might reveal possible physical mechanisms responsible for 
the accelerated evolution phenomenon. 
Complexity of the Spi-2 Locus in Rodents 
To establish the relative complexity and variability of the Spi-2 locus within the 
genus Mus, a Southern blot of rodent DNAs was carried out using the rat Spi-2.1 cDNA 
as a probe. This clone contains most of the coding sequence, including the relatively 
conserved 5' regions absent from the pLv54 contrapsin cDNA. The result is shown in 
Figure 4.1. It is apparent that the Spi-2 locus is more complex in Mus domesticus and 
its near relatives than in various rat strains. Since the probe employed was a rat 
sequence, this is unlikely to be due to sequence divergence at the rat Spi-2 locus. 
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Figure 4.1 Southern blot of rodent DNAs probed with the rat Spi- 2.1 cDNA. Ten j.tg of 
each rodent genomic DNA was digested with Barn HI, electrophoresed, and transferred 
to a membrane. The Mus caroli DNA was used at an incorrect concentration, giving a 
poor signal. The smearing and the intense band in the C57BL/6 lane are due to plasmid 
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The complexity of the Apodemus sylvaticus hybridisation pattern approaches that of the 
mice, and would support the idea of a considerable amplification of this gene family in 
ancestral mice, after divergence from the ancestral rat line. Alternatively the Apodemus 
expansion may have occurred independently, or the rat locus may have contracted since 
rodent radiation. Since the cDNA probe may span several exons it cannot be used to 
quantify the exact number of Spi-2 sequences in each species, but about twenty separate 
fragments are visible in the Mus musculus DNA compared to ten in the Wistar rat DNA 
for example (Figure 4.1). 
Analysis of Spi-2 DBA Genomic Clones 
Previously, eight mouse genomic clones had been isolated from a DBA spleen 
DNA bacteriophage library (C.Sime and R.Hill). The clones, in the phage 
vectorA.EMBL3 (Frischauf et al., 1983), had been selected by hybridisation with pLv54, 
the original contrapsin cDNA. The clones, which had not been further characterised at 
this stage, were numbered p54)-1 to p54A-9; there was no p54?-6. 
The clones were then amplified using the large scale plate lysate technique with the 
bacterial strain LE392. About lO.tg of phage DNA was obtained for each clone. Each 
DNA was cut with the restriction enzyme Eco RI and analysed by electrophoresis.This 
indicated that p54A-8 and p54?-9 were probably clonal, but that all the other clones 
appeared to be independently derived (not shown). The DNA was then transferred to a 
Hybond-N nylon filter which w . probed with the pLv54 cDNA, then with a specific 
oligonucleotide to a conserved sequence 5' to the reactive centre. The pLv54 probe 
hybridised to all the clones as expected, but only to a 1kb fragment in the case of p54X-
3 and only faintly in the case of p54k-5 (Figure 4.2). 
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Figure 4.2 Southern blot of Eco RI digested p54A. clones probed with the contrapsin 
pLv54 clone. Lane 1: A.-Hind III size marker, 2: p54A.- 1, 3: p54?-2, 4: p54?-3, 5: 
p54A.-4, 6: p54?.-5, 7: p54A.-7, 8: p54?.8, 9: p54X-9, 10: no DNA. The approximate 







Figure 43 Southern blot of Pst I digested p54? clones probed with the oligonucleotide 
p54/25-. Lane 1: A.-Hind III size marker, 2: p54X- 1, 3: p54?-2,  4: p54A.-3, 5: p54X-4, 6: 
p54A-5, 7: p54X-7, 8: p54A.-8, 9: p54A.-9, 10: no DNA. The approximate positions of the 
?-Hind III size markers are shown. The DNA in lane 3 (p54A,-2) ran abberantly, and 
was underloaded. 




The reactive centre oligo, p54/RC5'+, hybridised to clones 8 and 9, indicating that these 
clones contained reactive centre sequences (not shown). At this stage, p54)-8 was 
selected for further analysis, since it also hybridised to oligo p54/1-, a conserved 
sequence probe for a region SOObp 5' to the reactive centre (Figure 3.2). Direct dideoxy 
sequencing of the phage DNA was attempted using sense and anti-sense oligo p54/1 and 
also using oligo p54/RC5'+. The sequence data was not of very high quality, but indi-
cated that the archetypal Spi-1 and Spi-2 genomic structure (as in ai- proteinase inhibi-
tor and (xl-antichymotrypsin - see Figure 3.2) had been conserved, at least in the 
sequenced regions. Oligo p54/1- hybridises to an exonic sequence just 5' to intron B in 
antichymotrypsin, and the sequence data showed clear homology to inhibitor sequences 
using the antisense, but not the sense, oligo p54/1+ primer. Similarly, the oligo 
p54/RC5'+ sequence data demonstrated that the reactive centre was not directly flanked 
by introns, but shared the antichymotrypsin structure. This also eliminated an obvious 
exon shuffling event as the mechanism for reactive centre divergence, for this gene at 
least. 
Subcloning and Sequencing of DBA Spi-2 Reactive Centres 
The eight DBA genoniic clones were digested with PstI and run on an 0.8% 
agarose gel. After Southern blotting, the filter was probed with oligo p54/25-, an 18-mer 
which hybridises to sequence encoding the highly conserved GTEAAA motif immedi-
ately upstream of the reactive centre in Spi-2 genes (Figure 3.2). The oligo hybridised 
to clones 1, 2, 4, 7, 8 and 9, indicating that all these inserts contained a reactive centre 
region (Fig 4.3). The PstI-cut hybridising fragments for clones 1 and 2 were about 
1.2kb, for clone 4 greater than 7kb, and for clones 7, 8, and 9 about 0.9kb. It was 
noticeable that the oligo hybridised less efficiently to clone 7 than clones 8 and 9, indi-
cating a sequence difference despite their similar fragment size. Clones p54-1, 2, 7 and 
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8 were then Pst I digested and shotgun cloned into the PstI site of Bluescribe. Recom-
binant clones containing the reactive centre fragment were isolated, by probing with 
oligo p54/25-, for each positive p54? clone. The phage p54A.-4, which contained a >7kb 
oligo p54/25- hybridising PstI band, was further restriction mapped to determine a more 
clonable fragment. Eventually, a 3kb Eco RI/PstI fragment was selected and subcloned 
into Bluescribe. 
The plasmid subclones were then all sequenced directly, using a variety of primers 
around the reactive centre region (Figure 3.2 shows the location and sequences of these). 
Oligo p54/XV+, a sense 18-mer, hybridised to the first six codons of exon 5 and was 
useful for most of the clones (but not p54A.-4-13). Oligo p54/51-, an anti-sense 17 mer, 
hybridised to the FNRPFL motif, just 3' to the reactive centre region. It was also useful 
for all DBA clones except p54A.-4-13. Oligo p54/25- (antisense, 18-mer) and its comple-
mentary oligo, p54/129+ (sense, 18-mer) were also used at this stage. The sequences 
obtained for exon 5 and the 5' flanking intron of the DBA Spi-2 genomic sequences are 
shown in Figure 4.4a, and the predicted exon 5 protein sequence in Figure 4.4b 
The sequences obtained for p54A.-1-108 and p54X-2-100 were identical and it 
appears that these clones contain overlapping, but not identical, inserts. The putative P1 
residue for this inhibitor sequence is leucine, which immediately raised the question of 
whether it represented the functional murine equivalent of human al-antichymotrypsin, 
which also contains a leucine P1 residue (see Chapter Five). The sequences of p54?-7-
45 and p54A.-8-1 were clearly closely related to one another, but showed unique 
cysteirte-cysteine and histidine- cysteine residues, respectively, at the putative Pi-Pi' 
position. The partial sequence for p54X-4- 13 (due to lack of suitable sequencing primers) 
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Figure 4.4a Nucleotide sequences for exon 5 of the DBA Spi-2 genomic clones. 
Sequences obtained from the p54k subclones, including all of exon 5 where possible, 
and a portion of the 5' flanking intron (shaded grey). Region 2 (the reactive centre) is 
boxed. The coding sequences for contrapsin are included for reference. Dashes represent 
identity with the top sequence, asterisks represent deletions, and full stops represent 
undetermined sequence. The putative P1 residue is marked. 
8-1 	 AAAAACTCATGAGCAGGTGAGGCCTGCACTCGC 
7-45 t--a-----a------at 
1-108 CTTGGXxTCCAGGGTAGAGCCCATGAAAAGAACA ----- t-----ga---a ------- a ------ a- 
4-13 ------- c --------- ---t ---- ------- --- - --- t-ggc- ----- - ------- --a--atag 
-67 
8-1 TGCTTGCTCJATACCCTTCTCCTGCCCTCCCTGGT'CTCCAGTTTCTGATGTGTTTCTCTCC * 
7-45 ---- a ------ q--a--gt ------------------ t ----------------------- cc ---- 
1-108 --------- g-g-a--- --------------- t-----t-c-ca ---------- c ---- t-cc ---- 
4-13 --------- --g --- tc -------- t ---- a-c ---- ttg--ga ----------------- Ct ---- 
1 (exon 5) 
8-1 GTG GTC CAC AAG GCT GTG CTG GAT GTG GCT GAG ACA GGX ACA GAA GCA GCT 
7-45 --- --- --- --- --- --- --- --- --- --- --- - -- --C -----G --T 
1-108 --------------------A --C A-- --- --- --- --C ----------A- 
Co---- ----------------------------------- C ------------
4-13 A-- A-- --- -G- A- ...... 
Pt 
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8-1 GCT GCA ACA GGA GTX AAA GTT AAT CTA CAT TGT GGA AA ATC TAT TAT ATG 
7-45 -----C --- --- A-G GC- -G- GTC GG- TG- --- -- GTT T-T G-C -T- C--
1-108 -----C --- A-- T-C --- A-- GCC -CA -TG -C- --- --- T-T G-C AT- G--  
CO- -----C -----C --T-TT -G- GGC A-T -G- AAG -CC -T- T-A CCA 
4-13 	 ATG -C- --- --- C-T A-A cc- C-- 
103 
8-1 	ACA ATA TAT rTTC AAC AGG CCA TTC CTG ATG ATT ATC TCT GAC ATA AAT 
7-45 " GAT --- --- ------------------------------ --A 
1-108 *** -AT G-G A -- ---- -- T --- --- --- AAT --T --- G-- CTG TCT T-- G-- 
con "  G-T G-G C -- ---- --- -- -- --- --- T-T C-- --- -A- C-- -C- -C-
4-13 " TTT G-T A-A.--T C-C GAC -AG --- --- TAC --- G-T -TA --T CA- CC- 
154 
8-1 ACT CAC ATT CCC CTC TTC ATG CCC AAA CTT ACA AAT CCC AAG 
7 -45 G-------------. --T -----A ....... 
1-108 -----C C-- c- T-- A-G T-A -IC -----C TIC --- --- --- AGA GAC 
con 	C-- --G -C- AT - --- -- T --- --- --- -- C -AT --C ------ 
4-13 GA- TTG TGG AT- TAT --A --- --- --G --- -TC -XC --- TCA GAP. AP4 
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Figures 4.4b and 4.4c 4.4b: Predicted amino acid sequence for exon 5, again including 
contrapsin. Conserved residues are boxed. This illustrates the rapid nature of divergence 
of the reactive centre, as the boxes almost exactly flank region 2. Asterisks represent 
deletions, and full stops represent undetermined sequence. The putative P1 residue is 
marked. 4.4c: Tables showing increased divergence of exonic sequences compared to 
introns for the data from Figure 4.4a. The figures in the tables represent the percentage 
nucleotide identity for each DBA gene pair. Table A: intron, Table B: exon 5, Table C: 
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'VHKAVLDVAETGTEAAAATV IGGIRKjILP**AVH NRPF YHTSAQSILFMA 
4-13 MIST... . .MSAKLKPVFvK FEDQFLYIVLDQGDLWIYLMGKVINPSEK! 
Table A - intron4 	 Table B - exonS 	Table C - exon5 minus RC 
p7.45 
p8.1 p7.45 p1.108 
87% - - 
p 1 . 108 81% 78% - 
p4.13 1 	73% 72% 76% 
p7 . 45 
p7.45 pl.108 
80% - - 
p1.108 70% 66% - 
p4.13 
p7.45 
p8.1 p7.45 p1.108 
90% - - 
pl.108 74% 70% - 
p4.13 49% 47% 44%_- 
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indicated that this sequence, at least, might be pseudogenic since many highly conserved 
residues in the reactive centre-flanking domains had been replaced in this gene. How-
ever, the putative P1 -P1' residues are methionine-serine, identical to the highly active 
serpin al-proteinase inhibitor. 
Intergenic nucleotide sequence comparisons for the four DBA clones all showed 
greater conservation between introns than between exon sequences (Figure 4.4c). For the 
three genes which resemble functional Spi-2 sequences this may be due to accelerated 
divergence in the reactive centre, as all three are relatively conserved in Regions 1 and 
3. Additionally, gene conversion events involved in homogenising Region 1 may also 
have homogenised upstream intron sequences and retarded the apparent rate of intron 
divergence. However, for comparisons involving p54A.-4-13, the intron showed consider-
ably more conservation in terms of percent identity than the exon. Since this sequence 
appears to be pseudogenic in terms of loss of conserved residues in Region 3, intron and 
exon divergence values should be similar due to lack of selection on the coding 
sequences. It is possible that this sequence encodes a functional protein, or alternatively 
that gene conversion has homogenised intronic but not exonic sequences. 
None of the DBA -EMBL3 clones analysed contained more than one detectable 
reactive centre region per insert, and none encoded contrapsin. It was clear that the 
genes isolated from the phage library were only a fraction of the ten to fifteen predicted 
by Southern analysis of mouse DNA. Unfortunately, the DBA phage library underwent a 
dramatic (total) loss of tire at this time, and further screening was not possible. 
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Genomic Analysis of DBA Spi-2 Sequences 
To attempt to determine the distribution of the DBA Spi-2 sequences in various 
rodents, duplicate Southern blots of BamHI digested DNA from Mus domesricus, Mus 
caroli, Apodemus sylvaticus, and Wistar rat were analysed. Probes used were the reactive 
centre specific subclones from the DBA genomic clones p54-1-108, p54?-7-45, p54?-
8-1, and the contrapsin cDNA clone pLv54. The results are shown in Figure 4.5. 
As expected from their sequence similarity, the 7-45 (cys-cys) and 8-1 (his-cys) 
subclones give a very similar hybridisation pattern in the mouse DNA. These genes 
would appear to have diverged very recently, and to show little difference in their hybri-
disation specificity. The presence of several bands of similar intensity with both these 
genomic probes is an indication that a number of closely related genes exist in the mice 
and Apodemus. The 1-108 (leu-ser) subclone gives a related pattern, but with a 
difference in band intensities, indicating that it is less related to the 7-45 and 8-1 gene 
group. A single heavily hybridising band is apparent at about 4.5 kb, and presumably 
represents the corresponding genomic BamHI fragment for this gene. The absence of 
other heavy bands may indicate that this gene has not undergone recent duplication, or 
sequence conversion events. The contrapsin cDNA yields a slightly different pattern, 
recognisably related to that of the DBA genomic probes. Three intense bands can be 
seen, but it is not clear whether these represent separate genes, or are due to the fact that 
the probe probably spans several exons. The gencimic probes did not hybridise strongly 
to the Wistar rat DNA, probably due to the fact that they consist largely of intron and 3' 
untranslated sequences. Even the contrapsin cDNA probe is a poor rat probe, due to its 
lack of conserved Spi-2 sequences from the S'coding region. This is in contrast to the 
full length rat cDNA pSPFL2. 1, which is a good probe for both mouse and rat (Figure 
4.1). 
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Figure 4.5 Southern blots of rodent DNAs probed with mouse Spi- 2 sequences. Each 
lane contained 10 jig of Barn HI digested genomic DNA. DNAs: d = Mus domesticus 
(Greek), c = Mus caroli, a = Apodemus sylvaticus, and r = Rartus Norvegicus (Wistar). 
Probes: CON = pLv54 contrapsin cDNA probe, p108 = p54A.-1-108 subclone, p45 = 
p54A.-7-45 subclone, p8.1 = p54A.-8-1 subclone. Size markers are shown on the left in 
kilobasepairs. 
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Mapping of a DBA Spi-2 Gene to the spi-1/spi-2 Complex 
The BXD Recombinant Inbred (RI) strain series of DNAs (Taylor, 1982) had pre-
viously been used to localise and closely link the Spi-1 and Spi-2 loci on mouse chromo-
some 12 (Hill et al., 1985). The two gene complexes were thought to be 1 (+1- 1) cen-
timorgan apart, with one recombination event occurring between them within the BXD 
series. A number of sequences had been mapped to the Spi-2 locus using the contrapsin 
cDNA probe, pLv54. The DBA genomic probe p54?-1-108 was now used to search for 
a polymorphism between DBA/2 and C57BL/6 mice which could be used to determine 
whether this sequence mapped to the Spi-2 locus. The p54?-1-108 probe was a suitable 
DBA genomic sequence to use since it gave a single major band in Southern blots, and 
was considered a likely candidate for the DBA orthologue of the human al-
antichymotrypsin gene. The enzyme Hind III was found to give a DBA fragment of 8 
kb, and a corresponding C57BL/6 fragment of 6 kb. The probe hybridised to other bands 
at low stringency (Figure 4.5) but repeated analysis indicated that the major fragments 
were equivalent. A southern blot of HindlU-digested BXD Recombinant Inbred strain 
DNAs was analysed, and the result of probing with p54?.-1-108 is shown in Figure 4.6a 
and 4.6b. Surprisingly, the sequence mapped to the Spi-1 rather than the Spi-2 complex, 
probably indicating that the previously described recombination (Hill et al., 1985) had 
occurred within the Spi-2 complex rather than between the two families. This could indi-
cate very close linkage of the 'two complexes, or dispersion of the contrapsin-related 
Spi-2 subfamily from its related genes. At this stage, no information was available on the 
physical linkage of the Spi- 2 sequences to each other and mapping of the other DBA 
genomic clones was not carried out 
Figure 4.6 Southern blot and analysis of Hind HI digested BXD DNAs probed with 
p54X.-I-108. 4.6a: Autoradiograph obtained by hybridisation with the p54X-1-108 
genomic subclone. The numbers at the top refer to the BXD recombinant inbred line 
DNA in that lane, 131/6 = C57BL/6, DBA = DBAI2, deg = degraded DNA. The major 
C5713L/6 fragment was considered to be about 6 kilobasepairs, as the other hybridising 
bands were much less intense at higher stringencies. 4.6b: Strain distribution pattern 
obtained from the autoradiograph compared to that obtained for the Spi-1, Spi-2 and Igh 
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Screening of 129 Cosmid Library 
A cosmid library was obtained from Dr L. Stubbs (ICRF, London) to isolate 
further Spi-2 sequences. The library had been prepared from the inbred mouse strain 
129/St which was expected to be similar to DBA at the Spi-2 locus (Hill et al., 1985). It 
had been derived from spleen DNA by Sau3A partial digestion and cloned into the 
cosmid vector pcosEMBL2 (Ehrich et al., 1987). Five independently packaged aliquots 
were supplied, each equivalent to about one genome of mouse DNA. Thus, there was a 
reasonable chance that any one aliquot would contain clones for a particular DNA 
sequence, and a better chance that at least one aliquot would contain any specific 
sequence. 
Each aliquot of the library was screened in turn by plating 200,000 colony forming 
units onto a 20cm x 20cm Hybond-N filter. At pinprick size, (12 hours growth) two 
duplicate ("slave") filters were taken from the master plate and all three plates left to 
recover at 37 0C for five hours. The slave filters were then processed and probed using 
the usual Grunstein/Hogness protocol. Duplicate positive colonies were subjected to 
secondary screening, and could usually be isolated following this stage. The first aliquot 
was screened with the full length rat 2.1 insert from pSPFL2. 1 (see chapter 6). This con-
tains the whole protein coding region and was used because it contained more conserved 
5' sequences than any mouse probe at that time; it was thought that a broader range of 
sequences might be isolated in this way. The filters were washed to 2X SSC stringency. 
Ten positive colonies were selected for secondary screening, and eight were eventually 
isolated as single Spi-2 positive cosmid clones. These were amplified as cosmid DNA 
minipreps for further analysis. A rapid-boiling protocol was initially used, but gave a 
very low yield of DNA, probably because cosmid DNA is considerably more easily heat 
denaturable than plasmid DNA. Instead, a scaled down version of the alkaline lysis tech- 
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nique was found to give reasonable results. The clones were then digested with EcoRl 
and electrophoresed. It was clear that the clones fell into four groups: 
clones 1 + 4 / clones 2 + 3 / clone 6 / clones 7, 8 + 10 
Clones 1, 2, 6, and 8 were all given the suffix A, and grown up as large scale 
DNA preps. They were digested with Bamlil and PstI and electrophoresed on an 0.8% 
agarose minigel. This was then blotted and probed sequentially with the 1.1kb Pstl insert 
from p54A.-1-108, a 5'specific 200bp fragment from pDew7 (Figure 6.1), and oligo 
p54/25-, a conserved oligonucleotide flanking the reactive centre (Figure 4.7a - c). 
This analysis showed that all the cosmids except 6A appeared to have two reactive 
centre regions, and all cosmids, including 6A, appeared to have two conserved 5' 
regions. One gene in clone 2A contained a complementary sequence to oligo p54/25-. 
This was the first indication of how closely linked members of the Spi-2 family might 
be. More accurate mapping was now required to establish the nature of the linkage. 
Cosmid Mapping Strategies 
Complete single and double digests were carried out for cosmids 2A and 6A, using 
the enzymes BamHI, EcoRI, Sal!, XhoI and single digests with Smal and Sphl. The 
DNAs were run on 0.5% agarose gels overnight at low voltage. DNA was transferred to 
Hybond-N, and sequentially probed with a conserved exon 5 oligo, the p54A.-1-108 PstI 
fragment, and the 200bp 5' (exon 1-specific) insert, pDEW7 (see Fig 6.1). Fragments 
hybridising to the probes were then accurately sized, using the X Hind!!l fragment stan-
dards in conjunction with the gelsize computer program (Schaffer and Sederoff, 1981). 
For later cosmid analysis, the enzymes used for complete single and double digests were 
BamHI, EcoRl, Hindu!, Sal!, and XhoI. Smal was used if internal Sall sites were 
discovered in a cosmid. An example of a total- digest Southern blot for cosmids 1A, 6A 
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and 8A, using the 5'-specific 200bp probe pDEW7, is shown in Figure 4.8. 
To exploit the total-digest data fully, it was necessary to obtain a restriction map 
for each cosmid. Because of cosmid size (43kb - 52kb), most restriction enzymes with a 
six basepair recognition site will cut several times within an insert making mapping by 
complete digestion extremely difficult. Mapping strategies employing partial digestion 
have been developed but these require a linear starting molecule (Rackwitz et al., 1984). 
The bacteriophage-encoded enzyme terminase will specifically cleave a cosmid at a sin-
gle site within the vector, the cos I 2bp sequence formed by the circularisation of linear 
phage DNA, allowing partial digests to be performed (Rackwitz et al., 1985). Dr 
L.Stubbs kindly supplied a bacterial strain which had been engineered to overproduce 
terminase, but advised that the quality of extract activity was not entirely reproducible. 
Evidence for this was quickly produced. The crude extract produced by following the 
method of Rackwitz provided an activity which not only linearised cosmids, but exten-
sively degraded them. Since no commercial terminase was available at this stage, an 
alternative strategy was developed. 
Cosmids were first digested with the enzyme Sall, which has a single recognition 
site in pcosEMBL2, within the tetracycline resistance gene. Very few Spi-2 positive 
cosmids contained additional Sal! sites in their inserts. The enzyme contains a CpG 
dinucleotide in its recognition sequence and is found on average once every 100,000bp 
in CpG deficient mammalian genomes. As well as linear starting material, a second 
requirement for partial mapping of large DNAs is a specific DNA probe for each end of 
the molecule. These were obtained by isolating and subcloning the BaniHI-Sall (BS 
probe) and Sall-Acci (SA probe) sequences flanking the tetracycline gene in pBR322 
(the donor for the pCosEMBL2 gene). 
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Figure 4.7 Southern blot analysis of the initial Spi-2 positive cosmids. The filter was 
probed three times, from left to right with the p54A.-1-108 3'-specific subclone, the 5'-
specific rat Spi-2.1 subclone pDEW7, and the exon 5 specific oligonucleotide p54/25-. 
Lane 1: X-Hind III size marker, 2: Barn HI digested CoslA, 3: Barn HI digested Cos 
2A, 4: Barn HI digested Cos6A, 5: Barn HI digested Cos8A, 6: Pst I digested CoslA, 7: 
Pst I digested Cos 2A, 8: Pst I digested Cos6A, 9: Pst I digested Cos8A, 10: PhiX174 
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Figure 4.8 Southern blot analysis of Spi-2 positive cosmid total restriction digests. 
Probed with the 5'-specific subclone pDEW7. Approximately 0.5 p.g cosmid DNA 
loaded in each lane after digestion. Barn = Barn HI, Eco = Eco RI, Hind = Hind III, 
Sma = Sma I, B/E = Barn HI and Eco RI double digest, B/H = Barn HI and Hind III 
double digest, E/H = Eco RI and Hind III double digest. Relevant size markers from X - 
Hind III and PhiX174-Hae III digests are shown at left in kilobasepairs. 
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Figure 4.9 Southern blot analysis of Cos2A and Cos6A partial digests. Partial digests 
for each cosmid were electrophoresed in duplicate to give two panels for probing with 
the BS and SA end-specific fragments. Gels were 0.4% agarose to allow resolution of 
fragments over 30 kilobases. B = Barn HI, Bg = Bgl IT, E = Eco RI, H = Hind III, Sp 
= Sph I. Size markers (A.-Hind III) are shown at left in kilobasepairs. 
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It was now possible to use these probes on Sail linearised cosmid DNA in an analogous 
fashion to the method of Rackwitz which employs cosR and cosL oligos to map 
terminase-linearised DNA. 
Partial digests were carried out on Sall digested cosmids 2A and 6A. The same 
enzymes as for complete digests were normally used: Bam}ll, EcoR!, Hindu, and 
Xhol. Conditions for partial digestion were determined empirically. Dilution of enzyme 
to 1 unitljll in lx restriction buffer, and digestion of lp.g of linear cosmid with 1 unit of 
enzyme for three minutes at 37 0C usually gave good results. Reactions were stopped 
with Orange 0 mix, divided into two, and run in parallel sets on 0.4% agarose gels 
overnight (generally until the A/HindIII 2kb size markers had travelled at least 15 cm 
from the origin). The gels were then photographed with a ruler to give scale and south-
ern blotted to filters. The filter was then divided into two parts, each with a full set of 
digests, and probed with either the Bamlil-SalI (BS) or Sail- AccI (SA) probes. The 
resulting autoradiographs gave a pattern of the restriction site positions, with respect to 
the molecule ends, for each enzyme. These could then be accurately sized and located 
using the gelsize program and the data assembled into a precise restriction map of the 
cosmid. An early example for cos2A and cos6A is shown in Figure 4.9. 
Assembly of Spi-2 Contigs 
Combining the partial restriction maps with the complete digest gene hybridisation 
data gave an indication of the size and orientation of the Spi-2 sequences on each 
cosmid. The map for cos2A is shown in Figure 4.10. It contains two apparently com-
plete Spi-2 sequences in a head to tail orientation about 10kb apart. Both genes appear 
similar in size; also about 10kb. No significant difference in intensity of probe hybridisa-
tion was seen for the 3'specific (p54A.l-108) and S'specific probe (pDew7) between the 
two genes. 
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Figure 4.10 Restriction maps of Cos 2A, 6A, 1A and 8A. Maps were produced using 
the data from specific probes hybridised to total digests, and gelsize analysis of the par-
tial restriction digests. B = Barn HI, E = Eco RI, H = Hind III, Sal = Sal I, Xho = Xho 
I. Fragments hybridising to the p54?l-108 (3'specific) and pDew7 (5 ' specific) Spi-2 
probes are shown, with arrows indicating the putative direction of transcription. The 
cosmids are shown linearised at the vector Sal I site. Vector sequences are shown as 
heavier lines. 
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Figure 4.11 Restriction maps of remaining Spi-2 cosmids. Maps were produced using 
the data from specific probes hybridised to total digests, and gelsize analysis of the par-
tial restriction digests. B = Barn HI, E = Eco RI, H = Hind III, Sal = Sal I, Xho = Xho 
I. Fragments hybridising to 3' and 5'speciflc probes are shown, with arrows indicating 
the putative direction of transcription. The cosmids are shown linearised at the vector Sal 






























































































































Figure 4.11 (cont.) 
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This may indicate that they are both a similar evolutionary distance from the two probe 
sequences. Identical analysis of cos 6A, and coslA and 8A, provided maps of similar 
resolution (Figure 4.10). The two clones coslA and cos8A were found to overlap one 
another for most of their lengths, each cosmid having about 5kb of non-overlapping 
sequence at opposite ends. They did not overlap or "contig" with either cos2A or cos 6A 
which were also isolated from one another. Further aliquots of the library were screened 
at the same density to isolate more genes, and to produce more overlaps. The contrapsin 
cDNA subclone pBXC 1.4 was used as a probe to increase the probability of isolating 
the contrapsin gene. 
Screening of the second aliquot produced cosmids cosiB, cos2B and cos8B (Figure 
4.11). As with cos IA and cos8A, cos2B and cos8B overlapped one another almost com-
pletely, and contained two genes. They both overlapped with cosiB by about 8kb, and 
cosiB had a substantial overlap with the coslA/cos8A pair. Cos8B also overlapped with 
cos2A at its other end, thus linking all the cosmids except cos6A and providing a contig, 
a continuous cloned genomic region, of about 120kb, containing six closely linked Spi-2 
sequences. 
Subsequent screening of the remaining three aliquots of the library produced cos5C 
and 6C, coslE and 3E, and cos4F and SF respectively (Figure 4.11). Cos5C fell within, 
and cos6C extended to 138kb, the original contig (Contig 1), which now contained seven 
genes. Cos5F also fell within this region, but coslE, cos3E and cos4F all overlapped 
with each other, or with the previously unlinked cos6A, to form a second contig (Contig 
2) of 74kb containing three Spi-2 sequences. Partial and complete digests and probing of 
these clones were carried out as before to determine the gene orientations. The complete 
maps of both contigs are shown in Figure 4.12. 
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Figure 4.12 Restriction maps of Contigs 1 and 2 from the 129 mouse Spi-2 complex. 
These were constructed from overlaps of the cosmids in Figures 4.10 and 4.11 and show 
orientation of ten genes. B = Barn HI, H = Hind III, Sal = Sal I, Xho = Xho I. Frag-
ments hybridising to the p54-1-108 (3' specific) and pDew7 (S'specific) probes are 
shown, with arrows indicating the putative direction of transcription. The genes are 
named by the reactive centre subclone isolated from the relevant cosmid. The cosmid.s 
are shown in their overlapping configuration. Repeat sequences within the contigs are 
shown as checked boxes. 
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Figure 4.12 (cont.) 
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Analysis of Spi-2 Contig Features 
It is clear that the amplification of the Spi-2 sequences in the 129 mouse, relative 
to the human al-antichymotrypsin locus, has not occurred as a simple expansion of a 
tandem array by unequal crossover events. The ten genes were all transcriptionally orien-
tated by using the conserved 5'- specific and 3'-specific probes described above. This 
showed that there is no predictable pattern of gene orientation, or obvious substructure 
which has become further amplified. Comparisons of coding region restriction maps 
demonstrated no clear relationship between neighbouring genes in the contigs, in terms 
of gross physical structure. A series of amplifications and deletions may well have 
occurred, perhaps with obscuring, gene conversion events, although no evidence was 
found for gene conversion at this stage. 
A survey of repeated sequences withm the contigs was carried out to determine 
whether these could have played a role in the amplification of the Spi-2 locus. The prin-
cipal mouse repeat families are members of the SINE (Short INterspersed Element) and 
LINE (Long INterspersed Element) classes of repeated sequence (Hastie, 1989; Singer 
and Skowronski, 1985). In the mouse the B  and B2 repeats are SINE family members, 
and the Mif (now termed L1Md) repeat is the major full-length representative of the 
LINE family (Bennett and Hastie, 1984). Probes for all three repeat types were hybri-
dised to the cosmid digests used to construct the contigs, and the locations of repeats in 
the contigs are shown in Figure 4.12. The Spi-2 locus seems to be rather sparsely popu-
lated with repeats, as higher densities would be predicted in an average 220kb (Bennett 
et al., 1984). This may reflect recent amplification of the genes in the locus; repeats 
may simply not have had time to insert into this region. It is possible that repeat 
sequences were not detected by hybridisation, due to divergence. Several previously 
undetected divergent repeats were defined in the murine -globin locus following corn- 
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puter analysis of the complete locus sequence (Shehee et al., 1989). However, given the 
distribution of detectable Bi, B2, and L1Md repeats in the Spi-2 locus, there is no evi-
dence for their involvement in the gene amplification events. The presence of unrelated 
repeat classes, or smaller repeat motifs, responsible for unequal crossing-over events 
cannot be excluded. 
A search for restriction sites of infrequently cutting restriction enzymes in the con-
tigs was carried out to determine whether CpG enriched "island" sequences were associ-
ated with the 5' ends of any of the genes. CpG islands are commonly found associated 
with "housekeeping" or universally expressed genes, but more rarely with tissue specific 
sequences (Bird, 1986). The restriction enzymes BssH II, Mlu I, Not I, Pvu I, Sac II, 
and Sfi I were used to digest a set of cosmids completely spanning both contigs. 
Surprisingly, only one restriction site was found for one enzyme; a Bss HI! site between 
the genes pCos3E46 and pCos3E2. This lies within five kilobases of the only Sal I site 
in the contigs (Figure 4.12). This indicates that none of the cloned Spi-2 genes possess a 
5' CpG enriched island. 
Analysis of Reactive Centre Sequences in the Contigs 
A total of ten distinct Spi-2 related sequences had now been isolated from the 129 
genome, and these were further characterised by subclomng and sequencing. In almost 
all the cosmids, two Spi-2 sequences were present, and it was not possible to sequence 
the cosmid directly since conserved oligonucleotides would sequence both genes simul-
taneously. Subcloning was simplified by the existence of the detailed restriction maps 
used to construct the contigs, and it was often possible to "force-clone" selected gene 
fragments from double digests of cosmids without band isolation. In this way, all but 
one of the contig reactive centres was cloned into pBluescribe for sequence analysis. 
Sequencing was carried out directly on ds plasmid DNA using the conserved 
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oligonucleotides p54/XV+, p54/129+ and p54/51- where appropriate. The nucleotide and 
putative amino acid sequences obtained from the nine subcloned 129 Spi-2 genes are 
shown in Figure 4.13a and 4.13b. 
Inspection of the reactive centre sequences revealed that the genomic contrapsin 
sequence had not been isolated on the contigs. However, probable orthologues of all four 
DBA reactive centres were found in the 129 genes. These were not always identical 
between strains, but always highly related (Figure 4.14). Whether this represents 
polymorphism in possible Mus domesricus progenitors of the DBA and 129 strains, or 
whether the strains have separate species components at the Spi-2 locus is not clear. 
None of the 129 sequences bore obvious similarities to Spi-2 sequences from species 
outside the genus Mus, apart from the orthologue of the DBA p54A-1-108 leu-ser al-
antichymotrypsin-like gene described above. 
Translation of the reactive centre sequences showed that the cys-cys P1-P1' gene 
found in DBA, p54A.7-45, was not unique since three 129 reactive centres shared this 
P1-P 1' sequence. These genes were all clustered in one half of Contig 1 adjacent to the 
arg-cys 129 orthologue (pCos2B2) of the DBA his-cys gene (p54?8-1). Inspection of the 
cys-cys and arg-cys sequences showed that they were the most closely related, and 
presumably most recently diverged, sequences in the contigs. This was later confirmed 
using the PHYLIP computer programs (Felsenstein, 1985) to generate unrooted trees of 
the sequence phylogenies (see below). Three genes in the contigs look unlikely to 
encode active inhibitors, due to radical amino acid substitutions in the highly conserved 
FNRPFL and TEAAAAT domains which flank the reactive centre. No termination 
codons or frameshift mutations were found in any of the sequences, but the pCos3E2 
gene in particular shows very little conservation of amino acid sequence, and resembles 
a typical "rotting hulk" pseudogene (Howard, 1987). 
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Figure 4.13a Nucleotide sequences of the nine Spi-2 genomic clones (exon 5). Clones 
are shown in alphabetical and numerical order in two groups; putative active genes 
above and putative pseudogenes below. Sequence is shown from codon 1 of exon 5 to 
the termination codon if complete. The reactive centre and putative P1 residue is boxed. 
Dashes represent identity with the top sequence, stars represent deletions relative to the 
top sequence. 
2A1 GTG GTC CAC hAG GCT GTG CTG GAT GTG GCT GAG ACA GGC ACA GAA GCA GCT 
2A2--- --- --- --- --- --- --- --- --- --- --- --- --- --- -- G --T 
281 --- --- --- --- --- --- -- A --C A------------------------A- 
282 
6C28 --- --- --- --- --- --- --- --- --- --- --- --- --- --- -- G ------ 
3E46 --- --- --- --- --- --- --- -- C 
1A1A----------------------C -------------------------T-
6A1 
3E2 	 --C A-- A -- --- --- - -- --- --G -T -A- 
2A1 GCT GCC ACA GGA TAT CAA AAT CTC CAA TGT TGT CAA GGT GTA ATC TAC TCT 
2A2 --- --- --- --- ATG CC- GG- G-- --- *** -CA --T T-T G-- -T- 
2B1 --- --- --- A -TC A-- -T- GC- -C- CTG -C -CA' AA- T-T G-- AT- 




*** --A AA- --T 
6C28 --- --- --- -- G GTC A-- TTA ATT -T - ---- ---- 
C------ 
-AA AA- --T 
3E46 --- --- --- -- G -TC ATT TT- GG- TTT C-- -C- *** A-A AG- T-A C-A A-- 
1A1 --- --- --- -- G CTC A-T TT- -C-- ATT CT- A-- *** A-A AG- -C- 
6A1 	 -TC AA- TTC ATG -C- *** -CA AA- C-T A-A C-- 
3E2 --C A-T T-G A-- CCC AT- T-- AA- TTC CAA -C- *** TCA AA- --G -T- C-- 
2A1 ATG AAA ATA TAT 
2A2 C-- G------T-
2B1 G-- --T G-G A--
2B2 
6C28 ------------ 
3E46 --- -CT C-C C-C 
1A1 	-GT C-G -GG 
6A1 G-- TTT C-T A-A 
3E2 --X CTT T-- AGA 
TTC GAC AGG CCA TTC CTG ATG ATT ATC TCT GAC ACA AAC 
A-- --- --- --- --- --- --- --- --- --- --- -- A 
A-T --- --- --- hAT --T --- C-- CTG TCT TT- G-T 
A-T --- --- --- --- --- --- --- --- --- - -- --T 
A-- --- -- C --- --- --- --- --- --- --- - -- ---  
A -- --- --- --- --- --- G-C --- --- C -- --- GGT 
A----- A-----------C-C --- --- C-- --- GGT 
--T --C GAC -A - --- --- TAC --- G-T -TA G-T CA- GGT 
--A ATG T-T --- --- --- T-C --- C-T -TC AG- -A- GGT 
2A1 ACT CAT ATT CCC CTC TTT ATG GCA 
2A2C --C --- C--------------
281 -----C C-- C-- T-- G-G T-A -TG 
2B2 -----C --- G-- G-- --C -----C 
6C28 ? --C --- C -- --- --- --- -- C 
3E46 CT --G -C- A-- --- --- --- --C 
AAA GTT CCA hAT CCC AGA GAG TGA 
A -- --- -- A -AG 
C TTG --- --- - AG -CA GAC TAG 
A -- --- --- - AG TGA 
A -- --- --- - AG TGA 
C A-T --C 	-AG TGA 
1A1 TT- --C -C- A-T CTC -----A --C --- A-C A-T C-C --T -AG TGA 
6A1 GA- TTC TGC ATC .. polylinker sequence 
3E2 
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Figure 4.13b Predicted amino acid sequences of the nine Spi-2 genomic clones (exon 5). 
Clones are shown in alphabetical and numerical order in two groups; putative active 
genes above and putative pseudogenes below. Sequence runs from residue I of exon 5 
to the termination codon if complete. The putative P1 residue is starred. Dashes 
represent deletions relative to the top sequence. Region 2 (the reactive centre) is boxed. 
Below is a histogram showing the number of alternative residues found at each amino 
acid position in exon S. Data was taken from the seven complete aminoacid sequences. 
The hypervariability of Region 2 (the reactive centre) is obvious. The position of the P1 
residue is arrowed. 
* 
cos2Al VVHKAVLDVAETGTEAAAGTGY QNLQCCQGVIYSMKI Y FDRPFLMIISDTNTHIALFMAKVPNPP.E! 
cos2A2 VVHKAVLDVAETGTEAAAATGM AGVGCC-AVFDFLEIF FNRPFLMIISDTKAHIALFMAKVINPK! 
cos2B1 WHKAVLDMAETGTEADAATP.F K IAPLS -AXFD IVNVN FNRPFNI IVLSLDTQVPFVLVKVLNPKGD! 
cos 2B2 VVHKAVLDVAETGTEAAAATGV KVNLRC-GKIYSMTIY FNRPFLMIISDINTHIAVFMAKVTNPK! 
cos6C-28 VVHKAVLDVAETGTEAAAATGV KLILCC-EXIYSMTIY FNRPFLMI ISDINAHIALFMAKVTNPK! 
cos3E46 VVHKAVLDVAETGTEAAAATGF IFGFRS-RRLQTMTVQ FNRPFL1VISHTGVQTTLFMAKVINPK! 
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Figure 4.14 Comparison of DBA and 129 Spi-2 orthologues. The four sequences are 
aligned in pairs with DBA above and 129 sequence below. Region 2 (the reactive cen-
tre) is boxed. The P1 residue position is marked by a star. X indicates a difference 
between the DBA and 129 sequences. Numbers of synonymous and asynonymous sub-
stitutions in exon 5 are shown below each alignment. 
1-108 VVHKAVLDMAETGTEADAATRF KIAPLSAKFDIVNVN FNRPFNIIVLSLDTQVPF1LVKVLNPKRD! 
X 	 x 
cos2B1 VVHKAVLDMAETCTEADAATRF KIAPLSAKFDIVNVN FNRPFNIIVLSLDTQVPFVLvKvLNPKGD! 
2 asynonymous, 0 synonymous 
* 
8-1 	VVHKAVLDVAETGTEAAAATGV KVNLHCGKIYYMTIY FNRPFLMIISDINTHIALFMAKvTNpK 
X 	x 	 x 
cos2B2 VVHKAVLDVAETGTEAAAATGV KVNLRCGKIYSMTIY FNRPFLMIISDINTHIAVFMAKVTNpK! 
3 asynonymous, 1 synonymous 
* 
7-45 	VVHKAVLDVAEKGTEAAAATGM 1GVGCCAVFDFLEIF FNRPFLMIISDTKAHIALFMJK... 
X 
cos2A2 VVHKAVLDVAETGTEAAAATGH AGVGCCAVFDFLEIF FNRPFLMIISDTKAHIALFpjcvINpK 
1 asynonymous, 0 synonymous 
4-13 	 .....MSAKLKPVFVK FEDQFLYIVLDQGDLNIYLt4G1cvJNpSEK! 
cos6A1 	 . 	. INFMSAKLKPvFvK FEDQFLYIVLDQGDLWI>>polylinker 
0 asynonymous, 0 synonymous 
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Disregarding the DBA orthologues, recent Cys-Cys duplications, and probable pseu-
dogenes, the remaining sequence, pCos3E46, appeared likely to encode an active inhibi-
tor of predictable specificity. This gene had the P1-P 1' residues Arg-Ser in common with 
several known human serpins. Attempts to determine if it was expressed in the mouse 
are described in Chapter 5. 
The nucleotide and predicted amino acid sequences from the 129 contigs were 
analysed for evolutionary relationships by the DNAPARS and PROTPARS programs in 
the PHYLIP 3.1 computer program package mounted at DLVH (Daresbury). Both pro-
grams infer unrooted phylogenies from biological sequences using a maximum parsi-
mony method analogous to the traditionally employed Wagner tree algorithm (Felsen-
stein, 1985). A single tree was generated using either nucleotide and protein sequences 
(Figure 4.15). The relatedness of sequences did not correlate in an obvious fashion with 
their position or orientation on the contigs. Either a complex series of amplifications may 
have occurred, involving subsequent deletions or sequence inversions, or a considerable 
degree of gene conversion among the sequences has obscured the true phylogeny of the 
129 Spi-2 genes. A combination of both processes is probably more likely. Interestingly, 
the sequence which most resembled human al-antichymoirypsin in the reactive centre 
region is the most divergent mouse gene, and is closest to the ctl-antichymotrypsin out-
group. This is the pcos2B l/p54A.-1-108 leu-ser genomic sequence. It does not appear to 
have undergone recent duplication (Figure 4.5), but may well have given rise to two 
expressed rodent-specific Spi-2 sequences prior to rodent radiation (discussed in Chapter 
Five). 
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Figure 4.15 Phylogeny of the 129 genomic Spi-2 sequences. The unrooted tree shown 
was produced by the PROTPARS program in the PHYLIP 3.1 Phiogeny inference pack-
age (Felsenstein, 1985). An identical topology was produced using nucleotide sequences 
for the same region. The length of each branch indicates the number of aminoacid sub-
stitutions from the previous branchpoint. This tree is un-rooted, but taking human al-
antichymotrypsin (Hachy) as an outgroup indicates that the root should probably be 
located between Hachy and 2B 1. Below, a diagram of gene location and orientation on 
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Attempts to Isolate a Contrapsin-specific Genomic Sequence 
The contrapsin genomic sequence, shown by Northern analysis to exist in the 129 
mouse, had not been isolated at this stage, despite its use as a library probe. Specific 
library screens were undertaken to isolate cosmids containing the contrapsin gene using 
highly specific cDNA fragments, and oligonucleotides specific for the contrapsin gene. 
Two separate attempts using an exon 5 (reactive centre exon)/3' untranslated region 
probe at high stringency reisolated Spi-2 cosmids which had already been cloned, 
presumably due to partial similarities in the exon 5 coding sequences. A third screen 
using the contrapsin specific oligonucleotides p54/RC- and p54/3'- produced a single 
cosmid clone which hybridised strongly to the oligonucleotide mixture. This cosmid, 
appropriately named Coscon, was restriction mapped by partial and total restriction dig-
ests and a map is shown in Figure 4.11. The oligo mixture hybridised to a specific 
region of the insert, but repeated probings with the p54?-1-108 reactive centre exon 
probe, the pDEW7 conserved 5' specific probe, and even the contrapsin cDNA probe 
pBXC1.4 did not reveal any homologous sequences in the cosmid DNA. Either the con-
trapsin gene possessed a unique genomic structure with the reactive centre flanked by 
introns of at least 7 and 35 kilobases, or the oligonucleotide positive hybridisation had 
occurred to a random genomic sequence. Unfortunately, the sequencing to establish the 
nature of the oligonucleotide homology was not carried out at this stage. 
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Conclusions 
Genomic Spi-2 clones were isolated from two inbred mouse genomic libraries in an 
effort to establish the number, variability, and genomic organisation of these genes in 
Mus domesticus. The DBA/2 library yielded four independent reactive centre sequences, 
none of which encoded contrapsin. One of the sequences resembled the human a!-
antichymotrypsin sequence in the reactive centre region, but all efforts to detect expres-
sion in the mouse liver failed. This sequence, p54A.-1-108 was mapped to the Spi-1 com-
plex in the BXD recombinant inbred strain panel, although it is clearly an Spi-2 gene. 
This may indicate that the Spi-1 and Spi-2 complexes are virtually contiguous, with the 
BXD recombination occuring within the Spi-2 complex. The intragenic structure of the 
Spi-2 sequences seems to have been completely conserved since mammalian radiation, 
since all sequences examined display the human al-antichymotrypsin intron/exon struc-
ture. 
The second genomic library yielded ten distinct Spi-2 sequences contained in two 
contiguous genomic segments of 138 kilobases and 74 kilobases. Analysis revealed that 
the genes were closely clustered with an average spacing of 10 to 15 kilobases. Their 
orientation, and that of repeated sequences within the contigs, did not reveal an obvious 
mechanism for the amplification of the locus. Sequencing of the reactive centres from 
nine of the 129/St Spi-2 genes revealed orthologues of all four DBA genes, two probable 
pseudogenes, two further genes with Cys-Cys reactive centres, and a gene which resem-
bled the human PCI serpin in the reactive centre region. Analysis of the sequences with 
phylogeny inference programs confirmed the lack of relationship between location on the 
contigs and evolutionary descent, and indicated that pcos2B1/p54?-1-108 sequence may 
indeed represent the primordial Spi- 2 gene. 
CHAPTER FIVE 
Characterisation and Distribution of Expressed Spi-2 Sequences 
Introduction 
The liver is the major organ known to express Spi-2 transcripts in mammals, 
including rodents. The original pLv54 cDNA clone which encoded contrapsin (Hill et al 
1984) had been isolated from a Swiss mouse liver cDNA library. The rat cDNA clones 
pDex2 and pinf5, encoding the rat 2.1 (arg-arg) and 2.2 (val-ser) inhibitors, were also 
cloned from a liver cDNA library (Hill and Hastie 1987). 
A Northern blot to examine the tissue distribution of Spi-2 transcripts, carried out 
by R.Hill before this work, indicated that low levels (about 1/1000 of liver level) of a 
20S transcript could be seen in BALB/c spleen and testes, and a 16S transcript could be 
found in the submaxillary gland at a similar abundance. However, the teratocarcinoma 
cell line EB22, derived from the 129 strain of inbred laboratory mouse by Dr Martin 
Hooper, expressed a 20S transcript (or transcripts) at levels 10 to 20 fold higher than the 
tissues mentioned above; perhaps as high as 1/100 of the hepatic level. The exact nature 
of the EB22 cell line is not certain, but appears to have differentiated towards a chondro-
cytic phenotype (M.Hooper, personal communication). No other rodent tissues were 
known to express detectable levels of Spi-2 sequence. 
A series of cDNA library screens were carried out to determine the nature of novel 
expressed Spi-2 sequences: a) in the liver, using probes derived from novel genomic 
sequences (described in Chapter 4) and b) by screening species or tissues which had not 
been previously characterised for Spi-2 sequences. Initially, attempts were made to iso-
late cDNAs corresponding to cloned genomic sequences. 
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Screening Genomic Clones for Expressed Sequences 
Following isolation of the mouse genomic Spi-2 sequences from the DBA and 129 
strain genomic libraries (Chapter 4), the question arose as to which, if any of the genes 
were transcribed, and in what tissues. 
DBA genomic clones 
The original DBA-derived genomic clone p54--8.1 (cys-cys) did not resemble the 
expected anti-chymotryptic reactive centre, leu-ser. An oligonucleotide (oligo p54/62-), 
complementary to the putative mRNA, did not reveal any signal in various tissues exam-
ined. This oligo was also designed to hybridise to the rat Spi-2.2 sequence, and did give 
a 20S signal on Northern blots of rat liver RNA (not shown). 
The next DBA genomic clone to be isolated, p54-A.-1.108, had the Pi-Pi' residues 
leu-ser and looked an ideal anti-chymotrypsin candidate. An antisense 18mer oligonu-
cleotide (p54/LS-) was made, complementary to the DNA encoding the reactive centre 
amino acid residues APLSAK, and this was used to probe the DBA cDNA pBR322 
plasmid library. One apparent positive clone was observed on the primary screen of 
40000 colonies, but proved to be artefactual after repeated library screens. Several 
Northern blots using this oligo as a p54-X-1.108-specific probe never gave a detectable 
signal. It was concluded that this gene was unlikely to be the functional equivalent of 
human al-antichymotrypsin. The two remaining DBA genomic sequences, p54-A.-7.45 
(cys-cys), and p54-k-4.13 (met-ser) were not investigated in terms of tissue transcription 
at this stage. The use of the full length genomic fragments (1 to 3 kb) as Northern blot 
probes was not informative since all the sequences cross-hybridise to the contrapsin 
sequence with which they were initially isolated. 
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Figure 5.1 Alignment of cos3E-46 and human PCI reactive centre sequences. The pro-
tein and DNA sequences of the two genes are shown, with stars representing identical 
residues or nucleotides. Interestingly, the protein similarity in Region 2 (7/15 residues) is 
higher than the nucleotide identity over the same sequence (18/45 nucleotides). Region 2 
is boxed for both alignments. The location of the 18mer antisense oligonucleotide 
p54/PCI- is shown above the nucleotide sequence for pcos3E- 46. HuPCI = human PCI 
(Suzuki et at., 1987), 3E46 = pcos3E-46 (Figure 4.13) 
	
3E46 	A T G F I F C F R S R R L Q T M T V QIF N R 
HuPCI 	A T C T I F T F R S A R L N S Q R L yjF N R 
p54/PCI- 
** 
3E 46 GCCACAGGGTTcATTTTTGCCTTTCGTTCTAGAAGATTACAAACTATGACTGTGCAcTTCAACAGG 
** 	** 	* ** 	* 	* 	* 	** 	** 	* 
H uPC I GCCACCCCCACA1ATCTTCACTTTCACGTCGGCCCGCCTGAACTCTCACAGGCTAGTTTCAACAGC 
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Figure 5.2 Nucleotide and protein sequence of pMPCI-2 (exon 5 only). This sequence 
is identical to the 129-derived reactive centre sequence from pcos3E-46, despite its isola-
tion from a DBAI2 liver cDNA library (cf Figure 4.14). The amino acid sequence is 
repeated below, aligned with that of contrapsin. The P1 residue is indicated by an aster-
isk. 
V V H K A V L D V A E T G T E A A 
GTC GTC CAC AAG GCT GTG CTG GAC GTG GCT GAG ACA CCC ACA GAA GCA GCT 
A A T C F I F C F R S R R L Q T M 
GCT GCC ACA GGC TTC ATT TTT GGC TTT CGT TCT AGA PtGA TTA CAA ACT ATC 
T V Q F N R P F L N V I 	S 	H T G V 
ACT GTG CAG TTC AAC ACG CCA TTC CTG ATG GTC ATC TCT CAC ACA GGT GTT 
Q T T L F N A K V T N P K 
CAG ACT ACC CTC TTT ATG GCC AAA GTC ACT AAC CCC AAG TGA 
* 
MPCI-2 VVHKAVLDVAETGTEAAAATGF IFGFRSRRLQTMTVQ FNRPFLMVISHTGVQTTLFMAKVTN?K 
pLv54 ------------- --------V -G-I-KAI-P. .A-H ------F--Y--SA-SI ------N---- 
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129 strain genomic clones 
The characterisation of the Spi-2 genoniic sequences from the 129/St mouse strain 
again raised the question of which novel genes were expressed, and where. The 
sequence of pCos3E-46 was interesting in that it resembled the reactive centre of the 
human serpin PCI, (Protein C Inhibitor (Suzuki et a!, 1987)) in seven of ten residues in 
the amino terminal region of its reactive centre (Figure 5.1). 
An antisense 18mer oligonucleotide (p54/PCI-) was synthesised, corresponding to 
the sequence GFRSRR, and used to screen the DBA mouse liver cDNA library (50000 
colonies). Five hybridising signals were observed on duplicate filters, and positives were 
obtained for each primary on secondary and tertiary screens. Mini-preps of the plasmids 
were grown up, and the longest PstI insert, from clone 2 (1.4kb), was selected for 
further analysis. The insert was excised from the pBR322 vector with Pstl and sub-
cloned into pBluescribe. This plasmid was named pMPCI-2, and sequencing of CsC1 
purified dsDNA using flanking and internal oligonucleotides confirmed that it 
represented a transcript from the pCos3E-46 genomic sequence (Figure 5.2). 
This was the first Spi-2 sequence for which both a genomic and a cDNA sequence 
was available. Northern blots of mouse tissues, and of various murine species liver RNA 
were carried Out using the oligonuleotide, but unfortunately it hybridised fairly strongly 
to 18S and 28S ribosomal bands. This was not a problem when the cDNA library was 
screened since enrichment for mRNA sequences had occurred during library construc-
tion. However the pMPCI-2 transcript would be expected to be of low abundance (1 in 
10000 cDNA clones), and possibly about the same size as the 185 rRNA transcript. 
Even when poly (A)-4-RNA was used, no specific clean signal was observed for the 
pMPCI-2 oligonucleotide. 
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Figure 53 "Evolutionary blot" of liver RNA from the genus Mus. Four panels: a, b, c, 
d. 5.3a: probed with pMPCI-2 eDNA, pMP2 = pMPCI-2. 5.3b: probed with Apodemus 
pAP-5 cDNA. 5.3c: probed with Apodemus pAAC-8 cDNA. 5.3d: probed with antisense 
18mer reactive centre oligonucleotide p54/226- to pEB22/5 (see Figure 5.6b). Ten p.g of 
total liver RNA was loaded for each species. Lane 1. M. domesticus RNA, 2. DBA, 3. 
M.musculus, 4. C57BL/6, 5. M. hortulanus, 6. M. spretus, 7. M. caroli, 8. M. cooki, 9. 
M. cervicolor, 10. M. saxicola, 11. M. pahari, 12. M. minutoides, 13. A. sylvaticus, 14. 
R. norvegicus. Relative positions of 18S and 20S transcripts for all blots shown in 5.3a. 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
pMP© 
Wee 	 -18S 
4 





oligo 226 	 • tit  
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Figure 5.4 Sequence comparison of the MPCI gene to other inhibitors (exon 2). 5.4a: 
Alignment of the pMPCI-2 exon 2 nucleotide and predicted amino acid sequences with 
the published rat 4.12B (=Spi-2), human al-antichymotrypsin and human protein C inhi-
bitor amino acid sequences. The MPCI protein sequence is shown in upper case. MPC 
= pMPCI-2, 4.12 = rat 4.12B, HAC = human al-antichymotrypsin, HPCI = human pro-
tein C inhibitor. 5.4b: Table showing the proportion of identical residues for all four pro-
tein sequences shown in 5.4a. The figures support the idea that the MPCI sequence is 
Spi-2-like rather than PCI-like. 
Figure 5.4a 
MPC GAAGGCAAGGGCTCTGTACCAGACTGAGGCCTTCACAGCAGACTTACAGAAGCCTACTGA 
NPC K A R A L Y Q T E A F T A D L Q K P T 	E 
4.12 k t r a 1 y q a e a f v a d f k q C n 	e 
HAC d a k r 1 y g s e a f a t d f q d s a 	a 
FIPCI a in k t 1 y 1 a d t f p t n f r d s a 	g 
MPC GGCCAAAAACCTCATCAATAACTATGTGAGCAATCAGACCCAGGGGATGATCAAGGAACT 
MPC A 	K N L I 	N 	N Y V 	S N 	Q T Q G H I 	K 	K 	L 
4.12 a 	k k f i 	n 	d y v 	S n 	q t q g k i 	a 	e 	1 
HAC a 	k k 1 i 	n 	d y v 	k n 	g t q g k i 	t 	d 	1 
HPCI a 	in k q i 	n 	d y v 	a k 	q t k g k i 	v 	d 	1 
Figure 5.4b 
MPCI 4.12 HAC HPCI 
MPCI - 27/40 21/40 13/40 
4.12 - - 22/40 18/40 
HAC - - - 22/40 
123 
The pMPCI-2 insert was also used to probe Northern blots of various murine liver 
RNAs ("evolutionary blots"), and part of an evolutionary blot is shown (Figure 5.3a). 
The cDNA gives a similar hybridisation pattern to contrapsin and is presumably crosshy-
bridising to the abundant contrapsin message as well as its own less abundant 18S tran-
script. 
It appears from additional sequence analysis (Figure 5.4) that the pMPCI- 2 tran-
script may not be a strict orthologue of the human PCI gene, which diverged from 
antichymotrypsin about the time of mammalian radiation (Suzuki et al 1987). The 
mouse PCI-like gene appears to have diverged from the antichymotrypsin gene consider-
ably later, perhaps around the time of rodent radiation ( 15 million years ago). This will 
be further discussed after consideration of the other rodent results (Chapter 7). 
No other reactive centre sequences from the 129 cosmid contigs looked as likely as 
pCos3E-46 to encode functional inhibitors, either because of unusual P1 residues (eg 
cysteine), or because of potential disruption of the highly conserved TEAAAAT or 
FNRPFL boxes. Alternative approaches to defining expressed genes were attempted. 
Expressed Spi-2 Sequences in Apodemus sylvaticus Liver 
To establish the nature of expressed Spi-2 sequences in Apodemus sylvaticus, a 
?gt1O cDNA liver library (from R.Hill) was screened. The library was constructed from 
poly(A)+ RNA prepared from the male specimen trapped at the Bush estate for the origi-
nal contrapsin RNA sequencing study (Chapter 3). It had been shown by that study that 
A. sylvaricus did not express high levels of Spi-2 message in the liver, but that an 18S 
and a 20S transcript were visible in approximately equal amounts at low abundance (Fig-
ure 3.7). No evidence for a contrapsin-like sequence had been obtained. 
The library was plated out at a density of 1 x 10 plaques per 20x2Ocm plate and 
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screened with a 5'fragment of pSPFL2.1 (encoding the rat Spi-2.1 product) and a con-
served oligonucleotide (oligo p54/129+) on duplicate filters. A total of 12 positives were 
observed at the primary stage, these appeared to fall into two groups on the basis of 
hybridisation intensity. Four clones remained positive during secondary and tertiary 
screens using the 5' cDNA fragment only. Restriction analysis of the individual clones 
confirmed the presence of two classes of cDNA clone in equal abundance. These were 
sequenced, using oligonucleotide primers (oligos p54/51- and p54/129+) to conserved 
sequences which flank the reactive centre. The sequences obtained are shown (Figure 
5.5). 
Clone 12 (Figure 5.5a) showed considerable similarity to the rat Spi-2.2 (val-ser) 
sequence described by Hill and Hastie (1987). This sequence is considered to represent 
the rat equivalent of human al-antichymotrypsin on the basis of message size, chemical 
nature of P1 residue and inducibility during the acute phase response. The Apodemus 
clone appeared to be the direct equivalent of rat Spi2.2, with the interesting difference of 
a valine to leucine substitution at the P1 residue. This would be unlikely to alter the 
inhibitory specificity of the molecule since the putative human orthologue also has a leu-
cine residue in the P1 position 
Clone 1 (Figure 5.5b) was also very similar to a previously cloned sequence, the 
129 and DBA-derived gene pCos3E-46 (genomic) or pMPCI-2 (cDNA). Like its mouse 
counterpart, Apodemus clone 1 has an arg-ser reactive centre and shows a similar degree 
of Apodemus/mouse divergence to the al-PI and albumin transcripts in the RNA 
sequencing experiments (Chapter 3). The existence of such similar genes in both Apo-
demus and mouse echoed the similarity of the Apodemus Clone 12 (al-antichymotrypsin 
like) and the rat spi-2.2 sequence discussed above. 
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Both Apodemus sequences, Clone 1 and Clone 12 were subcloned into pBluescript 
for further analysis, yielding plasmids pAP-S and pAAC-8 respectively. Both cDNAs 
were used as probes to the murine "evolutionary blot" (Figure 5.3b and 5.3c) previously 
described in Chapter 3. This contains a series of liver RNAs from mice which diverged 
from M. domesticus after the rat. 
The PAP-5 clone (arg-ser) gives a very similar 18S mRNA hybridising pattern to 
that of contrapsin and of pMPCI-2, the DBA arg-ser cDNA. This would be expected as 
these sequences are closely related. The only obvious difference between the Apodemus 
and DBA probes is that the Apodemus probe hybridises more efficiently to the low abun-
dance Apodemus PCI-like transcript than the mouse probe. The equivalent effect for the 
DBA cDNA probe and DBA arg-ser transcript is obscured by the presence of the con-
trapsin sequence in mouse, to which both Apodemus and DBA probes hybridise with 
similar efficiencies. 
The pAAC-8 (Apodemus antichymotrypsin-like) probe preferentially hybridises to a 
20S mRNA transcript in the evolutionary blot. An 18S transcript is detected in recently 
diverged mice but this is probably due to high levels of contrapsin mRNA in these 
murids. The presence of contrapsin mRNA at levels perhaps one hundred-fold higher 
than the 20S transcript would compensate for decreased homology between the pAAC-8 
probe and conrrapsin transcript. The pAAC-8 probe hybridises efficiently to a 20S Apo-
demus transcript as expected, but less efficiently to the rat 20S, to which it appears 
orthologous by sequence. A 20S transcript is not visible in C57/BL6 or Mus musculus 
liver, confirming previous experiments (Hill et al, 1985) which demonstrated that the 
20S transcript was not constitutive at detectable levels in these mice. 
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Figure 5.5 Expressed Apodemus sylvaticus spi-2 Sequences. 5.5a: Sequence of Apo-
demus Clone 12 (exon 5). The DNA and protein sequences are shown. Below the pro-
tein sequences of Clone 12 and the rat orthologue Spi-2.2 are shown aligned. Apo 12 = 
Apodemus clone 12, rat 2.2 = rat Spi-2.2. 5.5b: Sequence of Apodemus Clone 1 (exon 
5). The DNA and protein sequences are shown. Below the protein sequences of Clone 1 
and the mouse orthologue MPCI-2 are shown aligned. Apo 1 = Apodemus Clone 1, mpci 
= MPCI-2. Dashes represent sequence identity. The position of the P1 residue is indi-
cated by an asterisk. 
Fig 5.5a 
Apo 12 V V H K A V L 0 V A E K G T E A A 
exon GTG GTC CAC AAG GCT GTG CTG GAC GTG GCT GAG AAA GGC ACA GAA GCA GCT 
5 
A A T G V K I V. P 	L S A K L 0 P L 
GCT GCC ACG GGA GTC AAA ATT GTC CCA CTG TCT GCA AAG CTG GAC CCT TTG 
T 	I 	Y F N R P F L V A 	I 	Y D T E T 
ACT ATA TAT TTC AAC CGG CCT TTC CTG GTG GCT ATC TAT GAC ACA GAA ACT 
E 	I 	I 	Y 	F 	L G K 	I 	S N 	P 	K 
GAA ATT ATC TAC TTT TTG GGC AAA ATA TCC AAC CCC AAA 
* 
Apo 12 VVHKAVLDVAEKGTEAAAATGV KIVPLSAKLDPLTIY FNRPFLVAIYDTETEIIYFLGKISNPK! 
rat 2.2 ----------- T ---------- ----V ------- I-A -D ---- t1I-S ---- A-AP--A--F---- 
Fig 5.5b 
V V H K A M L E V A E K G T E A A 
Apo 1 GTG GTC CAC AAG GCT ATG CTG GAA GTG GCT GAG AAA GGC ACA GAA GCA GCT 
exon 
5 	A A T G V K F V F R S G R V P T M 
GCT GCC ACA GGA GTC AAG TTT GTC TTT CGT AGT GGC AGA GTA CCA ACG ATG 
T V R F D R P F L N V V S H T G V 
ACT GTG AGG TTT GAC AGG CCA TTC CTC ATG GTT GTC TCT CAC ACA GGT GTT 
E S I L F F G K V T N P N 
GAG TCT ATC CTC TTT TTG GGC AAA GTC ACC AAC CCC AAT 
* 
Apo 1 VVHKAMLEVAEKGTEAAAATGV KFVFRSGRVPTMTVR FDRPFLMVVSHTGVESILFFGKVTNPN! 
mpci 	 V-D --- T --------- F I-G---R-LQ ---- Q -N------I-----QTT--MA--I--K! 
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The conservation of both the Spi-2.2-like and PCI-like genes between rodent species 
might be due to selection for internal physiological function. If this were the case, 
inbred mice would be expected to express an antichymotrypsin-like sequence, ortholo-
gous to rat Spi-2.2 and Apodemus Clone 12, and the rat would be expected to express a 
PCI-like sequence orthologous to mouse pCos3E-46 and Apodemus Clone 1. 
Screening for Mouse Anti-Chymotrypsin 
An attempt was made to isolate the putative mouse anti-chymotrypsin. Screening 
of the DBA cDNA liver library which yielded the pMPCI2 clone was carried out using 
an oligonucleotide complementary to the SAKLDP codons of the Apodemus Clone 12 
and Rat Spi-2.2 gene pair. This did not give any positive signals in a screen of about 5 x 
io 4 colonies. There was a high chance that the oligo would not be exactly complemen-
tary to the putative mouse antichymotryptic sequence even if the amino acid residues 
were conserved, due to codon degeneracy. This later proved to be the case. 
Screening of EB22 cDNA Library for Spi-2 Sequences 
The rodent liver could not readily be searched further for Spi-2 sequences which 
could be specifically screened for (excluding randomly selected reactive centre sequences 
from the genomic contig). The next tissue to be examined was the mouse cell line EB22. 
This is considered to represent a chondrocytic-derivative cell type from a teratocarci-
noma, and had been shown previously to express a 20S Spi-2 mRNA. Total EB22 RNA, 
isolated by R.Meehan, was used to produce poly(A)+ enriched RNA and a cDNA library 
was then constructed in XgtlO by R.Hill. Screening of 1O 5 plaques was carried out with 
pSPFL2. 1, the full length rat Spi-2.1 cDNA. Five positive plaques were obtained, and 
isolated clones examined by restriction analysis. These fell into two groups; clones 1, 4 
and 5, and clones 2 and 3. Sequencing was carried Out on clones EB22/3 and EB22/5, 
128 
using internal primers (oligos p54/129+ and p54/51-) to reactive centre flanking regions. 
The sequence from clone EB22/3 (Figure 5.6a) proved to be identical to that of the 
129 genomic sequence pCos2A2, which has a putative cys-cys reactive centre bond. This 
was unexpected as a cys-cys pairing had not previously been observed and it had been 
thought that the genomic cys-cys sequences discovered in the contigs (Chapter 4) might 
represent inactive descendants of duplication events. The fact that this gene was at least 
transcribed, and at equivalent levels to the EB22/5 met-ser gene, was an indication that 
other unusual sequences in the contig might also be active. The effect upon inhibitor 
specificity of a cysteine in the P1 positon is unclear. 
The sequence obtained from clone EB22/5 is shown (Figure 5.6b) aligned with the 
Apodemus Clone 12 and Rat 2.2 reactive centres. It appears likely to encode the mouse 
orthologue of the al-antichymotrypsin gene from the other two rodents. A major 
difference however is the presence of a methionine residue in the P1 position, compared 
to a valine in Rat and a leucine in Apodemus. This might be expected to alter the target 
specificity of the inhibitor to some degree, as methionine is a preferred residue for 
hydrolysis by elastase type proteinases, rather than chymotrypsins. 
Analysis of Putative Murine al-antichynwtrypsin 
If the EB22/5 clone actually represents the mouse orthologue of Apodemus clone 
12 and rat Spi-2.2, it should meet certain functional criteria. The other rodent sequences 
are expressed in the liver as a 20S transcript, which, at least in the case of the rat, are 
induced as part of the inflammatory response. The mouse also expresses an inducible 
20S transcript (Hill et al, 1985), which had not been characterised. EB22/5 represented a 
candidate sequence for this mRNA. 
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Figure 5.6 Expressed Spi-2 sequences from EB22 cells. 5.6a: Nucleotide and predicted 
amino acid sequence of exon 5 for clone EB22/3 (cys-cys). The cDNA sequence is 
identical to that of the 129 genomic Spi-2 subclone pcos2A2 over the region sequenced. 
5.6b: Nucleotide and predicted amino acid sequence of exon 5 for clone EB22/5 (met-
ser). The location of the antisense 1 8mer oligonucleotide p54/226- is shown. Below, the 
protein sequences for EB22/5, Apodemus Clone 12 (Apo 12) and the rat Spi-2.2 (rat 2.2) 
gene are aligned. Dashes represent residue identity. The P1 residue is indicated by an 
asterisk. 
Figure 5.6a 
V V H K A V L D V A E T G T E A A 
E822/3 GTG GTC CAC AAG GCT GTG CTG GAT GTG GCT GAG ACA GGC ACA GAG GCT GCT 
A A T G M A G V G C C A V F D F L 
GCT GCC ACA GGA ATG GCA GGT GTC GGA TGT TGT GCA GTT TTT GAC TTT CTG 
E I F F N R P F L M I I S D T K A 
GAA ATA TTT TTC AAC AGG CCA TTC CTG ATG ATT ATC TCT GAO ACA AAA GCT 
H I A L F N A K V T N P K 
CAC ATT GCC CTC TTT ATG GCA AAA GTT ACA AAT CCA AAG TGA 
Figure 5.6b 
V V H K A V L D V A E T G. T 	E A A 
EB2215 GTG GTC CAC AAG GCT GTG CTG GAT GTG GCT GAG ACA GGC ACA GAA GCA GCT 
A A T G V K F V P M S A K L I P L 
GCT GCC ACT GGA GTC AAA TTT GTT CCA ATG TOT GCG AAA CTG TAO COT CTG 
*** *** *** *** *** 
oligo p54/226- 
T V Y F N R P 	F L 	I 	M 	I F 	D 	T E T 
ACT GTA TAT TTC AAC AGG COT TTC CTG ATA ATG ATC TTT GAC ACA GAA ACT 
E 	I A P 	F 	I 	A 	K I 	A 	N 	P 	K 
GAA ATT GOC CCC TTT ATA CCC AAG ATA CCC AAC CCC AAA 
* 
EB2 2/5 	VVHKAVLDVAETGTEAAAATGV KFVPMSAKLYPLTVY FNRPFLIMIFDTETEIAPFIAKIANPK! 
Apo 12 ----------- K ---------- - ---L ---- D --- I - ------ VA-Y ------ IY-LG--S---! 







Figure 5.7 Induction of Mouse met-ser Spi -2 gene by acute phase reactants. A: Northern 
blot of liver and EB22 RNAs probed with the mouse met-ser specific oligonucleotide 
p54/226-. Lane 1: 2jig DBA poly(A)+ liver RNA, 2: 10 jig C57BL/6 total liver RNA 
(uninduced control), 3: 10 jig C57BL/6 total liver RNA (induced by 50 jig LPS), 4: 10 
jig EB22 total RNA (uninduced control), 5: 10 g.Lg EB22 total RNA (induced by Dex-
amethasone). B: Northern blot of liver and EB22 RNAs probed with the mouse met-ser 
specific oligonucleotide p54/226-. Lane 1: 10 jig DBA poly(A)+ liver RNA, 2: 1 jig 
DBA poly(A)± liver RNA, 3: 2 1 057BL/6 poly(A)+ liver RNA (uninduced control) , 4: 
2 jig C57BL/6 poly(A)+ liver RNA (induced by 50 jig LPS)5: 10 jig EB22 total RNA 
(induced by Dexamethasone). Sizes of 18S, 20S and 28S transcripts are indicated. 
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An oligonucleotide (p54/ 226-) was synthesised complementary to the reactive centre 
region and was used to probe a Northern blot of umnduced and induced mouse liver and 
EB22 cell RNA (Figure 5.7). These showed that EB22/5 did express a 20S inducible 
transcript in both liver and EB22 cells. This clone is highly likely to represent the strict 
murine orthologue of Apodemus clone 12 and the rat Spi-2.2 by sequence and function, 
and the functional equivalent of human al-antichymotrypsin. 
Oligo p54/226- was also used to probe the murine Northern "evolutionary blot" 
(Figure 5.3d). This showed that the reactive sequence was conserved and expressed in 
the livers of mice as divergent from Mus domesticus as Mus cervicolor and Mus caroli. 
This degree of conservation is similar to that of contrapsin and may represent fixation of 
the reactive centre sequence following the acquisition of the methionine P1 residue. 
Analysis of Spi-2 expression in the 16-day mouse 
Previous analysis (Barth et al., 1982; Meehan et al, 1984) of contrapsin gene 
expression in the developing mouse embryo had shown that contrapsin is not detectable 
in the liver before seventeen days of development, when it rapidly rises to the high level 
of transcription found in the adult. Apart from the adult tissues mentioned at the begin-
ning of the chapter (submaxilliary gland, spleen, and testis) no other mouse tissues were 
known to express Spi-2 sequences. In situ hybridisations to mounted sections of mouse 
embryo were carried out to establish further patterns of expression. The stage chosen 
was the sixteen day embryo as it was considered that the high levels of hepatic contrap-
sin expression from more advanced stages might obscure other areas of Spi-2 expression. 
Sections of sixteen day old mouse embryo (cut and prepared by D.Davidson) were 
probed with a 35S-UTP labelled RNA probe, transcribed using phage 77 polymerase, 
from the contrapsin subclone pBXC1.4. This probe is relatively specific for the Spi-2.1 
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family members, but can hybridise to most Spi-2 sequences at normal stringency (65°C, 
2X SSC). The in situ hybridisation procedure was supervised by E.Graham and fol-
lowed established protocols (Davidson et al., 1988). Slides were developed after a three 
week autoradiography period and examined, using dark-field microscopy, for areas of 
positive hybridisation. 
There was no detectable probe hybridisation to the liver, confirming the absence of 
hepatic contrapsin transcription before seventeen days of development. Areas of positive 
hybridisation were found in several sections, and upon examination appeared to be local-
ised to areas where cartilage-like tissue had been deposited. Three examples are shown 
in Figures 5.8 to 5.10. Figure 5.8.shows an area from a transverse section through the 
head of the embryo. The dark-field photograph shows increased hybridisation to an 
umbrella-shaped structure, which can be localised to a particular cell-type on the light-
field print. This structure is the nasal septum, separating the developing nostril airways, 
and is composed of cartilage. Figure 5.9 shows a detail from a transverse section 
through the mouse in the pectoral girdle region. The elbow joint is clearly visible in the 
upper centre of the light-field photograph, and cells of a similar appearance to the nasal 
septum cartilage can be seen on either side of the joint. In the dark-field photograph 
these can be seen to be positive for an Spi-2 transcript. The hybridisation does not 
extend to the boundaries of the bones at the joint; it appears that the transcripts are not 
found in fully differetitiated bone. Finally, Figure 5.10 shows part of a sagittal section 
through the mouse, in the area of the lower limb. The internal structure of the foot is 
obvious in the light-field illustration, and heavy hybridisation to inner areas of the skele-
tal structure can be seen in both light and dark-fields. Again, little signal is obtained 
from the boundaries of the skeletal structures. 
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Figure 5.8 Light and dark-field photomicrographs of a transverse section through 16 day 
mouse (head region). 56X magnification The light- field print (top) shows the cartilagi-
nous tissue forming the nasal septum as an umbrella shaped structure In the dark-field 
print below, the clustering of silver grains (light coloured) can be seen overlying this 
structure which is composed of a distinctive loosely-clustered cell type. 
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Figure 5.9 Light and dark-field photomicrographs of a transverse section through 16 day 
mouse embryo (pectoral girdle region). 56X magnification. The light-field print shows an 
upper limb joint in the centre of the photograph. The dark-field print shows that grain 
clustering is restricted to areas of tissue close to, but distinct from, the joint- forming 
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Figure 5.10 Light and dark-field photomicrographs of a sagittal section through a 16 day 
mouse embryo (hind limb region). 56X magnification. The light-field print shows the 
lower limb (foot) and silver grains are visible in this photograph, over the developing 
tarsals and metatarsals. The dark-field print (below) shows that grain clustering is res-
tricted to localised areas within the developing bones. Expressing cells have the same 
appearance as those in Figures 5.8 and 5.9. 
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Other regions of the embryo which gave a positive signal with the contrapsin probe 
always contained cells of cartilaginous phenotype, and were located in areas where car-
tilage is normally present. No hybridisation was observed in regions lacking a defined 
skeletal component. 
In the light of the EB22 cDNA library data, it seems likely that the transcript(s) 
detected by in situ hybridisation in the cartilage-like cells is one, or both, of the Spi-2 
sequences found in the EB22 library. A proteinase inhibitor activity has previously been 
reported for cartilage (Kuettner et al., 1977). A role for proteinase inhibitors in control-
ling matrix degradation during tissue re-modelling can readily be envisaged, and this 
could represent either a second function for al- antichymotrypsin in the mouse, or a 
function for the novel cys-cys serpin sequence, EB22-3. The latter is perhaps less likely 
since this gene is thought to have arisen after mouse/rat divergence and no other mam-
malian orthologues are known. 
Screening for the Rat Arg-Ser Orthologue. 
As discussed above, the presence of two very similar arg-ser inhibitor transcripts in 
mouse and Apodemus, and the existence of a conserved al-antichymotrypsin equivalent 
in mouse, Apodemus, and rat, suggested that an arg-ser inhibitor sequence might be 
expressed in rat liver. Searching for this sequence in a rat liver cDNA library was com-
plicated by the fact that the Spi-2.1 and 4.12B transcripts are expressed at high levels in 
this tissue, and while distinct from the putative rat arg-ser gene, are sufficiently similar 
to hybridise strongly to any cDNA probe available. The obscuring transcripts might be 
expressed fifty to one hundred-fold, more abundantly than the target arg-ser sequence, as 
in mouse liver. This made the characterisation of randomly isolated Spi-2 sequences 
from rat liver appear laborious, and instead a differential screen was carried out. 
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Triplicate Benton-Davis filter replicas were made from a .-gt1O rat liver cDNA 
library plating of 5 x 1O4 plaques. Two filters were probed with the DBA arg-ser insert 
pMPCI-2 at a stringency of 2X SSC, allowing equivalent hybridisation to all contrapsin-
like Spi- 2 sequences. The third filter was probed with a mixture of two oligonucleotides 
specific for the reactive centre regions of the Spi-2.1 and 4.12B sequences (see Figure 
3.12), and washed at stringency close to the predicted probe TM.  The majority (> 95%) 
of duplicate insert- positive plaques were also oligonucleotide positive, confirming the 
relative abundances of the three sequences. Six clones which were insert positive, but 
oligonucleotide negative were isolated. Restriction mapping to eliminate partial clones 
of the Spi-2.1 and 4.12B transcripts, yielded one clone which could not be either, and 
was not the Spi-2.2 rat transcript This insert was 1.7kb long and was subcloned to 
pBluescribe as pRPCI-5. Sequencing using the conserved oligonucleotide p54/129+ 
revealed that the clone was likely to encode the direct rat orthologue of the DBA and 
Apodemus arg-ser sequences (Figure 5.11). This gene class appears to be part of the 
Spi-2.1 family, based on transcript size (18S), reactive centre specificity (anti-tryptic), 
and sequence similarity to the contrapsin and rat Spi-2.1 genes. 
Two Conserved Spi-2 Functions in the Family Muridae. 
Two distinct expressed Spi-2 subfamilies had now been isolated from mouse, Apo-
demus, and rat. The putative inhibitory specificity of the genes appears to have been con-
served within each class, although in the Spi-2.2 subfamily the P1 residue is variable. 
This apparent functional stability may indicate that each class has a defined physiological 
role in vivo against a specific rodent proteinase. This is in contrast to the role evisaged 
for the contrapsin and rat Spi-2.1 proteins where selection by external (pathogenic) pro-
teinases was postulated to be responsible for their accelerated evolution. 
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Figure 5.11 Sequence of rat PCI-like cDNA (exon 5). The nucleotide and predicted 
amino acid sequences are shown for exon 5. Below, the protein sequences for the rat 
PCI-like cDNA (rpci-5), the Apodemus Clone 1 cDNA (Apo 1), and the mouse pMPCI-
2 (mpci-2) eDNA. Dashes represent identical residues. The position of the P1 residue is 
marked by an asterisk. 
V V H K V V L D V N E T G T E A A 
rpci-5 GTG GTC CAC AAG GTT GTG CTG GAT GTG AAT GAG ACA GGC ACA GAA GCA GCT 
A A T G A N L V P R S G R P P M I 
GCT GCC ACA GGA GCC AAT TTG GTC CCA CGT ACT GGA AGG CCA CCT ATG ATT 
V W F N R P F L I A V S H T H G 0 
GTG TGG TTC AAC AGG CCA TTC CTG ATA GCT GTC TCT CAC ACA CAT GGT CAG 
T I L F M A K V N N P W 
ACT ATC CTC TTT ATG GCC AAA GTC ATT AAC CCG TGG 
* 
rpci-5 VVHKVVLDVNETGTEAAAATGA NLVPRSGRPPMIVW FNRPFLIAVSHTHGOTILFMAKVNNPW 
Apo-1 	---- AN-K-A-K --------- V KF-F ---- V-T-T-R _D ---- MV ---- GVES --- FGTN 
mpci-2 ---- A ---- A ----------- F IFGF--RLQTTQ ------ HVIGVT ------ T-K 
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However comparative analysis of the sequences revealed several unusual features of the 
18S Arg-Ser gene evolution. Examination of the reactive centre P1' serine in the three 
rodent species showed that the serine was encoded by a different codon (TCT) in mouse 
than the corresponding codon in Apodemus and rat (AGT). To evolve from one codon 
to the other inevitably involves transient loss of the serine residue in this position, if 
mutations occur as single base changes. The loss of serine at the P1' position would be 
expected to have serious effects on inhibitor function, although other residues can be 
tolerated in certain circumstances (Stephens et al., 1988). However, mutation to the alter-
native serine codon could theoretically take place in one step by a gene conversion 
event. Further analysis was carried out on the rodent cDNAs to try to establish an evo-
lutionary descent for the 18S genes. 
Using a sense oligonucleotide primer to exon 4 (p54/X4+, see Figure 3.2), 
sequencing was carried out on the mouse and Apodemus 20S cDNAs, pEB22/5 and 
pAAC-8, and on the mouse, Apodemus and rat 18S PCI-like cDNAs, pMPCI-2, pAP-S 
and pRPCI-5. This provided sequence for 70% of exon 4 for these cDNAs, which are 
shown in figure 5.12 compared to the previously sequenced rat Spi-2.2 20S gene. An 
immediately striking observation was that a conserved serine codon in exon 4 showed 
the same codon type as the P1' residue in exon 5. For the rat PCI-like and Apodemus 
PCI-like sequences the codon was AGT, and for the other cDNAs, including mouse PCI, 
it was TCT. 
The exon 4 and exon 5 sequences of the rodent cDNAs including the rat Spi-2.1, 
rat 4.1213 and mouse contrapsin were used to generate phylogenetic trees using the PHY-
LIP computer program package. A number of equally parsimonious trees (not shown) 
were generated for the exon 4 sequences and for the exon 4 and 5 combined sequences, 
but only one for the exon 5 sequences alone. The trees showed clearly that the rodent 
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Spi-2.2 genes (mouse EB22/5, Apodemus clone 12 and rat Spi-2.2) form a clear subfam-
ily, and also that the rat PCI-like sequence, the rat Spi-2.1 and 4.12B sequences, and the 
Apodemus PCI-like sequence form a tightly clustered family. The position of the mouse 
PCI-like and contrapsin genes was more variable and their evolutionary relationships are 
therefore more ambiguous, although closely related to one another. Summarising all the 
tree data, together with the serine codon distribution, a model was developed for the 
evolution of the 18S (Spi-2.1) and 20S (Spi- 2.2) genes during rodent radiation (Figure 
5.13.). It appears likely that the mouse PCI-like gene may have undergone gene conver-
sion to the TCT serine codons after divergence from Apodemus. Contrapsin probably 
arose from the PCI-like gene after this conversion event, or may have been itself con-
verted. Similarly, the rat Spi-2.1 and 4.12B genes appear to have arisen from the rat PCI 
like sequence after rat and mouse divergence. These two genes have retained the AGT 
serine codons of their putative parental sequence. The model is undoubtedly simplistic, 
as short tracts of some cDNAs show similarities to sequences from separate subfamilies 
(see Figure 5.12). Evidently some sequence conversion has occurred in the evolution of 
the present day genes. The question of how the primordial, pre-rodent PCI-like sequence 
developed two AGT serines in separate codons is difficult to answer, but the timescale 
for this process may have been considerably longer than the twenty million years since 
rat and mouse diverged. 
The phylogenetic relationship of the genomic clone pcos2Bl/pS4A.-1-108 (Figure 
4.15) to the other Spi-2 sequences indicates that it may represent the primordial Spi-
gene (Figure 5.13). This gene may have surrendered its function following duplication, 
since the functional equivalent in rodents is probably the Spi-2.2 subfamily. 
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Figure 5.12 Nucleotide sequence of Exon 4 for 18S and 20S Rodent Spi-2 Genes. The 
sequences for six cDNAs are shown aligned below that of EB2215, the mouse 20S ul-
antichymotrypsin-like sequence. Dashes represent identity with the EB22/5 sequence. 
Mac = E1322/5, Aac = Apodemus clone 12, Rac = rat Spi-2.2, Mpc = pMPCI-2, Apc = 
Apodemus clone 1, Rpc = pRPCI-5. The conserved serine codon mentioned in the text is 
Mac TAC AGC CTG GAG CAT GTC CTT TCA AAG CTG GGC ATC AGG GAA GTC TTC TCC ACA 
AaC --- --- --- --- G-C A-- --C C-- G 
Rac --- --- --- --- G-C --- --- C-- G-- --- --- --- -AA --- -CT 
Mpc --- --- --- A-- G-C A-C --- C-- G-- --- --- --T -AA --- A-- --- --- -A- 
Apc --- --- --- --- G-C ------  --- G -- --- --- -- T -A - --- --- --- --- G--  
Rpc --- --- --- --- G-G ------C-- G-- --- --- --T -----T --- --- --- CAA 
Mac CAG GCT GAC CTG TCT GCA ATC ACA GGA ACC AAG GAT CTG AGA GTG TCT CAG 
Aac--- --- --- --- - -- C --T --- --- G-- -----C --- --- -- C --- ---  
Rac --- --- --- --- - - GG --------G GAT -----C --- -TG --- --- G--  
Mpc --A --- --- -- A --- -GG -----------------C -----T 
Apc --- --- --T --- AG- AGG G-- --G --G -----A --C -----T --C -----A 
Rpc--- --- -- T --- AG- AGG --------G G-- --- --C -----T --C ------ 
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Figure 5.13 Proposed Evolution of the 18S and 20S Spi-2 Genes in Rodents. Exons 4 
and 5 are shown for each extant gene, or putative precursor together with the actual or 
predicted serine codon state for each exon.Stages at which mammalian and rodent radia-
tion occurred are shown by a heavy dashed line. The putative gene conversion event is 
shown by an arrowed narrow dashed line. PCI refers to an 18S anti-tryptic inhibitor, and 
2.2 to a 20S antichymotryptic inhibitor. 
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Conclusions 
Analysis of expression of cloned genomic Spi-2 sequences was undertaken to 
establish which, if any, encoded actively transcribed (functional?) genes. Attempts to 
show expression of the DBA gene p54X-1-108 by Northern analysis and by screening of 
DBA liver eDNA libraries was unsuccessful. Expression of the 129 sequence pCos3E46 
was demonstrated by cloning of an identical sequence from a DBA liver cDNA library. 
This sequence, pMPCI-2 , resembles the related human PCI gene in the reactive centre 
region, but is clearly an Spi-2 gene. Northern analysis confirmed the Spi-2.1-like nature 
of the sequence, but gene- specific oligonucleotide analysis was unsuccessful. 
An Apodemus liver cDNA library was screened for Spi-2 sequences, yielding an 
orthologue of the rat valine-serine inhibitor Spi-2.2, and an orthologue of the mouse 
PCI-like sequence pMPCI-2. These were expressed at similar, low, levels. No evidence 
for an Apodemus conirapsin was obtained. 
A mouse EB22 (chondrocytic teratocarcinoma) cell line was screened non-
specifically for Spi-2 sequences. Two low abundance sequences were obtained. The tran-
script from the 129 genomic clone pCos2A2, a cys-cys reactive centre sequence, was 
cloned as A.EB22-3. This is the first cys- cys serpin shown to be expressed in any tissue, 
and may challenge their apparent pseudogene status. The second EB22 gene was a direct 
orthologue of the rat and Apodemus Spi-2.2 anti-chymotrypsin like sequences, with the 
interesting difference of a third P1 residue, leucine, in the reactive centre. This gene was 
shown to be expressed in the mouse liver, and to be inducible by Dexamethasone or 
bacterial lipopolysaccaride. It is almost certainly the functional rodent equivalent of 
human anti-chymotrypsin. 
In situ hybridisation of contrapsin antisense RNA to the 16-day mouse embryo 
supports the EB22 data, since expression was confined to chondrocytic tissue in the 
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developing animal. This may indicate an interesting and novel role for Spi-2 proteinase 
inhibitor genes in the control of skeletal tissue deposition. 
The existence of a rat PCI-like orthologue, deduced from the mouse and Apodemus 
PCI-like sequences and the general rodent Spi-2.2 orthologue, was demonstrated by the 
use of differential probing to isolate the rat sequence pRPCI-5. Analysis of this sequence 
indicates that it may represent an example of the primordial rodent Spi-2.1 sequence 
from which the mouse conirapsin and rat Spi-2.1 sequences arose independently, follow-
ing mouse/rat radiation. 
Finally, a model was developed for the evolution of expressed Spi-2 sequences in 
rodents (Figure 5.13). Following rodent/primate divergence, the primordial al-
antichymotrypsin-like Spi-2 gene (perhaps pcosB2?) duplicated to give the Spi-2.1 and 
Spi-2.2 subfamilies in the rodent lineage. The Spi-2.1 subfamily acquired an anti-tryptic 
PCI-like specificity before rodent radiation, and the Spi-2.2 sequences retained their 
antichymotryptic specificity. Following rodent divergence, the subfamilies have under-
gone further duplications, and exhibited accelerated reactive centre evolution during the 
acquisition of novel inhibitory specificities. 
CHAPTER SIX 
Expression of Cloned Spi-2 cDNAs 
Introduction 
A considerable amount of time during the project was spent attempting to produce 
functional inhibitor protein from cloned Spi-2 sequences. This was because arguments 
for accelerated reactive centre evolution in the gene family require an anti-proteinase 
activity for positive selection to act upon. The existence of several serpins whose physio-
logical role does not depend upon inhibition leaves open the formal possibility that the 
rodent Spi-2 sequences are essentially neutral in their reactive centre regions. An anti-
tryptic activity has been reported for the contrapsin protein (Takahori and Sinohara, 
1982) and possibly for the rat Spi-2.1-related sequence 4.12B (Le Cam et al., 1987). 
However it seems likely that the latter results were obtained with a mixture of the Spi-
2.1 and 4.12B proteins (Tecce et al., 1986; Yoon et al., 1987), and that the activity may 
have been derived from either or both genes. No inhibitory activity had been reported 
for the only other rodent Spi-2 protein characterised at this time, rat Spi-2.2. 
Several other serpin proteins have been successfully expressed recently in various 
prokaryotic (E. coli) and eukaryotic systems (yeast and mammalian cells). These include 
al-Proteinase Inhibitor (Courtney et al., 1984; Jallat et al., 1986; Johansen et al., 1987), 
a2-antiplasmin (Holmes et al., 1987), Plasminogen activator inhibitor (Pannekoek et al., 
1986), and human Cl inhibitor (Eldering et al., 1988). These studies have shown that 
while many serpins are extensively glycosylated in vivo, unglycosylated forms from 
prokaryotes show essentially no decrease in inhibitory activity. Expression of cloned 
genes in E. coli often requires less sequence manipulation, and this was therefore 
145 
146 
attempted first. Later efforts involved transient expression in mammalian COS cells, and 
in vitro translation of RNA produced from cloned cDNAs. 
Construction of a Complete Spi-2 Coding Sequence 
Initially, no full length cDNAs were available for use in expression studies, and 
various synthetically spliced constructs were produced from cDNA fragments. Efforts 
were concentrated on the rat Spi-2.1 gene partly because fragments covering most of the 
coding region were available, and because demonstration of contrapsin-like antitryptic 
activity would strengthen the argument for evolutionary orthology of the two genes. The 
strategy used to produce a full-length coding region from the fragments Dexl, Dex2, and 
a pair of synthetic oligonucleotides is shown in Figure 6.1. The final product, a DNA of 
1.2 kilobases, was cloned into the plasmid pSP64 and renamed pSPFL2.1 
Attempts to Express Inhibitor Protein in E. coli 
The cDNA from pSPFL2. 1 was inserted into two types of bacterial expression vec-
tor; ptac85 which utilises the tac fusion promoter for gene expression (Marsh, 1986) and 
the pJLA plasmid series which employ a tandemPL/PR promoter system (Schauder et 
al., 1987). The tac is a hybrid of the trp and lac bacterial promoters, and more closely 
approaches the consensus promoter sequence than either donor sequence (de Boer et al., 
1983). As a result, it is a more efficient promoter than either trp or lac, but is efficiently 
suppressed by the 1acI repressor protein in the absence of an inducing molecule such as 
0-galactosidase or the synthetic analogue IPTG. This promoter repression prevents 
expression of foreign sequences in the ptac85 plasmid which carries the lacI gene to 
ensure that no "leaky" expression occurs, even with a high plasmid copy number. 
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Figure 6.1 Strategy for construction of full-length Spi-2.1 coding sequence. The extent 
of the pDexl and pDex2 clones are shown below the predicted complete Spi-2.1 tran-
script, expected to be extemely similar to the 4.12B cDNA (Tecce et al., 1986). Coding 
regions of the transcript are stippled rectangles, untranslated regions are open rectangles, 
and the reactive centre region (RC) is shown as a dark rectangle. Inserts are shown as 
dark bars in the circular plasmids and the orientation of promoters by thin, right angled 
arrows. 
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The pJLA expression vector series is an extremely efficient system for producing 
high (up to 30%) levels of heterologous protein in E. coli (Schauder et al., 1987). The 
pJLA plasmid contains the bacteriophage ? P and P R  promoters in tandem, giving enor-
mous levels of transcription, and also expresses the heat-sensitive C1257 mutant of the ? 
repressor protein ensuring that bacterial growth at 30 °C occurs without gene expression. 
Raising the culture temperature to 42 °C destroys the mutant repressor and permits the 
expression of cloned sequences, at high levels. 
Unfortunately, neither vector system ever produced detectable amounts of recom-
binant protein. Detection was hampered by a number of technical problems. No antibody 
was available to detect Spi-2.1 expression and, in the absence of a established inhibitory 
assay, Coomassie staining of cell lysates to detect de novo expression will not reveal 
protein levels below about 1% of total cell protein. Since E. coli possesses major protein 
bands at the same mobility (about 43 kD) as the expected inhibitor, this made detection 
by eye virtually impossible. Pulse labelling of heat-induced pJLAJSpi-2. 1 containing 
clones with 35S-methionine for two minutes showed no evidence of increased expression 
in proteins of the expected size range (Figure 6.2). Attempts to detect inhibitory activity 
in bacterial lysates using standard methods gave negative results. Either the rat Spi-2.1 
gene lacks inhibitory activity for the proteases tested (trypsin, thrombin, plasmin, chymo-
trypsin and elastase), or the constructs were deficient, perhaps in transcription, or post-
translational processing of inhibitor protein. The protease-deficient E. coli strain CAG 
629 was used to counteract possible inhibitor degradation, but did not produce detectable 
levels of inhibitor. 
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Figure 6.2 Pulsed-labelling of E.coli proteins with 35S-Methionine. Lane 1: pJLF20 
uninduced (growth at 300C), 2: pJLF20 induced (growth at 42 °C for 10 minutes), 3: 
pJLF19 umnduced, 4: pJLFI9 induced, 5: pJLF21 uninduced, 6: pJLF21 induced. The 
three plasmids represent independent isolates of the putative full-length Spi-2.1 spliced 
construct. No induction of protein in the 45kD range is observed for any construct. The 










The vectors used have been shown to yield high levels of expression (5% - 30% of 
total cell protein) under optimal conditions, with appropriate eukaryotic sequences 
(Schauder et al., 1987). However it is difficult to predict in advance the suitability of a 
particular sequence and dramatic increases in expression can be obtained by deletion or 
mutation of short (15-30 base pairs) regions at the 5' end of the inserted DNA (Johansen 
et al., 1987). This is not always due to a simple disruption of a stable secondary mRNA 
structure. 
Inhibitor Expression by in vitro Translation 
To determine whether the pSPFL2.1 gene contained an open reading frame capable 
of encoding an inhibitor protein, the pSPFL2. 1 plasmid was linearised with Barn HI to 
produce a template for SF6 RNA polymerase (Krieg and Mellon, 1984). RNA was tran-
scribed from the 5' SF6 promoter using the di-nucleotide analogue pGpppGTP to gen-
erate a "cap" structure at the 5' end of the in vitro message (Contreras et al., 1982). The 
RNA was then translated using a rabbit reticulocyte lysate system and 35S-methionine to 
produce radiolabelled inhibitor protein. This was electophoresed on an 
SDS/Polyacrylamide gel, and proteins visualised by autoradiography. An example of a 
gel is shown in Figure 6.3. This shows that a single polypeptide of approximately 43 kD 
was translated from the pSPFL2. 1 encoded RNA. This was of the size expected for a 
full-length inhibitor, and indicated that the Spi-2.1 construct contained an open reading 
frame of the correct size. Incubation of radiolabelled protein with the proteinases trypsin, 
thrombin, plasmin, chymotrypsin and elastase failed to show interaction of inhibitor and 
proteinase. This may have been due to "swamping" of the proteinase by reticulocyte 
lysate proteins, and poor interaction between proteinase and inhibitor. Even at high pro-









Figure 6.3 Expression of Spi-2.1 protein in a reticulocyte lysate system. Lane 1: No 
mRNA (control), 2: Spi-2.1 mRNA - degraded pGpppG, 3: Spi-2.1 mRNA + degraded 
pGpppG, 4: Spi-2.1 mRNA - undegraded pGpppG, 5: Spi-2.1 mRNA + undegraded 
pGpppG, 6: degraded Spi-2.1 mRNA + undegraded pGpppG. Spi-2.1 protein can be seen 
in lanes 2, 4 and 5. The position of molecular weight standards in kiloDaltons are shown 
on the left. The inhibitory effect of degraded cap analogue upon yield of active RNA 
transcripts is obvious. 
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A second inhibitor construct was produced at this stage. The 3' coding sequence of 
the human al-antichymotrypsin gene (Hill et al., 1984) was fused to the 5' pSPFL2.1 
coding sequence at the unique Dra I restriction site common to both sequences. This 
chimaera would be expected to encode an inhibitor with the anti-chymotryplic 
specificities of the human gene if it was active. To establish that this construct, pCHEX, 
contained an open reading frame, it was translated in the reticulocyte lysate system used 
for pSPFL-2. 1. This also produced a single protein band of similar mobility to the Spi-
2.1 protein (not shown). Again, interaction with the proteinases mentioned above could 
not be demonstrated. 
A final attempt to produce inhibitor protein from the reticulocyte lysate system was 
carried out using the Apodemus full-length cDNA clone pAP3. This clone encodes the 
Apodemus PCI-like protein described in chapter 5, but in the opposite orientation, to 
enable T7 RNA polymerase transcription of insert sequences. It was considered that con-
struction of the pSPFL-2.1 and pCHEX clones might have introduced structural errors 
into the sequences, and that these might be avoided by using an intact unmodified inhibi-
tor cDNA. Protein of the correct size was produced from in vitro translation of pAP3-
encoded RNA, but incubation with the serine proteinase bovine Kallikrein did not show 
appreciable modification of inhibitor, even at high proteinase concentrations (not shown). 
The in vivo target for this inhibitor is unknown, but it was felt that kallikrein might 
represent a suitable target proteinase in terms of specificity. Unfortunately, trypsin, 
thrombin and plasmin which also demonstrate specificity for an arginine P1 residue were 
not tested with this inhibitor. 
Attempts to Express Inhibitors in Mammalian Cells 
The cDNA inserts from pSPFL2. 1 and pCHEX were cloned into the eukaryotic 
expression vector pSVL (Pharmacia) and transfected into a transformed African Green 
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Monkey kidney cell line (COS cells). This cell line constitutively expresses large 
amounts of SV40 T antigen, and will express heterologous sequences linked to the SV40 
late promoter at high levels. It was felt that the proteins expressed by reticulocyte lysate 
might lack a functionally important post-translational modification, although successful 
expression of active serpins in E. coli would argue against this. COS cells were 
transfected with pSVL/inhibitor constructs by the DEAE-Dextran and calcium phosphate 
techniques (McCutchan and Pagano, 1968; Graham and van der Eb, 1983) and allowed 
to recover in serum-free supplemented medium for 72 hours. Aliquots of cell extract, 
and of serum- free medium were then tested for the presence of inhibitory activity for 
the proteinases trypsin and chymotrypsin. All proved negative compared to control 
vector-only extracts. These experiments were not repeated, and were unlikely to have 
been optimal for inhibitor expression. Antisera to human al-antichymotrypsin (from 
SAPU) were used to probe a Western blot of pCHEX COS cell extracts and medium 
(assistance from P. Budd), since this sequence contains the 3' coding sequences from the 
human gene. No specific signal was obtained however. This may have been due to the 
fact that the construct was not expressed in COS cells, or because the rat/human gene 
fusion has destroyed the specific epitopes recognised by the human specific antisera. 
Conclusions 
Attempts were made to express cloned Spi-2 inhibitors in a variety of systems, and 
to test the inhibitory specificity of proteins produced. Initially, no full-length clones 
were available and extensive fragment manipulation was required to produce suitable 
sequences. These were tested in several E.coli systems but expression was never 
detected. Translation of RNA produced in vitro by a reticulocyte lysate system did pro-
duce polypeptides of the expected size, but these did not exhibit interactions with the 
common proteinase types tested. Transfection of constructs into mammalian COS cells 
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This thesis describes the analysis of the evolution of an Spi-2 gene, contrapsin, in 
the genus Mus and the structure and expression of the Spi-2 locus in the inbred labora-
tory mouse. The major findings can be summarised as follows. The accelerated evolu-
tion in the reactive centre region of the contrapsin gene appears to have occurred over a 
comparatively short period of time, followed by stasis when the inhibitor acquired a use-
ful specificity. Consideration of closely related rat sequences indicate that the mode of 
divergence may be via point mutation, or very restricted gene conversion events, in the 
reactive centre region. Analysis of genomic and additional expressed sequences indicates 
that more extensive sequence conversion may have occurred in some genes, obscuring 
phylogeny to some extent. Certain inhibitory specificities appear to have been retained 
since before rodent radiation, while other novel species-specific reactive centre 
specificities have arisen following recent gene duplications. 
The evolution of contrapsin 
The starting point for the project was the observation by Hill and Hastie (1987) 
that the reactive centre regions of cloned rodent Spi-2 sequences were behaving in a 
highly unusual fashion. The precise relationship of the genes to each other was not fun-
damentally important in this analysis, since the sequence divergence observed was so 
clearly localised to Region 2 (reactive centre) and to a lesser extent Region 3. However 
several lines of evidence indicated that the mouse conirapsin and rat Spi-2.1 were 
directly orthologous, including shared transcript size, putative inhibitory specificity, and 
similar levels of abundance in the rodent liver. In spite of this, their reactive centre 
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sequences were only aligned with difficulty and showed an identity of 33% for Region 2 
(compared to 84% for Region 1 and 75% for Region 3). The analysis of the contrapsin 
reactive centre sequence in the mice species closely related to the M. domesticus/M. 
musculus derived inbred mouse strains was expected to show a reduced but still detect-
able degree of divergence. The virtually complete fixation of the sequence (Figure 3.5) 
in the ancestor of Mus domesticus and Mus caroli was not expected, especially as 
Region 3 is continuing to evolve at a comparatively rapid rate relative to albumin. Con-
trapsin appears to have acquired a function soon after its appearance as a highly 
expressed liver gene (Figure 3.8), and a specificity which has remained unaltered over 
the last six to eight million years. 
The above arguments have assumed that contrapsin actually has an inhibitory role, 
but serpins can adopt other functions such as hormone transport (Hammond a al., 1987) 
or undergo proteinase cleavage o yield vaso-active or chemoattractant peptides (Banda 
et al., 1988; Hoffman a al., 1989). A non-inhibitory function might be less likely to 
select for an unchanging reactive centre sequence, and would not explain the stabilisation 
of the conirapsin reactive centre relative to Region 3. Conceivably, a non-inhibitory but 
anti-parasitic function for contrapsin could still depend upon a specific "inhibitor"-
proteinase interaction, in which case arguments for accelerated evolution would remain 
valid. There is indirect evidence that contrapsin may have an involvement in the mouse 
host response to parasitic infection, since schistosomes isolated from infected mice are 
associated with antigen which crossreacts with conirapsin-specific antibodies (Mohda et 
al., 1988). In addition, contrapsin with altered electrophoretic properties (presumably 
cleaved) is found in the serum of infected mice. This may well indicate a host-
inhibitor/parasitic-proteinase interaction, but this remains unproven since schistosome 
flukes are known to incorporate host proteins into their membranes, presumably to evade 
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the hosts immune response (McClaren and Terry, 1982; Simpson et al., 1983). It is possi-
ble, although highly unlikely, that contrapsin actually facilitates parasitic infection in this 
manner. 
The discovery of a well conserved Spi-2 function, the 18S PCI-like gene, in 
mouse, Apodemus and rat during the project raises the question of whether contrapsin 
and rat Spi-2.1 are true orthologues, or whether both sequences arose independently from 
the common parental PCI-like sequence after rat/mouse divergence. Certainly the intra-
species similarities are greater for the two gene pairs, but this might be due to sequence 
conversion events rather than a reflection of divergence time. The fact that Apodemus 
does not express an abundant 18S anti-tryptic type transcript also supports the idea of 
independent acquisition of the contrapsin'Spi-2.1 function. (This raises the additional 
question of why Apodemus does not require the contrapsin function). If it is true that the 
abundant rat and mouse liver Spi-2 sequences represent independently derived functions 
from the PCI-like gene, then the accelerated reactive centre divergence noted by Hill and 
Hastie actually occurred in a considerably shorter period than they assumed in their ori-
ginal calculation. Taking into account the stasis of the contrapsin reactive centre for the 
last six to eight million years, this considerably increases the already rapid rate of con-
trapsin reactive centre centre divergence 
The contrapsin sequence analysis failed to indicate the nature of mutations in the 
reactive centre region since so few were discovered. Comparison of the Mus domesticus 
and Mus caroli contrapsin sequences did reveal a high ratio (4:1) of nonsynonymous to 
synonymous substitutions in Region 3. As observed in Chapter 3, rapid divergence of 
the carboxyl terminus (Region 3) seems to be a general feature of serum serpins even in 
the absence of reactive centre divergence. The nature of reactive centre divergence is 
shown more clearly by comparison of the rat Spi-2.1 and 4.12B genes (Figure 3.13). 
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These sequences can be aligned with more confidence than contrapsin and rat Spi-2.1 
and show that the mechanism of divergence appears to involve multiple nonsynonymous 
point mutations, although some clustering of substitutions is apparent. Although the two 
genes are very closely related in Region 1, and would certainly seem to have arisen from 
a gene duplication event after mouse/rat divergence, Region 2 and Region 3 display a 
large number of amino acid substitutions, and a substantial (9 basepair) deletion. It is 
possible that one of the genes has become inactivated, although at least one of the two 
encodes an anti-tryptic inhibitor (Le Cam et al., 1987). This activity was reported for the 
4.1213 encoded protein, but the purification strategy probably co-isolated both rat pro-
teins. Certainly the 4.12B sequence resembles more closely an Spi-2 consensus with 
regard to conserved residues and reactive centre length (Figure 3.13). 
The Spi-2 locus in the laboratory mouse 
The isolation and physical linking of ten Spi-2 sequences, and sequencing of nine, 
from the mouse genome would be expected to reveal much of the locus complexity and 
evolution of this gene family. This is true to an extent, but the analysis leaves several 
questions about the precise mode of amplification unanwered. Two genomic sequences 
were later found to have expressed transcripts, isolated from cDNA libraries, but again 
two cDNAs exist for which no genomic counterpart was cloned (contrapsin and 
EB22/5). The evolutionary range of Spi-2 sequences cloned was wide enough to include 
either sequence, and their absence may be due to under- representation in the libraries 
analysed rather than radically different genomic structure or isolation from the rest of the 
family. 
The amplification of the Spi-2 locus certainly seems to be of recent origin in the 
mouse. The relatedness of the "cys-cys cluster" of genes at one end of contig 1 is pro- 
nounced, but is not due to clear-cut gene conversion events. The distinct lack of repeated 
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sequences detectable by hybridisation may also indicate recent amplification. Unfor-
tunately, no simple mechanism for the amplification which can account for gene orienta-
tion, sequence relationships and pattern of gene expression was established. A definitive 
description of the amplification process will require the isolation of the remaining Spi-2 
genomic sequences (at least two), further sequencing analysis of different gene regions, 
and probably analysis of the locus in related species such as Mus spretus, Mus caroli 
and Apodemus .sylvaricus. 
Examination of reactive centre sequences from the genomic clones indicates that 
divergence is occurring primarily in the reactive centre region and, to a lesser extent, 
Region 3 (Figure 4.13b). This process is probably not a result of the intron/exon struc-
ture of the genes, and does not appear to be due to whole-exon sequence conversion 
events, given the diversity of the reactive centres. The main conclusion from the 
genomic analysis is that the putative functional domain in this multigene family is hyper-
variable (Figure 4.13), and that evolution has generated a range of expressed and poten-
tially expressed novel inhibitory specificities. 
One possible model is that all of the genes are expressed, and are under selection 
for retention of inhibitor structure motifs, as well as for diverse reactive centre 
specificities. Expression was only established for two genomic sequences (pcos3E46 and 
pcos2A2), and in the case of the latter sequence was so low that the presence of other 
Spi-2 sequences at similar levels might go undetected. However, exhaustive attempts to 
isolate the p54A-1-108/pcos2B1 leu-ser sequence from the liver failed. Three of the 
129/St strain genomic sequences (pcoslAl, pcos6Al, and especially pcos3E2) seem 
highly likely to represent pseudogenes since they have unfavorable mutations in the con-
served reactive centre-flanking domains. However, no termination codons, or frameshift 
mutations were detected in either exon four or exon five of any Spi-2 sequence during 
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the project. 
Perhaps a more likely scenario is that only a subset of the genes are active (or at 
least under selection). Their presence in the Spi-2 cluster, and selection for retention of 
the critical conserved structural motifs flanking their reactive centres could in turn select 
for homogenisation of the non-expressed sequences to a functional structure sequence in 
these domains. A possible example of this type of localised conversion is the presence of 
a lysine P16 codon in Region 1 of both Apodemus cDNAs (Figure 5.5), as this residue 
is threonine in all other Spi-2 sequences bar one. Reactive centre regions do not appear 
to be homogenised in the same fashion. This suggests a potential analogy with the 
storage of the chicken A.-light chain immunoglobulin repetoire in a pseudogene pool 
(Reynaud et al., 1989), although Spi-2 diversification would occur at a far lower fre-
quency, and in the germline rather than as a somatic process. A combination of point 
mutations and restricted directional sequence conversion events could develop a pool of 
novel reactive centre specificities in silent genes. These could then transfer into 
expressed genes at low frequencies by conversion events, to await selection by protei-
nases with novel specificities. The episodic nature of parasitic invasion of a species 
might even favour low-level expression of "silent" genes as they accumulated novel 
reactive centre mutations. There would be some degree of endogenous selection against 
unbridled development of new inhibitory specificities in expressed genes, as these could 
interfere with important endogenous proteinase-mediated cascades. The al-antitrypsin 
Pittsburgh mutation described in Chapter 1 is an example of this type of selection. 
Expression of Spi-2 genes in the laboratory mouse 
It seems clear that the two Spi-2 transcript types isolated from mouse, Apodemus 
and rat represent genes which were present before rodent radiation, and which have rela- 
tively stable endogenous functions. These are the putative al-antichymotrypsin (or Spi- 
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2.2) orthologue with a 20S transcript, and the PCI-like (or Spi-2.1) anti-tryptic 18S tran-
script. Both classes have undergone different evolutionary events since rodent radiation, 
despite probable retention of their Original function(s). 
The Spi-2.2 genes are good candidates for the role of functional human Cd-
antichymotrypsin orthologue for a number of reasons. In the mouse and rat at least, they 
are inducible by inflammatory stimuli such as bacterial lipopolysaccharide treatment, and 
also by dexamethasone. They are expressed in the liver at fairly low constitutive levels 
in all three rodents examined. The reactive centre of the mouse gene, EB22/5, is con-
served in Mus cervicolor which diverged six to eight million years ago (Figure 5.4), a 
similar degree of stabilisation to that of contrapsin. The inhibitory specificity appears to 
have been relatively conserved throughout murid radiation, although the P1 is different 
in mouse, Apodemus and rat. The Apodemus (leucine) and rat (valine) P1 residues are 
conservative differences and should cause very little difference in specificity, as the 
human gene also has a leucine P1 residue. The mouse P1 residue, methionine, is also 
compatible for a chymotrypsin-type inhibitor (Potempa et al., 1988), and could have 
arisen from the primordial (leucine?) codon by a single point mutation. It was an unex-
pected P1 residue, since the considerably more abundant al-PI serum inhibitor (P1 
methionine) might be expected to perturb the physiological function of the EB22/5 
encoded protein. However, inhibitory specificity is not entirely dependent upon the iden-
tity of the P1 residue, and the two sequences display little identity in flanking reactive 
centre sequences. The remainder of the exon 5 amino acid sequence for the Spi-2.2 gene 
in the three rodent species shows a high degree of conservation (Figure 5.6b) 
The role of the Spi-2.2 anti-chymotryptic inhibitors is unknown, as is that of their 
proposed functional human orthologue cxl- antichymotrypsin. The target proteinases for 
this inhibitor are thought to be "mast cell chymase" and neutrophil cathepsin G, both 
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proteinases with a nebulous physiological role at present (Wintroub et al., 1981; Reilly 
et al., 1982). They are likely to have a role in response to parasitic infection or 
inflammation, given their sites of expression. A function in the control of the 
inflammatory response is also likely for the inhibitor since its levels rise rapidly in 
response to physiological insult (Fey and Fuller, 1987). Cathepsin G may have a role in 
tissue remodelling since it can degrade connective tissue proteins such as collagen and 
proteoglycans (Roughley and Barrett, 1977). This could account for the originally 
discovered site of EB22/5 expression, in chondrocytic-type tissue in the 16 day mouse 
foetus (Figures 5.8 to 5.10). Deposition of skeletal tissue during development might 
depend upon inactivation of proteinase activity while ossification occurs at bone and 
joint margins. This is an attractive, if extremely simplistic, scenario. 
The second Spi-2 sequence isolated from the EB22 cell line, EB22/3, had previ-
ously been observed as a genomic sequence in both DBA and 129 inbred mice. It con-
tains the unusual cysteine-cysteine P1-F1' sequence, and had been considered likely to 
be a pseudogene until its isolation as a full-length cDNA. The EB22/3 gene clearly falls 
into the Spi-2.2 subfamily in terms of transcript size (20S), and sequence relatedness to 
the (primordial?) Spi-2.2 anti-chymotryptic sequence, EB22/5. It is one of the most 
recently duplicated Spi-2 sequences, in the "cys-cys cluster" at the end of Contig 1 (Fig-
ure 4.12 and 4.15). The level of expression in the EB22 cell line is similar to that of the 
EB22/5 gene, at about 0.002% of independent cDNA clones. The nature of the activity 
encoded by the EB22/3 sequence is not known. Considerable selective pressure seems to 
exist for a serine residue at the P1' position in the majority of inhibitory serpins, 
although a2-antiplasmin contains a methionine P1' residue (Holmes et al, 1987). A 
deleterious condition involving substitution of leucine for serine at the P1 residue has 
been described, for antithrombin Denver (Stephens et al, 1987). A study employing 
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site-directed mutagenesis to exchange the antithrombin P1' serine residue for alternative 
amino acids indicated that a cysteine in this position reduced inhibitory activity by two 
orders of magnitude (Stephens et al., 1988). This might indicate that the EB22/3 
sequence is not a functional inhibitor. However the same study demonstrated complete 
abolition of antithrombin activity when methionine was substituted for serine, yet 
methionine occurs in the a2-antiplasmin P1' position. Definite evidence of the inhibitory 
capacity of the cys-cys EB 22/3 sequence will require expression and testing of the pro-
tein, perhaps in vitro. 
The second Spi-2 gene found in all three rodent species was the PCI- like 18S 
anti-tryptic transcript. This sequence has undergone an entirely different type of evolu-
tion following rodent divergence. In contrast to the Spi-2.2 antichymotryptic class, the 
P1 residue (arginine) has remained constant, but more extensive differential sequence 
conversion appears to have occurred in the reactive centre and Region 1 (Figures 5.12 
and 5.13). It seems likely that this gene gave rise to the abundantly expressed rat Spi-2.1 
and 4.1213 genes and the mouse contrapsin gene independently after the two species 
diverged. As in the case of the Spi- 2.2 genes, the function of the gene is unknown. The 
similarity of the mouse reactive centre sequence to human protein C inhibitor (Figure 
5.1) may be coincidence, or indicate the actual function of this subfamily. Sequencing 
data indicates that the rodent genes were derived from the primordial Cd-
antichymotrypsin rather than PCI lineage and, unless an unusual interfamily sequence 
conversion has occurred, this could conceivably represent a case of convergent evolution. 
Future directions 
This project has unavoidably left several questions about the evolution and expres-
sion of the Spi-2 locus unanwered. Approaches to answering some of these will be 
briefly discussed below. 
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Determination of the degree of polymorphism of the contrapsin reactive centre 
within a species is a problem that might be relatively simply addressed by RNA 
sequencing or a PCR sequencing approach. This was not undertaken due to lack of time, 
and the absence of a suitable mouse population. The demonstration of polymorplistv 
within a species could indicate that a number of alleles of any one inhibitor gene existed 
in a species to provide a range of specificities against parasite proteinases. Frequency 
dependent selection would ensure that none of these alleles were likely to be fixed, and 
their continuing presence in the gene pool would permit reactive centre targeted gene 
conversion events to generate novel specificities. This scenario has been proposed for the 
MHC (Howard, 1988). However the remarkable similarity of all contrapsin reactive cen-
tres sequenced, in inbred and wild mice as divergent as Mus domesticus and Mus caroli, 
may indicate that the sequence would show very little intraspecific polymorphism. 
If the contrapsin gene is truly restricted to mice which diverged from a common 
post-Apodemus ancestor around eight million years ago, analysis of a second expressed 
Spi-2 gene might extend the analysis throughout Mus. Either the Spi-2.2 or PCI-like 
sequences should be suitable for a cDNA/PCR based approach. The uncertain nature of 
the PCI-like gene evolution since rodent divergence would make this a doubly interest-
ing analysis. 
The precise association between the Spi-1 and Spi-2 loci is of interest given their 
close linkage in man (P. Kearney, personal communication) and the fact that at least 
some Spi-2 sequences map to the Spi-1 rather than the Spi-2 locus in the BXD recom-
binant inbred strain series (Figure 4.6). This might be most conveniently addressed by 
pulsed field analysis, using locus-specific probes. Tight linkage of the complexes might 
increase the likelyhood that Spi-1/Spi-2 hybrids could arise at the interface, allowing 
novel patterns of expression and novel specificities to flow between the two gene fami- 
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lies. The internal structure of the two complexes appears to differ, since the Spi-1 locus 
appears to contain fewer distinct sequences (Hill et al., 1985). Analysis of cosmids con-
taining Spi-1 sequences during the present work indicated that the mouse Spi-1 genes are 
more widely separated than their Spi-2 counterparts, with a maximum of one per cosmid. 
The relation of the human protein C inhibitor (PCI) to its putative rodent ortholo-
gue would also be of interest in determining the history of the Spi-2 locus. This 
sequence is more closely related to al- antichymotrypsin (Spi-2) than al-proteinase 
inhibitor (Spi-1), but probably diverged from cxl-antichymoirypsin before rodent radia-
tion (Suzuki et al., 1987). Whether it remains as a distinct lineage in rodents is unk-
nown. The mouse Spi-2 sequence pcos3E-46 shows striking similarities to human PCI in 
the reactive centre region (Figure 5.1). The question of whether the human PCI sequence 
has become subsumed into the Spi-2 lineage, donating its reactive centre but losing its 
separate identity, might be anwered by analysis of the mouse genomic clones with the 
human PCI probe. If the rodent equivalents of the human PCI and al-antichymotrypsin 
genes have intermingled to form a hybrid Spi-2 locus, unravelling the evolutionary ori-
gins of any one gene may prove impossible. 
To determine the recent evolutionary history of the Spi-2 locus, an analysis of the 
genomic structure and arrangement of Spi-2 sequences in species such as Mus spretus 
and Mus caroli could be carried out. This might establish the relative importance of gene 
conversion in the evolution of the locus, and. could shed light on possible intermediates 
in the amplification process. 
Determining the anti-proteinase specificities of the characterised inhibitors will be 
an essential next step in the analysis of the Spi-2 locus evolution, since the reactive cen-
tre evolution arguments depend on inhibitor function. Chapter six described attempts to 
express and characterise active inhibitors, largely in vain. Determining the in vivo pro- 
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teinase target for the cloned inhibitors may not be possible until more is known about 
the range of serine proteinases in the mouse. The existence of the kallikrein multigene 
family on mouse chromosome seven is interesting in this respect The kallikreins are ser-
me proteinases with highly specific cleavage sites, thought to be involved in the process-
ing of bioactive peptides from protein precursors (Mason et al., 1983). The family has 
become amplified in the mouse by a series of tandem duplications and about twelve (of 
twenty four) sequences in the locus appear capable of encoding active proteins (Evans et 
al., 1987; Drinkwater et al., 1987). They show hypervariability in residues flanking the 
catalytic cleft, and it is tempting to speculate that they might be co- evolving with the 
Spi-2 locus (Creighton and Darby, 1989). 
A collaboration with H. Miller (Moredun Institute, Edinburgh) has been established 
to determine whether any cloned rodent Spi-2 sequences represent functional inhibitors 
of the rat mast cell chymase II. This proteinase is induced to extremely high levels dur-
ing infection by Nippostrongylus sp. nematodes and has been shown to form an SDS-
resistant complex with a component of rat or mouse serum (H. Miller, personal com-
munication). Given the cleavage specificity of the chymase (hydrophobic P1 residue), 
and the suggested association of human al-antichymotrypsin with human mast cell chy-
mase, the conserved rodent Spi-2.2. protein is an attractive candidate inhibitor. 
Finally, the use of in situ hybridisation to locate expression of specific Spi-2 tran-
scripts in different tissues at different stages of development would be a powerful 
method for continued analysis of the family. The preliminary work described in Chapter 
Five revealed the unexpected expression of inhibitors in foetal cartilage, using a non-
specific probe. It is possible to use sequence-specific oligonucleotide probes to detect 
transcripts at low abundance with the in situ hybridisation technique. This could be 
undertaken with a range of adult tissue, as well as stages of foetal development, and 
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could be used to detect changes of Spi-2 expression in rodents exposed to parasitic and 
inflammatory stimuli. 
ABBREVIATIONS 
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cDNA. complementary deoxyribonucleic acid 
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